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Abstract 
Pharmaceuticals can interact with sunlight to cause skin photosensitization and increase 
skin cancer risk. Interaction of drug molecules with solar UVA or visible radiation 
results in electronically excited states that damage biomolecules directly or indirectly via 
the formation of reactive species (RS). RS cause damage to DNA and its precursors, as 
well as to proteins and lipids.  
 
I have devised methods to examine the induction of oxidative protein damage in 
cultured human cells and used these to investigate the effects of UVA-activated 
photosensitizing drugs on the formation of protein carbonyls and the oxidation of 
protein thiol groups. I examined the effects of 6-thioguanine (6-TG) (a surrogate for 
azathioprine, an immunosuppressant), fluoroquinolone antibiotics, and the malignant 
melanoma therapeutic vemurafenib, each of which is associated with clinical skin 
photosensitivity and increased skin cancer risk in patients. All of these drugs are shown 
to be synergistically cytotoxic with UVA in cultured human cells and toxicity is 
concurrent with the generation of RS. I identify singlet oxygen as a major component of 
these photochemically-generated RS and show that widespread protein oxidation is 
caused.  
 
The Ku DNA repair heterodimer is identified as one of several targets for oxidation 
damage and I show using biochemical assays that damage to Ku compromises its 
function in the repair of DNA strand breaks. UVA irradiation of cells treated with the 
photosensitisers significantly compromises the removal of potentially mutagenic DNA 
lesions by the nucleotide excision repair pathway. Since this DNA repair pathway 
removes sunlight-induced DNA lesions and is the major protection against skin cancer, 
my findings have implications for the increased skin cancer risk associated with 
azathioprine. The ability of structurally dissimilar drugs to recapitulate the effects of 6-
TG suggests that the observations may share a common mechanism. 
  4 
Acknowledgement 
First and foremost, I’d like to express my gratitude to Dr Peter Karran for his 
unwavering support and guidance over the past four years. His patience, generosity and 
good humour made working in his lab an absolute pleasure from start to finish. I’d also 
like to thank him for introducing me to the sport of racketball and graciously letting me 
win to build my confidence. Secondly, I’d like to thank my thesis committee members 
Drs Simon Boulton and Yao Zhong Xhu for their support and for helpful suggestions 
throughout my PhD. 
 
I’d especially like to thank the members of the Karran lab, past and present, for creating 
a fantastic working environment. Drs Quentin Gueranger and Reto Brem deserve 
special mention for dealing with an incompetent chemist with good grace and teaching 
me all of the techniques I used to carry out the work detailed herein. Mr Peter 
MacPherson was always willing to offer a helping hand despite having a packed 
schedule of his own. The company of Dr Lizzy McAdam-Gray and Miss Melisa Guven 
made my final two years in the lab far more enjoyable than they had any right to be. I’m 
especially grateful to Melisa for heroically polishing off the communal chocolate in a 
noble attempt to protect my waistline. My work stems from initial observations made by 
Drs Feng Li and Beatriz Montaner to whom I am also indebted.  
 
I’m grateful to many other members of Clare Hall for their assistance. LRI Core 
Services, especially Cell Services, as well as the Clare Hall lab aides and admin staff, 
ensured that my working life ran as smoothly as possible. Dr David Frith was 
instrumental in the initial stages of the project. Mr Mark Johnson was always on hand to 
offer cheerful assistance despite possibly being the busiest person in Clare Hall. Rafal 
Lolo, in addition to being a great friend and driving companion, sacrificed many hours 
of his life to teach me how to use a microscope. 
 
Finally I’d like to thank my Mum and grandparents for their continued love and support. 
Any success I’ve enjoyed is due to the start in life they gave me and I’ll always be 
grateful to them.  
 
  5 
Table of Contents 
UVA	  Photosensitisers,	  Protein	  Oxidation	  and	  DNA	  Repair	  .....................................	  1	  
Abstract	  ....................................................................................................................................	  3	  
Acknowledgement	  ................................................................................................................	  4	  
Table	  of	  Contents	  ..................................................................................................................	  5	  
Table	  of	  figures	  ......................................................................................................................	  9	  
List	  of	  tables	  ..........................................................................................................................	  12	  
Abbreviations	  .......................................................................................................................	  13	  
Chapter	  1.	   Introduction	  .................................................................................................	  15	  
1.1	   Oxygen	  and	  reactive	  oxygen	  ..........................................................................................	  15	  1.1.2	   Hydroxyl	  Radical	  ........................................................................................................................	  16	  1.1.3	   Hydrogen	  Peroxide	  ...................................................................................................................	  18	  1.1.4	   Superoxide	  ....................................................................................................................................	  20	  1.1.5	   Singlet	  Oxygen	  .............................................................................................................................	  22	  1.1.6	   Other	  Cellular	  Reactive	  Species	  ...........................................................................................	  24	  
1.2	   The	  actions	  of	  reactive	  species	  in	  cells	  ......................................................................	  25	  1.2.1	   Oxidative	  Stress	  ..........................................................................................................................	  25	  1.2.2	   Consequences	  of	  oxidative	  stress	  .......................................................................................	  25	  1.2.3	   Damage	  to	  cellular	  components	  ..........................................................................................	  27	  
1.3	   DNA	  Repair	  ..........................................................................................................................	  33	  1.3.1	   DNA	  Damage	  by	  RS	  ...................................................................................................................	  33	  1.3.2	   Non-­‐RS	  DNA	  damage	  ................................................................................................................	  36	  1.3.3	   Base	  Excision	  Repair	  ................................................................................................................	  41	  1.3.4	   Nucleotide	  Excision	  Repair	  ...................................................................................................	  43	  1.3.5	   Double	  strand	  break	  repair	  ...................................................................................................	  46	  1.3.6	   Mismatch	  Repair	  (MMR)	  ........................................................................................................	  50	  1.3.7	   Translesion	  Synthesis	  (TLS)	  .................................................................................................	  52	  1.3.8	   Crosslink	  Repair	  .........................................................................................................................	  54	  1.3.9	   DNA	  Damage	  Response	  ...........................................................................................................	  55	  
1.4	   Solar	  radiation	  ...................................................................................................................	  58	  1.4.1	   The	  solar	  radiation	  spectrum	  ...............................................................................................	  58	  
  6 
1.4.2	   Solar	  radiation	  and	  Cellular	  Components	  .......................................................................	  59	  1.4.3	   Solar	  radiation	  and	  the	  skin	  ..................................................................................................	  62	  
1.5	   Photosensitisers	  ................................................................................................................	  66	  1.5.1	   Mechanisms	  of	  photosensitisation	  .....................................................................................	  66	  1.5.2	   Photosensitisers	  and	  their	  effects	  ......................................................................................	  68	  
1.6	   Aims	  .......................................................................................................................................	  70	  
Chapter	  2.	   Materials	  &	  Methods	  .................................................................................	  71	  
2.1	   Chemicals	  and	  reagents	  ..................................................................................................	  71	  2.1.1	   32P	  Labelling	  of	  Oligonucleotides	  ........................................................................................	  71	  2.1.2	   Annealing	  of	  Complementary	  Oligonucleotides	  ...........................................................	  71	  
2.2	   Cell	  Biology	  ..........................................................................................................................	  72	  2.2.1	   Cell	  culture	  and	  cell	  maintenance	  .......................................................................................	  72	  2.2.2	   Drug	  Treatments	  ........................................................................................................................	  72	  2.2.3	   Irradiation	  .....................................................................................................................................	  73	  2.2.4	   Proliferation	  Assay	  ....................................................................................................................	  74	  
2.3	   Biochemical	  Techniques	  .................................................................................................	  74	  2.3.1	   RIPA	  cell	  extracts	  .......................................................................................................................	  74	  2.3.2	   Protein	  Gel	  Electrophoresis	  ..................................................................................................	  75	  2.3.3	   Immunoblot	  .................................................................................................................................	  75	  2.3.4	   FHA	  derivatisation	  ....................................................................................................................	  75	  2.3.5	   AFM	  derivatisation	  ....................................................................................................................	  76	  2.3.6	   2-­‐D	  PAGE	  .......................................................................................................................................	  77	  2.3.7	   EMSA	  ...............................................................................................................................................	  78	  2.3.8	   NHEJ	  Assay	  ...................................................................................................................................	  79	  2.3.9	   CM-­‐H2DCFDA	  Assay	  .................................................................................................................	  80	  2.3.10	   RNO	  assay	  ...................................................................................................................................	  80	  2.3.11	   Enzyme-­‐linked	  immunosorbent	  assay	  ..........................................................................	  80	  2.3.12	   DNA	  immobilisation	  for	  DDB2	  binding	  .........................................................................	  81	  
Chapter	  3.	   Protein	  oxidation	  by	  6-­‐TG/UVA	  ............................................................	  83	  
3.1	   Introduction	  ........................................................................................................................	  83	  3.1.1	   Protein	  oxidation	  by	  reactive	  species	  ...............................................................................	  83	  3.1.2	   Factors	  affecting	  likelihood	  of	  oxidation	  .........................................................................	  83	  3.1.3	   Thiol	  oxidation	  ............................................................................................................................	  84	  3.1.4	   Protein	  carbonyls	  ......................................................................................................................	  87	  
  7 
3.1.5	   Protein	  oxidation	  by	  photosensitisers	  .............................................................................	  90	  
3.2	   Results	  ..................................................................................................................................	  91	  3.2.1	   Detecting	  protein	  carbonyls	  .................................................................................................	  91	  3.2.2	   The	  effects	  of	  6-­‐TG/UVA	  on	  carbonylation	  ....................................................................	  94	  3.2.3	   Thiol	  oxidation	  ............................................................................................................................	  95	  3.2.4	   Identification	  of	  carbonylated	  proteins	  ...........................................................................	  96	  3.2.5	   Ku	  oxidation	  .................................................................................................................................	  99	  3.2.6	   Ku	  damage	  and	  NHEJ	  .............................................................................................................	  103	  
3.3	   Discussion	  .........................................................................................................................	  106	  3.3.1	   Detecting	  protein	  oxidation	  ................................................................................................	  106	  3.3.2	   FHA	  and	  2D-­‐PAGE	  ...................................................................................................................	  106	  3.3.3	   6-­‐TG/UVA	  and	  protein	  carbonylation	  ............................................................................	  108	  3.3.4	   Thiol	  oxidation	  ..........................................................................................................................	  110	  3.3.5	   Ku	  oxidation	  ...............................................................................................................................	  110	  3.3.6	   Ku	  damage	  and	  NHEJ	  .............................................................................................................	  113	  
3.4	   Summary	  ...........................................................................................................................	  115	  
Chapter	  4.	   Other	  photosensitisers	  and	  protein	  oxidation	  ..............................	  116	  
4.1	   Introduction	  .....................................................................................................................	  116	  4.1.1	   Photosensitisers	  and	  their	  effects	  ....................................................................................	  116	  4.1.2	   Thiopurines	  ................................................................................................................................	  116	  4.1.3	   Fluoroquinolones	  ....................................................................................................................	  121	  4.1.4	   Vemurafenib	  ..............................................................................................................................	  123	  
4.2	   Results	  ...............................................................................................................................	  125	  4.2.1	   Phototoxicity	  in	  CEM-­‐CCRF	  cells	  .......................................................................................	  125	  4.2.2	   Generation	  of	  RS	  .......................................................................................................................	  127	  4.2.3	   Protein	  oxidation	  by	  UVA	  photosensitisers	  .................................................................	  134	  4.2.4	   The	  effects	  of	  UVA	  photosensitisation	  on	  NHEJ	  .........................................................	  139	  4.2.5	   The	  effects	  of	  UVA	  photosensitisation	  on	  NER	  ...........................................................	  140	  
4.3	   Discussion	  .........................................................................................................................	  142	  4.3.1	   Assessing	  phototoxicity	  in	  the	  CEM-­‐CCRF	  cell	  line	  ...................................................	  142	  4.3.2	   Generation	  of	  RS	  .......................................................................................................................	  143	  4.3.3	   Protein	  oxidation	  by	  UVA	  photosensitisers	  .................................................................	  146	  4.3.4	   The	  effects	  of	  UVA-­‐induced	  phototoxicity	  of	  NHEJ	  ...................................................	  147	  4.3.5	   The	  effects	  of	  UVA	  induced	  phototoxicity	  on	  NER	  ....................................................	  148	  
  8 
4.4	   Summary	  ...........................................................................................................................	  152	  
Chapter	  5.	   Possible	  sequestration	  of	  an	  NER	  factor	  by	  6-­‐TG/UVA	  
photoproducts	  ..................................................................................................................	  153	  
5.1	   Introduction	  .....................................................................................................................	  153	  5.1.1	   Lesion	  recognition	  in	  NER	  ...................................................................................................	  153	  
5.2	   Results	  ...............................................................................................................................	  155	  5.2.1	   UVC	  and	  DDB2	  ..........................................................................................................................	  155	  5.2.2	   DDB2	  relocalisation	  induced	  by	  photosensitisers	  ....................................................	  157	  5.2.3	   DNA	  Damage	  ..............................................................................................................................	  157	  5.2.4	   DDB2	  binding	  6-­‐TG	  photoproducts	  .................................................................................	  162	  
5.3	   Discussion	  .........................................................................................................................	  166	  5.3.1	   The	  effect	  of	  photosensitisation	  on	  DDB2	  localisation	  ...........................................	  166	  5.3.2	   DDB2	  binding	  6-­‐TG	  photoproducts	  .................................................................................	  168	  
5.4	   Summary	  ...........................................................................................................................	  170	  
Chapter	  6.	   Discussion	  ..................................................................................................	  172	  
Reference	  List	  ....................................................................................................................	  178	  
 
  9 
Table of figures 
 
Figure 1.1 Sequential single electron reductions of oxygen ........................................... 16	  
Figure 1.2 Molecular orbital diagrams for molecular oxygen and singlet oxygen ......... 22	  
Figure 1.3 Reactions of singlet oxygen with double bonds ............................................ 23	  
Figure 1.4 Reactions of lipid peroxidation products ....................................................... 28	  
Figure 1.5: Protein carbonyl formation from arginine .................................................... 29	  
Figure 1.6 Structures of common DNA base oxidation products ................................... 34	  
Figure 1.7 Oxidation of guanine by singlet oxygen ........................................................ 35	  
Figure 1.8 Base pairing of 8-oxoG ................................................................................. 37	  
Figure 1.9 DNA photoproducts and their mechanisms of formation ............................. 39	  
Figure 1.10 Incoming solar wavelengths ........................................................................ 59	  
Figure 1.11 Electronic transitions in photosensitisation ................................................. 68	  
Figure 2.1 Emission spectrum of the UVA light source. ................................................ 74	  
Figure 3.1 Oxidation products of cysteine and methionine ............................................ 85	  
Figure 3.2 The “switch” method for derivatising reversibly oxidised cysteines. ........... 86	  
Figure 3.3 Carbonylation by MCO and 1O2. ................................................................... 89	  
Figure 3.4 Derivatisation of protein carbonyls. .............................................................. 90	  
Figure 3.5 Excitation spectra for Sypro Ruby and Alexa Fluor 647. ............................. 92	  
Figure 3.6 Optimization of FHA derivatisation .............................................................. 93	  
Figure 3.7: Protein carbonylation induced by 6-TG/UVA treatment ............................. 94	  
Figure 3.8 Treatment with azide reduces carbonylation by 6-TG/UVA ........................ 95	  
Figure 3.9 Detecting thiol oxidation ............................................................................... 96	  
Figure 3.10 Two dimensional gel electrophoresis of the FHA treated samples ............. 98	  
Figure 3.11 Effects of 6-TG/UVA on identified proteins from 2D gels ......................... 99	  
Figure 3.12 Crosslinking of the Ku Complex ............................................................... 100	  
Figure 3.13 Persistence of Ku crosslinking .................................................................. 100	  
Figure 3.14 Electrophoretic mobility shift assays of Ku binding. ................................ 102	  
Figure 3.15 Optimisation and validation of the NHEJ assay ........................................ 104	  
Figure 3.16 The effect of 6-TG/UVA on NHEJ in vitro .............................................. 105	  
Figure 3.17 Complementation of in vitro NHEJ. ......................................................... 106	  
Figure 3.18 ARP derivatisation .................................................................................... 108	  
  10 
Figure 3.19 Mechanism of histidine-lysine crosslink formation mediated by 1O2. ...... 112	  
Figure 3.20 Ku heterodimer structure with highlighted candidate residues for 
crosslinking. .................................................................................................................. 112	  
Figure 3.21 Neutral comet assay of 6-TG/UVA treated cells ....................................... 114	  
Figure 4.1 Metabolism of thiopurines .......................................................................... 118	  
Figure 4.2 Toxicity of thiopurines ................................................................................ 119	  
Figure 4.3 Absorption spectra of guanine and 6-TG .................................................... 119	  
Figure 4.4 Structures of nalidixic acid and notable fluoroquinolones. ......................... 121	  
Figure 4.5 Proliferation of CEM cells after photosensitisation .................................... 127	  
Figure 4.6 Mechanism of CM-H2DCFDA function ..................................................... 128	  
Figure 4.7 FACS analysis of intracellular RS by CM-H2DCFDA ............................... 129	  
Figure 4.8 RS produced at equitoxic doses of photosensitiser ..................................... 130	  
Figure 4.9 Reaction scheme for RNO bleaching .......................................................... 131	  
Figure 4.10 RNO assay for 6-TG ................................................................................. 132	  
Figure 4.11 RNO assay for ciprofloxacin ..................................................................... 133	  
Figure 4.12 Modified RNO assay for vemurafenib ...................................................... 133	  
Figure 4.13 Fluoroquinolones replicate the protein oxidation characteristics of 6-TG 136	  
Figure 4.14 Protein oxidation by vemurafenib. ............................................................ 137	  
Figure 4.15 D2O-PBS incubation exacerbates Ku and PCNA crosslinking ................. 138	  
Figure 4.16 Persistence of ciprofloxacin protein oxidation. ......................................... 138	  
Figure 4.17 In vitro NHEJ assay of extracts from FQ/UVA treated cells .................... 139	  
Figure 4.18 In vitro NHEJ assay of extracts from vemurafenib/UVA treated cells ..... 140	  
Figure 4.19 Inhibition of NER by photosensitisers ...................................................... 142	  
Figure 4.20 Chemistry of CM-H2DCFDA oxidation ................................................... 144	  
Figure 4.21 A potential route to carbene formation by vemurafenib ........................... 146	  
Figure 4.22 Nucleotide excision repair in vitro ............................................................ 151	  
Figure 5.1 6-Thioguanine and its oxidation products ................................................... 155	  
Figure 5.2 Effects of UVC and UVA on DDD2 on CEM cells .................................... 156	  
Figure 5.3 Effect of photosensitisers on DDB2 ............................................................ 158	  
Figure 5.4 Effects of 6-TG dose on DDB2 relocalisation ............................................ 158	  
Figure 5.5 Kinetics of DDB2 localisation induced by 6-TG ........................................ 159	  
  11 
Figure 5.6 CPD and (6-4)PP ELISA absorbance after UVC, UVA, 6-TG and 
ciprofloxacin treatment. ................................................................................................ 160	  
Figure 5.7 Comparison of CPD induction with DDB2 extractability for FQs ............. 161	  
Figure 5.8 Binding of DDB2 by membrane bound genomic DNA .............................. 164	  
Figure 5.9 EMSA for irradiated 6-TG containing oligonucleotide .............................. 165	  
Figure 6.1 Structures of OGG1 and UNG with highlighted cysteines ......................... 174	  
 
  12 
List of tables 
 
Table 1.1 Mammalian DNA Glycosylases and some of their substrates ........................ 43	  
Table 1.2 Photoproduct induction in human skin by UVA and UVB ............................ 61	  
Table 2-1: Oligonucleotides used in this work. X= 6-TG .............................................. 71	  
Table 2-2: Cell lines used in this work. .......................................................................... 72	  
Table 2-3: Antibodies used in this work ......................................................................... 76	  
Table 2-4: Conditions used during isoelectric focussing ................................................ 77	  
Table 3-1: Rate constants for reaction of selected amino acids with 1O2  and HO ..... 109	  
 
  13 
 Abbreviations 
 
1O2    Singlet oxygen 
4-HNE  4-hydroxynonenal 
(6-4)PP  6-4 pyrimidine:pyrimidone photoproduct 
6-MP  6-mercaptopurine 
6-TG  6-thioguanine 
8-oxoG  8-oxoguanine 
AFM  Alexa Fluor 647 Maleimide 
ALE  Advanced Lipid Peroxidation End Product 
BCC  Basal Cell Carcinoma 
BER  Base Excision Repair 
CMM  Cutaneous Malignant Melanoma 
CPD  Cyclobutane pyrimidine dimer 
DNPH  Dinitrophenylhydrazine 
DSB  Double Strand Break 
ELISA  Enzyme linked immunosorbent assay 
EMSA  Electrophoretic mobility shift assay 
FA  Fanconi Anaemia 
FHA  Fluorescent hydroxylamine 
FQ   Fluoroquinolone 
GSH  Glutathione 
GSO2  Guanine sulfinate 
GSO3  Guanine sulfonate 
HR   Homologous recombination 
HO  Hydroxyl Radical 
MCO  Metal Catalysed Oxidation 
MDA  Malondialdehyde 
MED  Minimal erythemal dose 
MMPP  Magnesium monoperoxyphthalate  
MMR  Mismatch Repair 
NEM  N-ethylmaleimide 
  14 
NER  Nucleotide Excision Repair 
NHEJ  Non-homologous end joining 
NMSC  Non-melanoma skin cancer 
NO  Nitric Oxide 
O2-  Superoxide 
PDT  Photodynamic therapy 
RNO  p-nitroso-N,N-dimethylaniline 
RS  Reactive Species 
ROS  Reactive Oxygen Species 
SCC  Squamous Cell Carcinoma 
SSB   Single Strand Break 
TLS  Translesion Synthesis 
XP  Xeroderma Pigmentosum 
 
 
 
 
Chapter 1 Introduction 
 
 15 
Chapter 1. Introduction 
The central role of oxygen as a toxic, mutagenic gas that is nevertheless indispensible 
for all aerobic life is somewhat paradoxical. The chemical and physical properties that 
allow oxygen to participate in aerobic respiration also permit the formation of potentially 
damaging reactive species (RS). This duality is not exclusive to oxygen; RS also include 
both radical and non-radical species that result when cellular nitrogen, halogen and 
sulphur atoms transiently assume more reactive forms. This may not always be 
inadvertent on the cell’s part and the traditional view of RS as inherently harmful has 
been supplanted as their essential cellular functions continue to be revealed. The 
extensive countermeasures employed by the cell, however, point to the potential threat 
that they pose. 
1.1 Oxygen and reactive oxygen 
Molecular oxygen is a diradical. Ground state oxygen exists in a triplet state; in other 
words, it contains two unpaired electrons with parallel spins. In contrast, most cellular 
macromolecules exist in singlet ground states and have electrons paired in molecular 
orbitals with antiparallel spins. A molecule in a triplet state cannot accept paired 
electrons due to the Pauli exclusion principle, which states that electrons in the same 
orbital must have different spins, and therefore reactions between triplet and singlet 
state molecules occur very slowly, if at all (they are said to be spin restricted).  
Although O2 is essentially unreactive with cellular molecules, it does react very rapidly 
with other radical species. 
 
In cells, the majority of oxygen is utilised as the terminal electron acceptor in oxidative 
phosphorylation. During this process, cytochrome c oxidase catalyses the concerted and 
complete, four-electron reduction of oxygen to yield water. As well as being completely 
reduced to water, oxygen can also exist as a number of intermediate species that are 
generated by successive one-electron reductions (Figure 1.1). These states are more 
reactive than molecular oxygen or water and are hence known as reactive oxygen 
species (ROS). 
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Figure 1.1 Sequential single electron reductions of oxygen 
Successive one-electron reductions of oxygen yield the ROS illustrated above. 
 
1.1.2 Hydroxyl Radical  
The hydroxyl radical (HO) is the most reactive known ROS and can take part in the 
widest range of reactions with cellular molecules. Reaction rates between HO and 
most organic molecules are essentially diffusion-controlled and are limited only by how 
quickly HO can be generated (Gaetke 2003).  Its major modes of reaction are 
abstraction of hydrogen from hydrocarbons and addition to carbon-carbon double bonds 
(Valko et al. 2006).  
 
There are several physiological and non-physiological sources of HO with the most 
widely studied being the decomposition of H2O2 and the radiolysis of water(Halliwell & 
Gutteridge 2007). H2O2 decomposition can be induced by UV radiation. H2O2 absorbs 
strongly at shorter UV wavelengths(Holt et al. 1948) and UVC is most commonly used 
for generating HO in vitro, for example, in water purification(Legrini et al. 1993).  
 
The Fenton reaction (1) is the Fe(II) catalysed disproportionation of H2O2 to yield a 
hydroxyl radical and a hydroxyl anion. The catalytic Fe(II) can be regenerated by 
superoxide-mediated reduction of the resulting Fe(III) (2) however it is likely that other 
species can play this role in cells(Burkitt 2003). The Fenton reaction has been proposed 
as a source of HO in vivo(Kehrer 2000).  
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 Fe2+ + H2O2  Fe3+ + HO + -OH    (1) 
 Fe3+ + O2
-  Fe2+ + O2    (2) 
Net: O2
- + H2O2  HO + -OH + O2    (3) 
 
The low bioavailability of potentially harmful iron in a redox-active form is an 
important constraint on Fenton chemistry in the cell. Specialised proteins mediate 
intracellular iron storage and transport; ferritin and transferrins being the best 
characterised. Historically, the presence of free iron was considered to reflect a 
pathological condition (haemochromatosis). More recently it has become apparent that, 
despite tight control of iron homeostasis, cells do maintain a “labile iron pool” for the 
synthesis of iron-containing proteins - a mixture of Fe(II) and Fe(III) weakly chelated 
by low Mw ligands including citrate, phosphate and nucleosides. Chelate oxidation can 
liberate free iron from iron-containing proteins. The best known example of this is 
superoxide-induced Fe(II) release from the iron sulphur cluster (4Fe-4S) of the 
mitochondrial protein aconitase which leads to HO formation (Vasquez-Vivar 2000)). 
Oxidation can also release iron from ferritin (Rudeck et al. 2000). This indicates that 
free iron (and hence HO) can be generated by less reactive forms of ROS thereby 
exacerbating their effects. Copper, chromium, cobalt and vanadium are all capable of 
Fenton-like chemistry although the low intracellular concentrations of these metals 
probably limit their ability to generate OH (Gaetke 2003; Valko et al. 2006). 
 
The interaction of water with ionizing radiation generates OH via homolytic fission 
(4): 
 
      H2O*  H + HO                (4) 
 
where H2O* is water excited by radiation. 
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HO can also be generated during phagocytosis. The hypochlorous acid and superoxide 
produced by neutrophils can react rapidly to yield HO(5): 
HOCl + O2
-  O2
 + Cl- + HO    (5)
  
1.1.3 Hydrogen Peroxide 
Hydrogen peroxide (H2O2) is a non-radical and relatively unreactive ROS. Its biological 
importance reflects its ubiquity and its ability to form reactive decomposition products. 
The chemistry of H2O2 is mediated by its labile oxygen-oxygen single bond and hence it 
has a propensity for disproportionation and oxidation reactions. Given that only a 
limited number of reactive substrates are oxidised by H2O2, the majority of adverse 
cellular effects caused by H2O2 actually result from HO produced by H2O2 breakdown. 
 
Intracellular steady-state concentrations of H2O2 are estimated to be micromolar (B. 
Chance et al. 1979).  Most H2O2 derives from mitochondria but other organelles such as 
peroxisomes may contribute. The majority of mitochondrial H2O2 is formed from the 
enzyme-catalysed dismutation of superoxide (see Section 1.1.4). Many oxidases 
generate both H2O2 and superoxide as by-products(Halliwell & Gutteridge 2007). In 
addition, H2O2 is produced by auto- and metal-catalysed oxidation of various molecules 
including ascorbate and flavonoids(Halliwell 2008). H2O2 is an important intracellular 
signalling molecule and is transiently produced by NADPH oxidases in response to 
various extracellular stimuli such as growth factors and cytokines (Rhee 2003). H2O2 
detoxifying enzymes ensure that signalling remains localised by destroying any H2O2 
that diffuses away from the generation site(Rhee et al. 2000). It follows that excess 
H2O2, despite its lack of reactivity, can be deleterious by disrupting these signalling 
pathways.  
1.1.3.1 Antioxidant measures against H2O2  
Catalases, glutathione peroxidases and peroxiredoxins ensure that excess H2O2 is 
quickly destroyed. These enzymes are highly conserved and ubiquitous in aerobes. 
Their conservation highlights the inevitability of H2O2 production and the importance of 
resolving the threat it poses.  
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Catalase is mainly localised within peroxisomes. It disproportionates H2O2 to water and 
oxygen via the following steps (6 & 7): 
 
 Catalase (Porphyrin-FeIII) + H2O2  Compound I (Porphyrin+-FeIV=O) + H2O    (6) 
 Compound I (Porphyrin+-FeIV=O) + H2O2  Catalase + H2O + O2    (7) 
 
Total : 2H2O2  2H2O + O2 
 
Since two H2O2 molecules are required in the catalytic cycle, catalase is not efficient at 
low H2O2 concentrations and probably only becomes significant under conditions of 
oxidative stress or when scavenging the H2O2 produced locally during signalling or 
within peroxisomes(Rhee et al. 2005). Loss of catalase (acatalasemia) only results in a 
mild phenotype illustrating the importance of other antioxidant measures.  
 
Glutathione peroxidases (GPx) and peroxiredoxins (Prx) reduce H2O2 to H2O. GPx are 
present in the cytosol and mitochondria of all mammalian cells. GPx uses glutathione 
(GSH) as a hydrogen donor to catalyse the reduction of H2O2. All GPx isoforms contain 
a selenocysteine in their active site. The lower pKa of selenocysteine means that it is 
deprotonated at physiological pH allowing it to react with peroxides to form selenic 
acid via the following reactions (8, 9 & 10): 
 
 GPx-Se- + H2O2 + H+  GPx-SeOH     (8) 
 GPx-SeOH + GSH  GPX-Se-GSH + H2O   (9) 
 GPX-Se-GSH + GSH  GPx-Se- + H+ + GSSG    (10) 
 
Total: H2O2 + 2GSH  GSSG + H2O + H2O 
 
GPx is not essential. Under normal conditions its absence in knockout mice is not 
associated with any overt phenotype although the mice are less able to cope with 
oxidative stress(Klivenyi et al. 2000).  
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Peroxiredoxins are extremely abundant and may comprise as much as 0.5% of total 
soluble protein. Despite exhibiting slower kinetics than catalase and GPx, they are 
thought to be the major effector of H2O2 disproportionation under normal conditions. 
All Prx isoforms have active site cysteines. Cysteine oxidation to sulfenic acid 
accompanies H2O2 reduction (11). 
 
PrX – SH + H2O2  PrX – SOH + H2O   (11) 
 
 At high H2O2 concentrations, Prx can be inactivated by sulphinic acid formation or 
glutathionylation. Concomitantly, catalase and Gpx are upregulated. In this way, the 
three enzymes work in concert to manage antioxidant capacity over a range H2O2 
concentrations(Rhee et al. 2005). 
1.1.4 Superoxide 
Like H2O2, superoxide (O2-) is a reduced form of molecular oxygen that is inevitably 
generated during aerobic metabolism and is utilised by the cell in a number of ways. 
 
O2- exhibits minimal reactivity with most biomolecules. This is partly due to the same 
spin restrictions that govern molecular oxygen reactivity and partly to its anionic nature 
that deters interaction with the electron rich centres that are the preferred targets of 
radicals(Winterbourn 2008). 
 
The major source of O2- in mammalian cells is thought to be electron leakage from 
Complexes I and III in the mitochondrial electron transport chain. Cells also produce 
O2- intentionally via oxidases as part of cell signalling.  
 
1.1.4.1 Antioxidant measures against superoxide 
O2- undergoes spontaneous dismutation under physiological conditions (Halliwell & 
Gutteridge 2007). Dismutation is a bimolecular process and proceeds via the 
hydroperoxyl radical (HO2), the protonated form of superoxide (pKa 4.8): 
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 O2- + H+      HO2   (12) 
 
 HO2 + O2- + H+   H2O2 + O2   (13) 
 or 
 HO2 + HO2   H2O2 + O2   (14) 
 
Although spontaneous dismutation is fairly rapid, superoxide dismutases (SOD), which 
increase the rate of dismutation by around 3-4 orders of magnitude, are found in almost 
all eukaryotes.  
 
 M(n+1) + O2-  Mn+ + O2   (15) 
 Mn+ + O2- + 2H+  M(n+1) + H2O2   (16) 
 Total: 2O2- + 2H+  O2 + H2O2 
 
CuZnSOD (also known as SOD1) is a highly abundant (~10-5 M), dimeric protein 
located primarily in the cytosol. The structurally unrelated tetrameric MnSOD (SOD2) 
is almost exclusively mitochondrial.  
 
The extracellular CuZnSOD (EC-SOD or SOD3) - a tetrameric glycoprotein that is 
bound to cell surface carbohydrates and the extracellular matrix - shares 60% homology 
with SOD1. It is especially abundant in blood vessels, where it may play a role in 
mediating nitric oxide signalling(Fattman et al. 2003).  
 
The phenotypes of SOD-deficient mice underline the importance of controlling O2- 
levels. SOD1 knockout mice are hypersensitive to oxidants and show accelerated age-
related deterioration. SOD2 knockout mice have cardiac abnormalities, mitochondrial 
dysfunction and dramatically shortened lifespans. Overexpression of SODs confers 
resistance to hyperbaric O2. 
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1.1.5 Singlet Oxygen  
The electronically excited singlet state of oxygen (1O2) occurs by energy transfer to 
molecular oxygen in its triplet ground state and consequent antiparallel alignment of its 
outer shell electrons (illustrated in Figure 1.2) (1O2).  
Figure 1.2 Molecular orbital diagrams for molecular oxygen and singlet oxygen 
The molecular orbital energy levels of dioxygen (shown as short, horizontal lines) are flanked 
by their constituent atomic orbital energy levels. The energy levels increase from bottom to top. 
Electrons are depicted as arrows and the direction denotes their spin. The electrons in the 
outermost orbital of O2 have the same spin and are in different orbitals (triplet). Excitation to 
singlet oxygen causes electrons to pair in one orbital with opposite spins. 
 
1.1.5.1 Chemistry of Singlet Oxygen 
The major 1O2 source in biological systems is likely to be photosensitisation(M. J. 
Davies 2004) which is covered in Section 1.5.  
 
Physical quenching by the solvent is the fate of most cellular 1O2. It has a shorter 
lifetime in pure H2O (4 µs) than in pure D2O (68 µs). This isotope effect is also 
observed in cells saturated with D2O (lifetime ~30 µs). The short half-life of 1O2 (≤ 4 
µs) means that its radius of diffusion is small (< 250 nm) and its primary effects will be 
localised to the immediate vicinity of its generation(Redmond & Kochevar 2006). Other 
molecules can also efficiently inactivate 1O2. These include the azide ion, α-tocopherol, 
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β-carotene and ascorbate. In many cases the interaction of 1O2 generates new products. 
Because the spin restrictions that limit the reactivity of O2 no longer apply to 1O2, it is 
much more reactive with cellular macromolecules. It is electrophilic and reacts mainly 
with aromatic groups, sulphur atoms and alkenes. Reactions with double bonds can 
result in three possible products: endoperoxides, hydroperoxides and dioxetanes 
(Detailed in Figure 1.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Reactions of singlet oxygen with double bonds 
The products of 1O2 reaction depend on the configuration of the double bonds plus the nature 
and arrangement of the other substituents. Endoperoxide formation occurs via [4+2] 
cycloaddition to conjugated cis-dienes (top) in a Diels-Alder like reaction. Endoperoxides are 
unstable and will decompose to yield other products including hydroperoxides. Allylic 
hydroperoxides can also be formed via the “ene” reaction with alkenes (middle). Reactants with 
electron-rich atoms adjacent to the double bond can also form unstable dioxetanes via [2+2] 
cycloaddition (bottom). 
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The interaction of 1O2 with cellular thiols is almost entirely via chemical reaction (in 
contrast to the interaction with double bonds, 95% of which proceeds via physical 
quenching)(Breen & Murphy 1995; Devasagayam et al. 1991). The resulting products 
include disulphides and various sulphur oxyacids including sulfinate, sulfonate and 
sulfoxide.  
 
No specialised enzymes have evolved to detoxify 1O2. Because it is longer lived than 
HO, 1O2 can exert its influence over a wider area and cellular antioxidants may be 
important in minimising its harmful effects. Thiol quenching is likely to be most 
significant in a biological context owing to the high cellular concentrations of 
glutathione and cysteine(Di Mascio et al. 1990). Although carotenoids and tocopherols 
are more reactive, their lipophilic nature suggests that their protective effects will be 
confined to membranes. Other potential hydrophilic quenchers include ascorbic acid 
and aromatic amino acids, either free or within proteins. It has been estimated (Bisby et 
al. 1999) that the ability of cytoplasm to quench 1O2 is 10 times greater than that of pure 
water. This suggests that the cellular lifetime of 1O2 is around 0.4 µs. Overall, studies 
(Baker & Kanofsky 1992; Bisby et al. 1999) concur that cellular antioxidant defences 
are insufficient to protect proteins against damage by 1O2 . 
 
1.1.6 Other Cellular Reactive Species  
Other RS containing a variety of heteroatoms have also been described. Like ROS, 
some RS arise naturally during the course of normal cellular function whilst others are 
induced by pathology or exogenous stimuli. Important examples include the non-radical 
RS hypochlorous acid (HOCl) that is generated by the enzyme myeloperoxidase within 
neutrophils and may assist in the killing of pathogens through oxidation or chlorination 
of DNA, proteins and lipids. HOCl modification of proteins has be detected in patients 
with inflammatory diseases(Pullar et al. 2000). 
 
The nitric oxide radical (NO) is generated by nitric oxide synthases (NOS) and 
regulates a variety of physiological processes ranging from blood pressure to 
inflammatory responses. It is an important signalling molecule that acts by modification 
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of its target proteins, usually by binding to transition metals or causing nitrosylation of 
susceptible cysteines. Many of the deleterious consequences originally ascribed to NO 
are now known to be due to the peroxynitrite anion (OONO-), which forms extremely 
rapidly upon NO reaction with O2-. ONOO- is an extremely potent oxidant and causes 
DNA strand breaks, lipid peroxidation and protein oxidation. Its more selective 
reactivity enables ONOO- to diffuse 10000 times further than HO (2-3 cell diameters 
vs the diameter of a small protein(Pacher et al. 2007)) whilst remaining extremely 
reactive. This property is reflected in the ability of ONOO- to kill cells at lower 
concentrations than HO(Beckman 1994). 
 
I will now consider some of the effects of the abovementioned reactive species on cells. 
 
1.2 The actions of reactive species in cells 
1.2.1 Oxidative Stress 
The energetic cost of antioxidant systems, and the fact that some RS have roles in cell 
signalling means that the optimal RS level for a cell is not necessarily zero.  Disruption 
of the oxidant/antioxidant balance, either through depletion or dysfunction of 
antioxidant defences or increased production of RS, leads to a condition termed 
oxidative stress. Unchecked RS are then able to damage cellular components. This 
undesirable state provokes a coordinated protective response. 
 
1.2.2 Consequences of oxidative stress  
Oxidative stress causes Nrf2 to upregulate transcription of genes involved in oxidant 
homeostasis. These include genes related to antioxidant synthesis such as glutathione-S-
transferase and glutathione reductases, and antioxidant enzymes such as GPxs and 
Prxs(Ma 2013). The unifying feature of these genes is the presence of a 41-base-pair 
enhancer sequence, known as an antioxidant response element (ARE). Under normal 
conditions, Nrf2 is suppressed by Keap1, which marks Nrf2 for degradation and keeps 
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intracellular levels low. Oxidation of reactive cysteines within Keap1 results in 
inactivation, allowing Nrf2 to avoid degradation and enter the nucleus to bind AREs. 
 
Oxidative stress also activates members of the MAP kinase superfamily. They can be 
subcategorised into three classes: extracellular-signal-related kinases (ERK), p38 
kinases and c-Jun N-terminal kinases (JNK). Oxidation of reactive cysteines inactivates 
protein tyrosine phosphatases leading to ERK activation whilst oxidation of ASK1 
cysteines leads to p38 and JNK activation(Runchel et al. 2011). These are just two 
examples and MAPK activation can result from numerous stimuli. Activation of ERK 
promotes phosphorylation of downstream transcription factors that induce proliferation 
whilst sustained p38 and JNK activation leads to apoptosis; the final outcome for the 
cell depends on the relative activation of these pathways(Sonntag 2006; Martindale & 
Holbrook 2002).  
 
Some gene promoters such as γ-glutamyl transferase contain an ARE in addition to 
binding sites for AP-1 (stimulated by MAPK activation) and NFκB (another RS 
activated transcription factor) indicating complex interactions at play between these 
systems. By way of a multifaceted, dynamic response, low to moderate levels of RS can 
be tolerated by cells and in fact the increased antioxidant measures may persist for some 
time, equipping cells to better deal with future challenges.  
 
If these adaptive measures cannot restore the oxidant/antioxidant balance, cells undergo 
senescence or cell death via apoptosis or necrosis. Moderate oxidative stress first results 
in cell cycle arrest by checkpoint activation. This can be achieved by many routes 
depending on the site of RS generation(Folkes et al. 1995; B. Liu et al. 2008), however 
one potential mechanism is p53 activation due to DNA damage. Prolonged MAPK 
stimulation leads to senescence (Halliwell & Gutteridge 2007; Boonstra & Post 2004). 
High levels of RS that disrupt essential cellular functions induce apoptosis. This is 
characterised by mitochondrial permeability transition, the release of pro-apoptotic 
factors and caspase activation. Necrosis may predominate at very high RS levels because 
caspases contain essential cysteines that are susceptible to oxidation. Apoptosis and 
necrosis represent the final recourse for the cell to prevent pathology arising from 
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oxidatively damaged cellular components; some examples of these products and their 
potential for deleterious effects are detailed in the following section.  
 
1.2.3 Damage to cellular components 
Oxidative damage can affect all cellular components however the precise nature of this 
damage depends on the chemistry of the RS and where they are generated. The most 
reactive RS such as HO will react with the first molecule they encounter whereas less 
reactive RS will react with a more limited spectrum of targets and generate relatively 
specific products. 
1.2.3.1 Lipid Peroxidation 
Cellular membranes are a mixture of saturated and unsaturated fatty acids of varying 
chain lengths that contain embedded and attached proteins. Unsaturated bonds confer 
important membrane fluidity but polyunsaturated fatty acids (PUFAs) are vulnerable to 
attack by RS. Peroxidation occurs when an RS (usually HO) abstracts a hydrogen atom 
from a lipid (LH) leaving a radical species (L). This quickly reacts with O2 to yield a 
peroxyl radical (LOO) that then abstracts hydrogen to form a lipid hydroperoxide 
(LOOH) and a new L. In this way, a chain reaction proceeds until terminated by an 
antioxidant or the meeting of two L. 
 
 HO + LH  L + H2O    (17) 
 L + O2  LOO   (18) 
    LOO + LH  LOOH + L    (19) 
 
Lipid peroxides can be formed in a non-radical reaction by the action of 1O2, which 
reacts with unsaturated double bonds via the “ene” reaction shown in Figure 1.3. 
 
Lipid peroxidation causes loss of membrane fluidity, reduces membrane integrity and, 
damages and inactivates membrane proteins. Importantly, chain cleavage adjacent to the 
peroxide moiety generates reactive aldehyde products that can form adducts with DNA 
and proteins. The most studied aldehydes are malondialdehyde (MDA) and 4-
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hydroxynonenal (HNE) - both bifunctional electrophiles capable of reacting with DNA 
and proteins. Addition to DNA proceeds preferentially at guanine (the MDA-guanine 
adduct is known as M1G and has been identified in human DNA) whilst protein adducts 
form via a Schiff base resulting in protein dysfunction and aggregation(Negre-Salvayre 
et al. 2008) (Figure 1.4). 
 
 
 
 
 
 
 
 
Figure 1.4 Reactions of lipid peroxidation products 
Top: Malondialdehyde (MDA) can react with the nucleophilic N2 of guanine. The reaction 
product can then undergo ring closing to give M1G. Bottom: HNE protein adduct formation via 
a Michael addition with a lysine residue. These reactions are examples and lipid peroxidation 
products will react with any appropriate nucleophile. 
 
1.2.3.2 Protein oxidation 
Their abundance and the reactivity of their side chains make cellular proteins a 
significant target for reactive species. An extremely wide range of oxidation products 
are possible; the likelihood of formation is determined by the identity of the reactive 
species, the accessibility of protein side chains and the local redox environment.  
 
Unsurprisingly, the hydroxyl radical exhibits the most extensive and complex pattern of 
modifications. Although HO is sufficiently reactive to modify all amino acid side 
chains, reaction with electron rich amino acids is favoured. At physiological pH, direct 
H-abstraction from S-H and C-H bonds is the predominant reaction giving rise to thiyl 
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and alkyl radicals respectively(Xu & M. R. Chance 2007). Thiyl radicals go on to form 
disulphides and sulphur oxyacids.  
 
Carbon centred radicals on α and β carbons can combine with oxygen to yield peroxyl 
radicals, eventually leading to cleavage of the protein backbone. Peroxyl species formed 
on side chains can yield a variety of residue-specific hydroperoxide, hydroxide and 
carbonyl products. The structure of some side chains makes protein carbonyl formation 
more favourable due to the presence of leaving groups (Figure 1.5, illustrated using 
arginine)(Xu & M. R. Chance 2007). The potential for chain reaction means that a 
single HO radical can be responsible for the modification of up to 15 amino 
acids(Neuzil et al. 1993). 
 
 
 
 
 
 
Figure 1.5: Protein carbonyl formation from arginine 
After oxidation via HO the resulting hydroxide can rearrange and eliminate the guanidino 
group to yield a protein carbonyl. 
 
Hydrogen peroxide does not react with most proteins, even at mM 
concentrations(Halliwell & Gutteridge 2007).  It can, however, inactivate a number of 
enzymes with active site cysteines including glyceraldehyde 3-phosphate 
dehydrogenase(Brodie & Reed 1987), phosphotyrosine protein phosphatase(Meng et al. 
2002) and caspases(Borutaite & Brown 2001).  
Some enzyme-H2O2 reactions may exacerbate oxidative stress. Heme oxidation with 
resultant release of iron(Gutteridge 1986) and activation of nitric oxide synthase and 
NADPH oxidase to increase O2-  levels(Coyle et al. 2006) are two examples.  
 
O2- is also generally unreactive toward proteins. An important exception is iron-
sulphur cluster modification. Reaction with O2- inactivates the enzyme and releases 
ferrous iron: 
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 [4Fe-4S]2+ + O2- + 2H+  [4Fe-4S]3+ + H2O2    (19) 
 [4Fe-4S]3+  [3Fe-4S]+ + Fe2+    (20) 
 
Acontinase and dehydratases are particular targets and their inactivation leads to energy 
metabolism defects(Halliwell & Gutteridge 2007).  
 
1O2 reacts predominantly with electron-rich aromatic residues and sulphur containing 
side chains(M. J. Davies 2003). The major products of tryptophan oxidation, N-
formylkynurine and kynurine formed 2+2 cycloaddition (as seen in Figure 1.3) can act 
as photosensitisers, perhaps exacerbating damage by further 1O2 production.  Tyrosine 
modification proceeds via endoperoxide formation (Figure 1.3) leading to an unstable 
hydroperoxide, which may promote protein crosslinking. Hydroperoxide decomposition 
may also cause fragmentation and ring opening. Histidine oxidation occurs via 
endoperoxide formation on the imidazole ring, which then goes on to form a number of 
poorly characterized breakdown products, some of which may participate in His-His 
and His-Lys protein crosslinking. Oxidation of methionine leads to methionine 
sulfoxide whilst cysteine likely forms oxyacids and disulphides. Structures of singlet 
oxygen reaction products can be found in Figures 3.1 and 3.3. 
 
In addition to protein carbonyl formation and thiol oxidation, peroxynitrite can form 
specific nitration products of aromatic residues(Ischiropoulos & al-Mehdi 1995). The 
formation of 3-nitrotyrosine may result in the downregulation of phosphotyrosine-
dependent signalling as it is a poor tyrosine kinase substrate. 
 
The numerous consequences that arise from protein oxidation are determined by the 
identities of the proteins and reactive species in question. Specific oxidative 
modification of key residues can reversibly regulate protein function as part of cell 
signalling or inactivate proteins in an uncontrolled or irreversible manner as part of RS-
mediated pathology. Gross modification to protein structure caused by severe oxidative 
stress will cause loss of function as well as fragmentation, aggregation and proteasomal 
degradation.  
Chapter 1 Introduction 
 
 31 
 
Redox regulation of proteins, which almost always occurs via thiol oxidation, 
inactivates an enzyme if the thiol is necessary for catalytic activity (e.g. GapDH), or 
induces a conformational change that modulates activity. This modulation can be 
activating or inactivating and proceeds through a wide range of mechanisms including 
disrupting interaction with a repressor (Nrf2(Kansanen et al. 2013)), loss of metal 
binding (PKC(Korichneva 2005)) or reducing DNA binding (AP-1(Klatt et al. 1999)). 
Although less studied, methionine sulfoxide formation can also play a role in signalling. 
Methionine is considered a hydrophobic amino acid however addition of an oxygen 
atom renders it hydrophilic and can cause large scale conformational changes; in this 
way, methionine oxidation regulates calmodulin(Bigelow & Squier 2011). In the 
context of H2O2 signalling, the likelihood of a cysteine undergoing oxidation is 
determined in the first instance by accessibility but also by its pKa as the thiolate anion 
is much more nucleophilic. More reactive RS such as OH, 1O2 and ONOO- will be less 
selective in their reactions with protein thiols and more likely to form higher oxyacids. 
Thiol oxidation and the conformational changes it causes can also have deleterious 
effects on non-redox regulated proteins with susceptible cysteines and methionines. 
 
Limited local oxidation leading to functional inactivation can also occur by the action of 
RS upon aromatic residues. Tyrosine nitration inactivates SOD2(Radi 2004), loss of 
tryptophan leads to inactivation of lysozyme(Jiménez et al. 2000) whilst histidine 
oxidation leading to loss of metal binding has been shown to inactivate the bacterial 
transcription factor PerR(Lee & Helmann 2006). The susceptibility of thiol and 
aromatic amino acids is consistent with their being the most reactive targets and thus 
multiple RS can modify them; modification of aliphatic residues will likely only be 
effected by OH. As outlined previously, this generally proceeds via H-abstraction in 
addition of oxygen in some form. This alters the hydrophobicity of sidechains resulting 
in misfolding and exposure of hydrophobic domains leading to non-specific interaction 
and aggregation(Mirzaei & Regnier 2008). Aggregation can also occur through 
formation of interprotein cross links; these can be either radical mediated such 
dityrosine crosslinks, which can cause pathology in vivo(Souza 2000), or result from 
reaction between oxidation products such as those of histidine and a nucleophile 
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(Balasubramanian et al. 1999).  Oxidation induced aggregation leading to inactivation 
may have implications for disease progression; aggregates may be inherently toxic 
regardless of their composition(Bucciantini et al. 2002). Severe oxidation or diminished 
removal capacity may result in the formation of lipofuscin, a persistant lipid-protein 
aggregate which may inhibit removal of other oxidised species and promote further 
oxidation through redox-metal binding.  
 
Cells possess proteolytic systems that play roles in normal cellular function but are able 
to participate in the detoxification of oxidised proteins. The proteasome comprises a 
core (20S) subunit, which contains the proteolytic active sites. Its activity and 
specificity are modulated by the attachment of regulatory binding partners. The 
unmodified 20S subunit alone degrades oxidised proteins independently of ATP 
(oxidative stress actually causes dissociation of other proteasomal complexes, liberating 
20S subunits). The mechanism by which oxidised proteins are targeted is still unclear 
but is thought to be via recognition of hydrophobic patches exposed by partial 
unfolding(Höhn et al. 2014) although Hsp90 has been shown to target oxidised but not 
native calmodulin for 20S degradation in vitro suggesting a role for 
chaperones(Whittier 2004). Proteasomal degradation peaks at a certain level of 
oxidation for each protein above which they can no longer be processed leading to 
lipofuscin formation and pathology. Proteasome concentrations are highest in the 
nucleus (mirroring total protein concentrations) which is likely a major factor in the 
lower relative levels of oxidised proteins found there (Jung et al. 2007). The proteasome 
is not expressed in mitochondria however they possess the specialised Lon protease for 
removal of oxidised proteins(Bota & K. J. A. Davies 2002). Lysosomal degradation is 
the other main route by which oxidised proteins are detoxified. Lysosomes contain the 
cathepsin proteases along with a wide range of other enzymes. Cathepsins (after 
activation by the low pH of lysosomes) can cleave at cysteines and aspartates depending 
on the isoform. Oxidative modifications may cause individual proteins to become 
substrates for microautophagy. Larger aggregates can be digested via macroautophagy; 
again there exists an upper limit of oxidation after which lipofuscin will accumulate in 
lysosomes. 
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1.3 DNA Repair 
A variety of DNA modifications can arise due to the action of endogenous and 
exogenous damaging agents or spontaneous chemical and enzymatic reactions 
occurring during normal cellular function. Cells have evolved a number of different 
pathways to address these lesions and hence avoid the potential for lethality and 
mutagenesis.  Continuing from the previous section, DNA damage by RS will be 
addressed first before moving on to other mechanisms of DNA damage and finally, how 
the cell processes this damage. 
1.3.1 DNA Damage by RS 
Radiation or chemical treatment of nucleosides in vitro generates more than 80 different 
base modifications. The majority have not been detected in cellular DNA either because 
they occur at levels below current detection limits or because conditions within the cell 
preclude their formation.   
 
1.3.1.1 HO mediated damage 
HO is a significant source of DNA damage. It reacts almost indiscriminately with all 
DNA bases at near diffusion-controlled rates. It can add to double bonds to generate an 
OH-adduct radical or it can abstract hydrogen. OH-adduct radicals can react with O2 or 
become oxidised/reduced to yield stable products. Among the canonical DNA bases, 
guanine has the lowest reduction potential and therefore is most susceptible to 
oxidation(Sirbu & Cortez 2013; Steenken & Jovanovic 1997). Guanine OH adduct 
radicals can form at carbons 4, 5 or 8. The C4 and C5 adducts can rearrange to form C8 
adducts or revert back to guanine. One electron oxidation of the C8-OH-adduct leads to 
formation of 8-hydroxyguanine (8-OH-G), the enol tautomer of 8-oxo-7,8-
dihydroguanine (8-oxoG, Figure 1.6), which predominates in cellular DNA. The other 
possible fate of the C8-OH-adduct is ring opening and one electron reduction to give 
2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyGua, Figure 1.6). Although the 
two products form in comparable yields in vivo, the ratio between them is influenced by 
redox environment (high O2 levels favouring 8-oxo-G formation)(Dizdaroglu & Jaruga 
2012). Historically, 8-oxo-G has received more attention. It is easier to detect and its 
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miscoding properties indicate an obvious potential for mutagenicity. Some authors 
believe that the contribution of other products (such as FapyGua) has been 
underestimated (Dizdaroglu et al. 2008). 8-oxo-G is detectable in urine and urinary 8-
oxo-G is used as a biomarker for oxidative stress. The major products of DNA adenine 
oxidation, 4,6-diamino-5-formamidopyrimidine and 7,8-dihydro-8-oxoadenine 
(FapyAde and 8-oxo-A, Figure 1.6) are formed at levels an order of magnitude lower 
than those of DNA 8-oxoG. Reactions with thymine proceed via addition at C5 and C6 
and to a lesser extent abstraction of the methyl H. The resulting radical adducts form a 
variety of hydroxy-thymine products including 5,6-dihydroxy-5,6-dihydrothymine 
(thymine glycol, Figure 1.6) and 5-hydroxymethyl-uracil (Figure 1.6), which are 
mutagenic and detectable in patient urine(Evans et al. 2010) and patient lymphocyte 
DNA(Halliwell 1998). Cytosine behaves similarly to thymine with a stronger 
preference for forming C5-OH-adduct radicals, which yield 5,6-dihydroxy-5,6- 
dihydrocytosine (cytosine glycol, Figure 1.6) and 5-hydroxy cytosine. 
 
Figure 1.6 Structures of common DNA base oxidation products  
8-oxoG ,8-oxo-7,8-dihydroguanine; Fapy Gua, 2,6-diamino-4-hydroxy-5-
formamidopyrimidine; 8-oxoA, 7,8-dihydro-8-oxoadenine; Fapy Ade, 4,6-diamino-5-
formamidopyrimidine; thymine glycol, 5,6-dihydroxy-5,6-dihydrothymine, 
5-hydroxymethyl-uracil; cytosine glycol, 5,6-dihydroxy-5,6-dihydrocytosine, 5-
hydroxycytosine 
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1.3.1.2 O2 - and H2O2 mediated damage 
Cellular DNA is unreactive towards O2- or H2O2 although O2 may react with DNA 
radicals to yield peroxy products. More importantly, excess O2- increases unbound iron 
levels and promotes Fenton chemistry (Keyer & Imlay 1996). The DNA strand 
breakage induced by treatment of cells with H2O2 is due to OH formation via the 
Fenton reaction. As OH is too reactive to diffuse, DNA breakage implies that metal 
ions are in close proximity to DNA. The overall negative charge of DNA allows it to 
chelate positively charged ions, although metal chelation by DNA in vivo has not been 
demonstrated. 
 
1.3.1.3 1O2 mediated damage 
1O2 can oxidise guanine directly. It does not oxidise other DNA bases and it cannot 
induce strand breaks(Cadet et al. 2006). The major observed DNA product resulting 
from the action of 1O2 on cellular DNA is 8-oxo-G. It seems likely that secondary 
oxidation products resulting from [2+2] cycloaddition to the C4-C5 bond (Figure 1.7) 
will also be formed but they have not been detected in cellular DNA and their biological 
relevance, if any, is unclear (Neeley & Essigmann 2006). 
 
 
 
 
Figure 1.7 Oxidation of guanine by singlet oxygen 
Guanine oxidation proceeds via a [4+2] cycloaddition to the imidazole ring, generating 
an unstable endoperoxide that decomposes to give 8-oxoG. 8-oxoG is still reactive 
towards 1O2 and may form secondary oxidation products via [2+2] cycloaddition to the 
C4-C5 bond. 
 
1.3.1.4 Other RS mediated damage 
OONO- also forms DNA 8-oxo-G together with several other oxidation products. These 
include 8-nitroguanine and strand breakage via H abstraction(Burney et al. 1999). HOCl 
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mainly oxidizes pyrimidines (thymine glycol is the major product in cellular DNA) and 
also gives rise to chlorinated bases such as 5-chloro-uracil(Spencer et al. 2000). 
 
DNA-protein crosslinks and DNA interstrand crosslinks can arise from RS by indirect 
mechanisms. These include DNA-radical/protein-radical coupling or attack of base 
radicals on susceptible amino acids such as tyrosine. Breakdown products of lipid 
peroxides (Section 1.2.3.1) can also generate indirect DNA damage.  
 
1.3.2 Non-RS DNA damage 
In addition to damage by excess RS, DNA can be damaged by other exogenous agents 
and during normal cellular function. Cells have evolved multiple pathways to address 
these DNA lesions and thereby avoid lethality and mutagenesis.   
 
1.3.2.1 Spontaneous damage 
The most common DNA damage under normal cellular conditions is spontaneous base 
loss via N-glycosyl bond hydrolysis. This reaction generates apurinic/apyrimidinic (AP) 
sites and occurs around 10000 times per cell per day(Lindahl 1993). Guanine is lost 1.5x 
faster than adenine whilst rates of depyrimidation are around 5% those of depurination. 
AP sites also arise from oxidative damage and as intermediates in base excision repair 
(BER, see Section 1.3.3 below). They can undergo mutagenic bypass by replicative 
polymerases with preferential insertion of adenine(Avkin et al. 2002). The deoxyribose 
that remains after base loss exists mainly in the closed ring furanose form but can 
tautomerise to give a ring-open aldehyde which can either undergo β-elimination, 
inducing cleavage of the 3’-phosphodiester bond, or react with nucleophiles to generate 
cross links. The ubiquity and conservation of AP endonucleases(Barzilay & Hickson 
1995) emphasizes the potential dangers posed by AP sites and the need for their correct 
resolution. 
 
 DNA bases also undergo spontaneous hydrolytic deamination. Cytosine is deaminated 
to uracil which, in double-stranded DNA generates a U:G mispair. Cytosine deamination 
Chapter 1 Introduction 
 
 37 
occurs approximately 100-500 times per cell per day. To avoid GCTA transition 
mutations, DNA uracil is removed (by BER, see below) thereby generating an AP site. 
Uracil can also be incorporated opposite adenine during DNA replication. These U:A 
pairings are also resolved by BER. Human DNA also contains 5-methylcytosine (5-
meC). This normal epigenetic mark is confined to CpG sequences and 60-90% of 
cytosines in these dinucleotides are methylated. Methylation increases the rate of 
cytosine deamination by three to four fold. Deaminated 5-meC yields thymine and T:G 
mispairs in double-stranded DNA. If left uncorrected, this would cause a CT transition 
mutation. 
 
Oxidised DNA bases also arise spontaneously at baseline RS levels. 8-oxoG is the major 
product of endogenous RS (up to 2000 per cell per day(Friedberg et al. 2004)). It is 
mutagenic due to its ability to form a Hoogsteen base pair with adenine (Figure 1.8) 
leading to GCTA transversion mutations upon strand replication. In addition to the 
RS-induced damage to DNA bases described in the previous section, the oxidized 
deoxynucleotide pool is also a source of DNA lesions. dNTPs are susceptible to 
oxidation and are substrates for incorporation by replicative DNA polymerases. 8-oxo-G 
incorporation opposite adenine directed by Hoogsteen base pairing leads to ATCG 
transversion mutations if uncorrected(Pavlov et al. 1994). Mutation via incorporated 
oxidized bases is minimized by a nucleotide pool sanitizing system in which the MTH1 
enzyme hydrolyses oxidised purine triphosphates thereby preventing their incorporation.  
 
 
 
 
 
 
 
 
 
Figure 1.8 
Base pairing of 8-oxoG 
Left: Watson-Crick base pairing of guanine and cytosine. Right: Hoogsteen base pairing of 8-
oxoG and adenine. 
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1.3.2.2 Damage from exogenous sources 
DNA absorbs ultraviolet radiation (UVR) and this induces the formation of potentially 
mutagenic photoproducts. UVC (100-280nm) is absorbed most strongly but UVB (280-
320nm) and UVA (320-400nm) are more relevant to terrestrial life. The most abundant 
DNA photoproducts of solar UVR are cyclobutane pyrimidine dimers (CPDs) (Figure 1-
9). These lesions are formed via a [2+2] cycloaddition reaction between the C5-C6 
double bonds of adjacent pyrimidine bases. Although various stereoisomers exist, the 
constraints of the B-DNA structure mean that the cis-syn dimer is the major product. The 
trans-syn form is observed in less structurally-constrained single stranded DNA. 
Although all possible CPDs (T<>T, C<>T, T<>C, C<>C) have been isolated from DNA 
irradiated in vitro, in cells, the T<>T dimer predominates, making up over 50% of 
photoproducts in DNA extracted from cells exposed to simulated sunlight(Douki et al. 
2003). UVA also induces CPDs albeit 1000x less efficiently than UVB(S. Mouret et al. 
2006). UVA can achieve this indirectly through triplet energy transfer via endogenous 
and exogenous photosensitisers(Cadet et al. 2012). In the past, this was thought to be the 
major mechanism by which UVA induces CPDs but recently, a direct excitation of DNA 
was shown to occur and, by assessing product distributions, judged to be the 
predominant mechanism in cells(S. Mouret et al. 2010). 
 
Although the 5’ residue hydrogen bonding is disrupted, CPDs remain stacked within the 
helix and induce a modest 9° DNA bend. Pyrimidine (6-4) pyrimidone photoproducts 
((6-4)PPs) (Figure 1-9) are also generated by UVB and UVC irradiation of DNA. Like 
CPDs, (6-4)PPs can form between all combinations of pyrimidines. In DNA from UVB 
irradiated cells, TC products predominate followed by TT and CT. CC (6-4)PPs are not 
observed(Cadet et al. 2012). UVA irradiation does not induce significant numbers of (6-
4)PPs, an observation that has implications for the mechanisms of formation of 6-4PPs 
and CPDs. The DNA distortion caused by (6-4)PPs is much greater than is caused by 
CPDs; the pyrimidine rings are almost perpendicular to each other and confer  a 44° 
helical bend and loss of hydrogen bonding for the 3’ base. This greater structural 
distortion is thought to facilitate more efficient recognition by repair factors and (6-
4)PPs are repaired 5 to 10 times faster than CPDs. When (6-4)PPs absorb UVA, they 
undergo photoisomerisation to yield Dewar valence isomers (Figure 1.9). These bicyclic 
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β–lactam-containing pyrimidine isomers are repaired as rapidly as their (6-4)PP 
counterparts(Courdavault et al. 2005).  
 
All 3 classes of UV photoproducts block DNA and RNA polymerases and must be 
removed or bypassed to allow replication and transcription to continue.  
 
 
Figure 1.9 DNA photoproducts and their mechanisms of formation 
Top: CPDs are formed via a [2+2] cycloaddition reaction between the C5-C6 double bonds of 
adjacent pyrimidine bases. Bottom: (6-4)PPs form via a photochemical [2+2] cycloaddition 
between a 5’ C5-C6 pyrimidine double bond and a 3’ C4 thymine carbonyl or C4 cytosine 
imine tautomer. This results in a covalent bond between 5’-C5 and 3’-C4 via an unstable 
oxetane or azetidine respectively. Upon absorption of UVA, (6-4)PPs photoisomerise to yield 
Dewar isomers. 
 
1.3.2.3 Alkylation of DNA 
Numerous endogenous and exogenous electrophiles can add alkyl groups to nucleophilic 
centres in DNA. Endogenous alkylating agents include S-adenosylmethionine, which is 
a weak methylating agent, and lipid peroxidation products (as mentioned in Section 
1.2.3.1). Exogenous alkylating agents include tobacco smoke components, therapeutics 
and various chemical weapons. The pattern of alkylation is dependent on the 
nucleophilic selectivity of the alkylating species and the properties of the bases. In 
general, alkylating agents with high nucleophilic selectivity preferentially react with 
nitrogens such as guanine N7 via an SN2 mechanism. Less selective agents react via an 
SN1 mechanism to yield O-alkylation and phosphotriester adducts in addition to the 
nitrogen products. 7-methylguanine (7meG) and 3-methyladenine (3meA) are the 
primary N-methylation products whilst O6-methylguanine (O6meG) is the major oxygen 
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adduct. Although 7meG is neither mutagenic nor cytotoxic, its N-glycosyl bond is labile 
and it is therefore more susceptible to depurination to generate an AP site. DNA 3meA is 
also highly susceptible to depurination. This potentially lethal DNA lesion also blocks 
DNA polymerases.  O6meG is responsible for the majority of mutagenesis and toxicity 
associated with SN1 methylating agents. It mispairs with thymine and causes GA 
transition mutations. O6MeG can be directly reversed via a dedicated enzyme - O6-
methylguanine-methyltransferase (MGMT). MGMT transfers the methyl group to an 
active site cysteine to regenerate DNA guanine. Direct reversal of alkylation can also be 
achieved by AlkB and its homologues in a process termed oxidative DNA demethylation. 
AlkB hydroxylates the methyl group on 1-methyladenine and other lesions, which then 
rearranges and spontaneously eliminates to reform the undamaged base with loss of 
formaldehyde(Falnes et al. 2002). 
 
N-methylated bases are excised by the BER pathway whereas more complex alkylation 
products are removed by NER.  Bifunctional alkylating agents such as nitrogen mustards 
and mitomycin C can induce crosslinks by bridging two nucleophilic centres. Crosslinks 
can be DNA-protein crosslinks (DPCs) or intra- and interstrand DNA-DNA crosslinks 
(ICLs). These lesions all impede transcription and replication and must be repaired or 
bypassed.  
 
1.3.2.4 Strand Breakage 
In addition to modification of nucleobases, modification of the backbone can lead to 
strand breakage. Ionizing radiation (IR) can interact with DNA directly, through 
ionization of the DNA atoms, or indirectly, through the radiolytic decomposition 
products of water. The majority of cellular damage is due to indirect effects, mainly via 
the hydroxyl radical. Besides the addition products to DNA bases outlined in Section 
1.3.1.1, OH can also abstract a deoxyribose hydrogen although this accounts for < 20% 
of OH reactions with DNA. Abstraction at C’4 and C’5 predominates due to greater 
accessibility and the resulting radicals can decompose with loss of the 3’ or 5’ 
phosphodiester or abasic site formation. If the ends derived from a single strand breaks 
consist of a 3’-OH and 5’-P then the nick can be simply repaired by direct DNA ligation. 
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This is rarely the case, however. More frequently, the ends must be processed and any 
lost bases replaced. For this reason, single strand break repair overlaps significantly with 
the post incision events of BER and will be discussed in more detail below. SSBs can 
also result from Fenton chemistry, as an intermediate in BER or due to abortive action of 
DNA topoisomerase 1. Unrepaired SSBs can result in stalled transcription and, more 
seriously, stalling and collapse of replication forks leading to double strand break (DSB) 
formation. DSBs are considered the most harmful DNA lesion; just one may be 
sufficient to induce apoptosis if left unrepaired(Ide et al. 2011; Khanna & Jackson 2001). 
Formation of two SSBs in close proximity (10bp) on opposing strands results in a DSB. 
Radiomimetic drugs such as bleomycin and topoisomerase inhibitors also induce DSBs. 
Aberrant repair of DSBs can lead to gross chromosomal rearrangements and mutation 
and as such cells devote significant resources to their repair.  
 
1.3.3 Base Excision Repair  
Small chemical modifications that do not significantly distort the helical structure of 
DNA are repaired by base excision repair (BER). These include most oxidative base 
modifications, uracil resulting from deamination, methylated and some other alkylated 
bases and AP sites. Furthermore, many of the main enzymes in BER are also involved in 
single strand break repair (SSBR). This section is informed by the recent review of BER 
by Krokan(Krokan & Bjoras 2013). 
 
The initial step in BER is recognition and removal of the damaged base by one of 13 
distinct DNA glycosylases that catalyse hydrolysis of the N-glycosyl bond. Each 
glycosylase has a preferred substrate although there is some degree of redundancy and 
many recognise multiple lesions (Table 1). Glycosylases bind to the minor groove and 
kink DNA at the damage site. The active sites of glycosylases can only accommodate 
extrahelical bases and so the damaged base must be flipped out of the major groove. It is 
unclear whether the enzyme induces this or captures temporarily extrahelical bases. 
Glycosyl bond hydrolysis is achieved via a water molecule activated by a catalytic acidic 
amino acid to generate an AP site. DNA glycosylases can be monofunctional or 
bifunctional. Bifunctional glycosylases also possess an AP lyase activity by which they 
cleave the DNA backbone via an elimination mechanism. BER initiated by 
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monofunctional glycosylases relies on the APE1 AP endonuclease to perform backbone 
incision. APE1 cleaves 5’ to the AP site to generate a 3’OH and a 5’ deoxyribose 
phosphate (5’dRP). AP sites generated by spontaneous base loss will also enter the BER 
pathway at this point. Bifunctional enzymes generate additional DNA end configurations 
that require further processing before the subsequent step can take place. This could 
entail removal of a 3’-phosphate or phosphorylation of a 5’-hydroxyl both of which can 
be performed by PNKP, which also participates end processing during NHEJ (see 
Section 1.3.5). At this stage, repair can proceed via the short or long patch BER 
subpathways. In the predominant short patch BER pathway, DNA Pol β removes the 
5’dRP and fills the single nucleotide gap. In long patch BER, 2-8 nucleotides are added 
either by Polβ or replicative polymerases/PCNA, displacing the existing 3’ strand. The 
resulting flap is cleaved by FEN1/PCNA. The factors that determine the selection of 
short or long patch BER are not fully understood but they may include ATP 
concentration, the nature of the 5’dRP (oxidised sugars cannot be removed by Pol β) and 
the proliferation status of the cell(Robertson et al. 2009). In the final step of both 
pathways, the resulting nick is sealed by DNA LigIII (complexed with XRCC1) or DNA 
LigI. BER functions are generally thought to be coordinated to avoid the persistence of 
potentially dangerous intermediates (AP sites, SSBs). After glycosylase recognition and 
hydrolysis, intermediate substrates remain sequestered until they are acted on by the next 
enzyme in the pathway(Prasad et al. 2011). 
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Table 1.1 Mammalian DNA Glycosylases and some of their substrates 
Adapted from (Krokan & Bjoras 2013). Abbreviations: U, uracil; 5-FU, 5-fluorouracil; 
5-hmU, 5-hydroxy-methyluracil; 3meA, 3-methyladenine; 7meG, 7-methylguanine; 
3meG, 3-methylguanine; 5-hC, 5-hydroxycytosine; Tg, thymine glycol; 5-hU, 5-
hydroxyuracil. 
 
1.3.4 Nucleotide Excision Repair  
Nucleotide excision repair (NER) is the other major pathway tasked with removing 
single strand lesions. NER is a more complex process than BER and involves more than 
25 gene products. It acts upon a broad range of DNA lesions that, whilst chemically 
distinct, all have a destabilizing or distorting effect on the DNA helix. These include UV 
photoproducts and bulky lesions formed by environmental mutagens and 
pharmaceuticals. NER comprises two subpathways : global genome NER (GG-NER), 
which processes damage occurring throughout the genome, and transcription-coupled 
NER (TC-NER), which only removes lesions from the transcribed strands of active 
genes. This section is informed by the recent review of NER in eukaryotes by Schärer 
(Scharer 2013). 
 
Enzyme Location Mono/Bifunctional Substrate 
UNG2 Nuclear Mono U, 5-FU, U:A, U:G 
UNG1 Mitochondrial Mono Like UNG2 
SMUG1 Nuclear Mono 5-hmU, U:G, U:A, ssU, 5-FU 
TDG Nuclear Mono U:G, T:G, 5-hmU, 5-FU 
MBD4 Nuclear Mono U:G, T:G, 5-hmG 
MPG Nuclear Mono 3meA, 7meG, 3meG, 
OGG1 Nuclear Bi 8-oxoG:C, FapyG:C 
MUTYH Nuclear Mono A opposite 8-oxoG/C/G 
NTHL1 Nuclear Bi Tg, FapyG, 5-hC 
NEIL1 Nuclear Bi Tg, FapyG, FapyA, 8-oxoG, 5-hU 
NEIL2 Nuclear Bi Like NEIL1 
NEIL3 Nuclear Bi FapyG, FapyA 
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The two NER subpathways diverge at the initial damage recognition step. GG-NER 
utilises XPC (stabilised by RAD23B) to recognise damage and recruit repair factors, 
although the UV-DDB complex is necessary to facilitate the recognition of CPDs. XPC 
binds to the non-damaged strand and locates damaged sites by inserting a hairpin 
domain between the two strands and encircling the non-damaged strand. Hairpin 
insertion is facilitated by the loss of helical structure and attendant thermodynamic 
destabilisation caused by the lesion(Y. Liu et al. 2011). XPC-RAD23B also induces 
bending and local unwinding of the DNA that presumably aids in hairpin insertion. 
Because it recognises the distortion caused by the lesion rather than the lesion itself, 
XPC is able accommodate a wide range of structurally unrelated substrates. The 
accessory factor UV-DDB comprises two subunits DDB1 and DDB2. DDB1 binds to 
the CUL4-RBX1 complex and forms a ubiquitin ligase. DDB2 also uses a hairpin 
domain to sense damage but in this case DDB2 extrudes the lesion from DNA and binds 
to it. Lesion binding by UV-DDB2-CUL4 induces a 40° kink in DNA and facilitates its 
recognition by XPC(Scrima et al. 2008). This is especially important for CPDs, which 
induce minimal distortion and are poor XPC substrates. Mutations in DDB2 compromise 
CPD repair whilst 6-4 PP repair remains largely unaffected.  
 
In TC-NER, damage recognition is a consequence of lesion-induced stalling of RNAPII. 
This in turn recruits TFIIH in a process that requires CSA, CSB and XAB2. The exact 
mechanism is unknown but the roles of some essential TC-NER proteins have been 
partly elucidated(Gaillard & Aguilera 2013). CSB tightly associates with stalled RNAPII 
and recruits various factors including CSA, TFIIH, XPA and XPF-ERCC1. CSA recruits 
XAB2, which binds XPA and may act as a scaffold. CSA also forms an E3 ligase with 
DDB1-CUL4 and can ubiquitylate CSB leading to its proteasomal degradation. This 
may be prevented by a deubiquitinase USP7, which is localised to the site by UVSSA - a 
CSB, CSA and RNAPII interaction partner. An important step in TC-NER is thought to 
be RNAPII backtracking to allow access by repair factors. One view is that by 
preventing CSB degradation, UVSSA/USP7 allows time for CSB to remodel the 
transcription complex(Schwertman et al. 2013). CSB also recruits chromatin 
remodelling factors p300 and HMGN1, which may loosen the chromatin structure 
behind the lesion to permit RNA backtracking(Hanawalt & Spivak 2008). 
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After recruitment of TFIIH and repair factors, the two NER subpathways converge. 
TFIIH comprises 10 subunits, including XPB and XPD, two essential NER proteins. 
XPB opens a 30-nucleotide stretch around the lesion in an ATP dependent manner that 
allows the XPD helicase to proceed along the damaged strand until it reaches the lesion 
and stalls due to a damage-sensing domain(Mathieu et al. 2013). Confirmation by TFIIH 
of both the presence and location of the lesion precedes formation of the preincision 
complex. Following recruitment of XPA, XPG and RPA, XPC-RAD23B departs. XPA 
interacts with many NER factors and is thought to ensure their correct localisation. It 
binds to the 5’ end of the open DNA bubble where it can interact with RPA and ERCC1-
XPF(Krasikova et al. 2010). The RPA heterotrimeric single stranded binding protein has 
at least two roles in NER. It binds to the undamaged strand and protects it from nuclease 
activity. RPA also assists in the orientation of the incision nucleases XPG and ERCC1-
XPF(de Laat et al. 1998). The XPG endonuclease, which is recruited through an 
interaction with TFIIH binds 3’ to the lesion and specifically cuts at double strand/single 
strand junctions with 3’ ssDNA overhangs. ERCC1-XPF completes the pre-incision 
complex and is positioned 5’ to the lesion by its interactions with XPA and RPA. 
ERCC1-XPF makes the first incision followed by XPG-mediated incision 3’ to the 
lesion. The ERCC1/XPF complex is also involved in other DNA repair pathways 
although its function is not always known in detail(Kirschner & Melton 2010).  
 
Dual incision by ERCC1-XPF and XPG is followed by release of the cleaved 
oligonucleotide and repair DNA synthesis. Three different polymerases - Pol δ, Pol ε 
and Pol κ - can carry out this resynthesis step(Lehmann 2011). All require PCNA for 
recruitment (PCNA must be monoubiquitinated in the case of Pol κ, which is a Y family, 
translesion polymerase) but the clamp loader differs in each case. Pol δ requires RFC, 
Pol ε a variant RCF and Pol κ requires XRCC1. Depletion studies reveal that Pols δ and 
κ probably work on the same pathway and Pol ε in another. The criteria that determine 
the selection of one polymerase over another remain an area of active research. Non-
proliferating cells reveal a preference for Pols δ and κ whilst proliferating cells also 
utilise Pol ε suggesting that cell cycle effects such as polymerase or dNTP 
concentrations may influence polymerase choice. The ligase that seals the nick depends 
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on the polymerase used; LigIII with Pols δ and κ and LigI with Pol ε. LigIII is the major 
NER ligase in non-dividing cells. 
 
1.3.5 Double strand break repair 
Mammalian cells have two main DSB repair pathways: non-homologous end-joining 
(NHEJ) and homologous recombination (HR). HR requires the presence of a sister 
chromatid to serve as a template for repair and so can only operate in S or G2 phase of 
the cell cycle. NHEJ is the major DSB repair pathway in G1 phase. The two pathways 
also have roles in addition to their DNA repair function. HR is involved in meiotic 
division whilst NHEJ is involved in antibody generation and telomere maintenance. 
NHEJ is considered the more error prone of the two pathways as it does not rely on 
sequence homology. In contrast, HR is considered to be essentially error free. A backup 
end-joining system known as alt-NHEJ operates through minimally resected ends. 
Although suppressed under normal conditions, there is evidence to suggest that it is 
responsible chromosomal translocations linking it to carcinogenesis(Kehrer 2000; 
Bunting & Nussenzweig 2013). 
 
NHEJ is initiated via rapid detection of DSBs by the Ku70:Ku80 heterodimer. Ku is an 
abundant (1 x 106 molecules per cell) nuclear protein that avidly binds free DNA ends 
by threading the broken strand through its double ring structure (Grundy 2014). Ku 
binding protects ends from nucleolytic activity and also serves as a platform for 
recruitment of other NHEJ factors. The ends of DSBs are structurally diverse and must 
be processed before they can be ligated. The essential NHEJ proteins: Ku, DNA PKcs, 
XRCC4, DNA Ligase IV and XLF make up a core complex to which processing factors 
are recruited. These end-processing factors include nucleases (Artemis, APLF, TDP1), 
polymerases (λ and µ) and phosphatases (PNKP and aprataxin). A model of core 
complex assembly based on interaction studies envisages sequential recruitment of Ku, 
followed by DNA PKcs, then XRCC4-Lig4 and XLF. More recent real time imaging 
suggests that after initial DSB detection by Ku, the remaining factors are recruited 
simultaneously to form the core complex(Yano et al. 2009). DNA PKcs binds to Ku in a 
DNA dependent manner by threading DNA through its N-terminal channel to form a 
stable holoenzyme known as DNA PK. Ku and DNA binding activates the kinase 
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activity of DNA PKcs allowing it to phosphorylate other NHEJ factors and itself. DNA 
PK phosphorylation (either by ATM or itself) is essential for NHEJ activity and induces 
conformational changes that regulate access to DNA ends by processing factors(Waters 
et al. 2014). DNA-PKcs is also thought to be involved in the initial tethering of the two 
ends known as synapsis(Weterings 2003). XRCC4-Lig4 is recruited as a preformed 
complex. Lig4 is a NHEJ-specific DNA ligase that rejoins the ends once processing has 
taken place. XRCC4 stabilises Lig4 and forms long filaments with XLF that may play a 
structural role in stabilising synapsis(Chiruvella et al. 2013). 
 
It has been suggested that the processing of DNA ends is iterative with NHEJ factors 
binding and departing multiple times until the ends are ready for ligation(Lieber 2010). 
Lesion complexity (i.e. the amount of processing needed) may be a deciding factor in the 
likelihood of processing errors(Schipler & Iliakis 2013) which can cause deletion (by 
nuclease action), insertion ( by template-independent polymerisation) or aberrant 
synapsis. Ligation-appropriate ends can actually be joined in a rapid DNA-PKcs 
independent mechanism that requires only Ku, XRCC4, LigIV and XLF(Reynolds et al. 
2012).. Current thinking frames NHEJ as taking place within a dynamic, multi-subunit 
complex with Ku mediating the recruitment of repair factors as needed(Radhakrishnan et 
al. 2014).  
 
Rejoining of DSBs by HR can be divided into 3 stages – pre-synapsis, synapsis and post-
synapsis. The initial stage in pre-synapsis is resection of the 5’ ends to yield 3’ single 
stranded DNA. Resection is carried out by MRN in conjunction with CtIP, Exo1, Dna2 
and BLM. The MRN heterotrimer comprises Mre11, which possesses both endonuclease 
and 3’-5’ exonuclease activity, Rad50, which mediates DNA binding and tethers broken 
ends through a flexible hinge, and Nbs1, which recruits Mre11 and Rad50 to DSBs via 
its interaction with γH2AX and both recruits and is a target of ATM and ATR(Y. Zhang 
et al. 2006). The current working model of rejoining is a two-step process in which the 
Mre11 endonuclease first nicks the 5’ strand at a site distant from the DSB and then uses 
its 3’-5’ exonuclease activity to resect towards the end, possibly displacing Ku in the 
process. Resection is extended by the 5’-3’ nuclease activity of Exo1 and the combined 
action of helicase/endonuclease activity of BLM/Dna2. CtIP mediates this process via its 
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interaction with BRCA1 (discussed below). The resulting single stranded region is 
quickly coated with RPA, which is then displaced by the recombinase Rad51, a process 
requiring BRCA2 and Rad52. Rad51 forms a nucleoprotein filament, in a process that 
also requires five mammalian Rad51 paralogues, and this initiates the search for the 
undamaged homologous duplex. Rad51 contains two DNA-binding sites, one binds the 
resected single stranded DNA and the second binds to target strands to be probed for 
homology. More rapid repair at less stable AT-rich regions supports the notion that 
target strand binding occurs at transitory ssDNA bubbles resulting from DNA 
“breathing”. DNA stretching within the Rad51 filament results in 3 bp segments of DNA 
that retain B-DNA conformation separated by extended internucleotide regions. In order 
to interact with the extended DNA-Rad51 filament, target DNA must deform and stable 
binding can only be achieved if the energy required for deformation is offset by base 
pairing and thus only the homologous region is targeted(Renkawitz et al. 2014).  
 
Once the homologous region has been found, HR enters the synaptic phase and strand 
exchange leads to the formation of a D-loop that comprises the newly formed 
heteroduplex and the displaced strand. In the post-synaptic phase, repair synthesis by Pol 
η commences from the broken 3’ end(McIlwraith et al. 2005). In mitotic cells, the 
primary outcome is displacement of the newly synthesised strand by helicase action and 
re-annealing with the original broken DNA end in a process termed synthesis-dependent 
strand annealing. An alternative outcome is capture of the other DNA end by the D-loop 
to form a double Holliday junction which is cleaved by resolvases to yield crossover 
products (favoured in meiotic cells) or non-crossover (favoured in mitotic cells) products, 
or dissolved by the BLM-TopoIIIα-RMI1-RMI1 complex.  
 
alt-NHEJ can perform Ku- and Lig4- independent end-joining. In view of the severe 
consequences of NHEJ and HR loss, alt-NHEJ is unlikely to make a major contribution 
to overall DSB repair. Alt-NHEJ is thus far poorly characterised. Current knowledge 
presents the following model, which consists of three key steps – recognition and 
tethering, processing, and ligation(Frit et al. 2014). All alt-NHEJ factors are repurposed 
from other repair pathways including BER, NER, HR and TLS. The initial recognition 
of the break is carried out by PARP1 (PARP inhibitors suppress alt-NHEJ), which both 
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tethers the ends and recruits other factors including XRCC1, Lig3, PNK and MRN, 
which may also assist in tethering the ends. If present, Ku can outcompete PARP1 for 
ends thus suppressing alt-NHEJ if classical NHEJ is functional. The next step is short-
range resection of the ends by HR factors MRN and CtIP (knockout of either supresses 
alt-NHEJ) to expose regions of microhomology (6-8bp), which may aid in synapsis 
through annealing. Although not absolutely essential to all alt-NHEJ reactions, 
microhomology use seems to predominate. Tumours that show reduced Ku activity have 
increased evidence of microhomology around rejoining sites and are subject to gross 
chromosomal rearrangements(Bentley et al. 2009). Pol λ is the most likely candidate for 
gap filling whilst FEN1 and PNK process the ends ready for ligation; XRCC1-Lig3 
seems to be the prime candidate for this role but Lig1 can substitute. There is by no 
means a definitive list of factors owing to alt-NHEJ’s apparent flexible and opportunistic 
nature. 
 
End resection seems to be a key determinant in the choice of DSB repair pathway. 
Selection is mediated by an antagonistic relationship between 53BP1, which promotes 
NHEJ, and BRCA1, which positively regulates HR. Upon detection of a DSB by MRN, 
ATM is recruited and histone H2AX is phosphorylated. The product, γH2AX, is 
recognised by MDC1, which in turn recruits more MRN and ATM, in a positive 
feedback loop. Another consequences of MDC1 binding is 53BP1 recruitment to 
chromatin, where it cooperates with RIF1 to oppose end resection. This blocking 
mechanism can be counteracted in S phase via CtIP phosphorylation and association 
with BRCA1. BRCA1-CtIP mediates the exclusion of 53BP1-RIF1 from chromatin thus 
allowing end resection and hence HR to take place(Panier & Boulton 2013). End 
resection is also a necessary step in alt-NHEJ initiation. Deletion of 53BP1 leads to 
excessive end resection and an increase in alt-NHEJ. It can also rescue genomic 
instability associated with BRCA1 deficiency by promoting HR, thereby highlighting 
the delicate balance between NHEJ and HR(J. R. Chapman et al. 2012). More extensive 
resection and formation of Rad51 filaments are both refractory to alt-NHEJ thus 
suppression occurs on multiple fronts provided that primary repair pathways are 
functional. 
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1.3.6 Mismatch Repair (MMR) 
Replicative DNA polymerases incorporate a non-complementary nucleotide every 105 to 
106 base pairs. Intrinsic proofreading activity of the polymerase improves fidelity by a 
further two orders of magnitude. Post-replicative DNA mismatch repair (MMR) corrects 
insertion errors missed by proofreading and reduces the overall replication error rate to 
around 10-9 nucleotide. Insertion/deletion loops (IDLs) generated by strand slippage 
during DNA replication of repeated mono- or dinucleotide sequences (microsatellites) 
are also corrected by MMR. MMR failure is associated with a mutator phenotype and an 
approximately 100-fold increase in the rate of spontaneous mutation. Mismatches 
represent a unique challenge for DNA repair as they are only apparent in duplex DNA 
and the lesion is lost as soon as the strands are no longer annealed. This section 
summarises the content of the 2013 review by Jiricny(Jiricny 2013). 
 
MMR consist of three steps – recognition, degradation of the error containing strand, 
and error-free resynthesis. MMR must recognise a range of different distortions and 
ensure that the mismatched (i.e. nascent) strand is degraded. The recognition step is 
performed by heterodimers of MSH proteins. Each has a conserved C-terminal ATPase 
domain that controls key conformational changes. The ability to utilise different 
combinations of subunits give the cell scope to recognise a wider variety of substrates. 
For example, the MSH2-MSH6 heterodimer (known as MutSα) recognises single base 
mismatches (eg G:T) and 1/2 nucleotide IDLs most efficiently whereas larger IDLs are 
more efficiently recognised by the MSH2-3 dimer (MutSβ). The current proposed model 
of mismatch recognition begins with MutSα loosely bound to DNA, hydrolysing ATP as 
it translocates along the helix. When it encounters a mismatch (perhaps identified 
through unfavourable electrostatic or H-bonding interactions), a conformational change 
is triggered. A phenylalanine residue is inserted into the helix where it stacks with the 
aberrant base. At this point, after a final ADPATP exchange, the ATPase domain of 
MSH6 is inhibited. A similar ADP-ATP exchange in MSH2 triggers removal of the 
phenylalanine and transition to a more tightly bound clamp that is free to slide along 
DNA. The MutLα (MLH1: PMS2 heterodimer) is recruited to form a ternary 
MutSα/MutLα/DNA complex. The exact timing of this interaction is unknown although 
MutSα can assume its sliding clamp form in the absence of MutLα suggesting that their 
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association follows mismatch recognition. MutLα also encircles DNA via an ATP-
driven conformational change. MutLα was initially thought simply to serve as a 
“matchmaker” to assemble MMR factors. The more recent discovery of its endonuclease 
ability, activated by the interaction between the ternary complex and PCNA, has forced 
reconsideration of its role.  
 
Degradation of the incorrect strand follows mismatch recognition. To accomplish this, 
Exo1, the 5’3’ nuclease associated with MMR, has to be loaded onto the nascent 
strand, 5’ to the mismatch. Exo1 loading occurs at nascent strand discontinuities which 
allow MMR to distinguish it from the template strand. Okazaki fragments provide many 
opportunities for Exo1 loading on the lagging strand. On the leading strand, the 
endonuclease activity of MutLα introduces nicks 5’ to the mismatch. More distant, 
replication related nicks facilitate RFC-mediated PCNA loading onto DNA. The 
MutSα/MutLα complex can diffuse along DNA in either direction until it reaches a 
loaded PCNA forming a quaternary complex. If the PCNA is 5’ to the mismatch, Exo1 
can be loaded and degradation can begin. If PCNA is 3’, the complex must travel back 
past the mismatch and Exo1 loading is accomplished at nicks introduced by MutLα. The 
defective DNA strand can then be replaced in an error-free manner by Pol δ. 
 
In the case of a template nucleotide without a complementary base (e.g. O6meG), repair 
synthesis directed to the nascent strand will retrigger MMR. This cycle occurs 
repeatedly leading to the formation of a persistent SSB, which will be converted to a 
potentially lethal DSB upon attempted replication. This is a mode of cell killing for 
many methylating agents and MMR deficient cells are highly resistant to this family of 
drugs. Loss of MMR also greatly increases mutation frequency. Lynch syndrome 
patients who inherit a mutated MMR allele have a high predisposition toward colon 
cancers that are characterised by early onset, complete loss of MMR and high mutation 
rates.  
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1.3.7 Translesion Synthesis (TLS) 
Although classified as a DNA damage tolerance mechanism rather than a repair pathway, 
TLS is integral to maintaining genome stability.  
 
The high fidelity exhibited by replicative polymerases is a consequence of rigorous 
steric and electrostatic constraints imposed by their active sites. These constraints render 
them unable to process template distortions resulting from DNA lesions, some of which 
inevitably are not removed prior to replication. In contrast, TLS polymerases possess a 
more accommodating active site capable of accepting a variety of templates. This 
relaxed tolerance carries the unwelcome consequence of potential mutagenesis and 
deployment of TLS must be tightly regulated. The Y family is the most abundant class 
of TLS polymerases. Y family members include Rev1 and Pols η,ι and κ. These are the 
primary exponents of TLS and also significant contributors to DNA damage–induced 
mutagenesis(Sale et al. 2012). 
 
In addition to the less stringent active site, the Y family polymerases also lack 3’-5’ 
exonuclease proofreading activity. They are less processive owing to fewer contacts with 
both the template and incoming nucleotide. Each of these factors contributes to their 
decreased fidelity.  
 
Pol η is able to bypass T<>T CPDs with higher fidelity than any other known 
polymerase albeit with slightly higher chance for misinsertion at for the 3’T(McCulloch 
et al. 2004). It does, however, exhibit low fidelity when acting upon undamaged DNA. 
The risk is minimised by the reduced processivity of Pol η that disengages from the 
template after the addition of three bases(Biertümpfel et al. 2010). A Pol η defect in 
XPV patients is associated with increased UV induced mutagenesis due to the 
cooperative action of the alternative TLS polymerases Pol ι and Pol κ together with Pol ζ 
on CPDs. Replication past (6-4)PPs proceeds normally in XPV cells suggesting another 
polymerase is responsible for their bypass(Yoon et al. 2010). Pol ι can accurately bypass 
8-oxo-G (avoiding Hoogsteen pairing with A) and contributes to UV photoproduct 
bypass(Kirouac & Ling 2011). Pol κ can bypass a limited spectrum of alkylation 
products. It is also an efficient extender from mismatched primer termini although this 
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role is likely played by Pol ζ (discussed below). Rev1 inserts dCMP opposite a wide 
range of lesions although it has another important function as an adaptor for the 
recruitment of the other Y-family polymerases to PCNA, for which its catalytic domain 
is dispensable. 
 
Pol ζ, a B family polymerase related to δ and ε, is inefficient at lesion bypass but is 
highly efficient at extending mismatched termini. It is able to participate in a two-step 
mechanism for lesion bypass in which Pol ζ binds and extends the initial nucleotide 
inserted by a stalled Y family polymerase at a damage site. This concerted action is 
thought to be the major mode of lesion bypass and this Pol η-mediated bypass of CPDs 
is somewhat atypical(Shachar et al. 2009). 
 
Upon encountering a lesion on the leading strand, the replication fork stalls. This halts 
replication and also increases the risk of DSB formation upon fork collapse(Aguilera & 
Gómez-González 2008). Lesions on the lagging strand present less of a problem as a 
polymerase can disengage and reengage downstream(Fu et al. 2011), leaving a single-
strand gap between two Okazaki fragments. Leading strand blockages result in 
uncoupled replication as template unwinding and lagging strand synthesis can continue. 
Historically, all leading strand synthesis was thought to be continuous. Re-priming has 
now been observed in yeast suggesting that downstream re-initiation occurs in 
eukaryotes as well as prokaryotes, which possess dedicated replication restart 
proteins(Yeeles et al. 2013). In these cases, post-replicative TLS is required to fill in the 
tracts of single-strand DNA on both leading and lagging strands.  
 
The need for extensive gap-filling can be avoided and fork progression maintained by 
the transient recruitment of a TLS polymerase by the replication machinery. The TLS 
polymerase bypasses the lesion and then departs allowing the replicative polymerase to 
resume synthesis. The post-replicative gap filling and fork-associated lesion bypass 
polymerases are recruited by mono-ubiquitination of PCNA and Rev1 
respectively(Edmunds et al. 2008). Following replication arrest, RAD18 and RAD6, an 
E3 ubiquitin ligase and an E2 ubiquitin conjugating enzyme respectively, are activated 
by interaction with RPA at single-stranded DNA and mono-ubiquitinate PCNA. This 
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PCNA modification serves to recruit Y-family polymerases via their C-terminal 
ubiquitin-binding domains. Mutation of K164 causes a defect in gap filling although 
some TLS activity appears to be independent of PCNA ubiquitination. PCNA can also 
be poly-ubiquitinated at the same site. This serves as a signal to commence an error-free 
repair mechanism that functions via recombination.  
 
1.3.8 Crosslink Repair 
Bifunctional electrophiles can induce DNA mono-adducts plus covalent DNA-protein, 
DNA intrastrand, and DNA interstrand crosslinks (ICLs). DNA monoadducts impede 
polymerases and impair both replication and transcription. In common with other bulky 
and polymerase-blocking lesions, most are resolved by BER and NER and can be 
bypassed by TLS. ICLs form an absolute block to replication and transcription as they 
prevent separation of the DNA strands by helicases and as a consequence an estimated 
20-40 ICLs are lethal to cells deficient in ICL repair(Clauson et al. 2013). Fanconi 
anaemia (FA), a disorder characterized by defective ICL repair, results from mutation of 
one of sixteen members of the FA pathway. Many DNA repair gene mutations sensitise 
cells to crosslinking agents as the proteins are repurposed for ICL repair by the 
coordinated action of FA factors.  
 
Following ICL-induced stalling of a replication fork, FANCM, FAAP24 and MHF are 
recruited to DNA. The replication fork is remodelled via the ATP-dependent translocase 
activity of FANCM, which leads to RPA recruitment to ssDNA at the damage site and 
subsequent ATR and checkpoint activation. Damage signalling is amplified by 
phosphorylation of FAND2 and FANCI by ATR, which also activates the MRN 
complex and CtIP. FANCM, FAAP24 and MHF form part of a larger complex with 
FANCs A, B, C, E, F, G and L and FAAP20, which is necessary for monoubiquitination 
of phosphorylated FANCD2-FANCI by the E3 ligase FANCL. FANCD2-FANCI 
phosphorylation is essential for ICL repair and coincides with the complex localising to 
chromatin where it recruits the nucleases and polymerases - including SLX4 FAN1 and 
Pol ν - involved in subsequent repair steps. SLX4 interacts with XPF-ERCC1, which is 
thought to make the 3’ incision in the lagging strand required for crosslink unhooking. 
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XPF mutants are much mores sensitive to crosslinking agents than other NER mutants 
and the XPA binding site of XPF is dispensable for its role in crosslink repair. Incision 
5’ to the crosslink allowing unhooking of the crosslink and generates a DSB(Clauson et 
al. 2013). The nuclease responsible for the 5’ incision remains unidentified. The 
unhooked crosslink attached to the leading strand is bypassed by a TLS polymerase. 
This restores the double stranded template and allows repair of the lagging strand DSB 
by HR. Mutations of Pol ζ and Rev1 sensitise cells to crosslinking agents as do 
mutations of Pol η, Pol κ and Pol ν, suggesting polymerase selection may be lesion 
dependent. Strand invasion by the 3’ lagging strand, begins HR-mediated repair, which 
restores the lagging strand and allows the replication fork to proceed. The remaining half 
of the ICL (now effectively a monoadduct) can be removed by NER. Thus, the FA 
pathway effectively routes ICL repair through HR and NER. In FA cells, erroneous 
attempts to fix ICLs by NHEJ generate chromosome breaks and radials; inhibition of 
NHEJ improves the survival of FA cells upon exposure to crosslinking agents(Adamo et 
al. 2010). 
 
1.3.9 DNA Damage Response  
DNA repair is one facet of a complex system that minimises the potential genotoxic 
effects of DNA damaging agents. This system, the DNA damage response (DDR), is a 
signal transduction pathway that coordinates attempted repair of DNA damage with 
apoptosis. The DDR has three tiers (signal sensors, transducers and effectors) and DDR 
signalling via a kinase cascade ultimately modulates various processes with links to 
genomic stability. These processes include DNA replication and repair, and cell cycle 
progression(Marechal & L. Zou 2013). 
 
The serine/threonine kinases ATM, ATR and DNA-PKcs sense DNA damage and serve 
as transducers for the DDR. ATM and ATR mediate the phosphorylation of hundreds of 
targets in a DNA damage-dependent manner whilst DNA-PKcs targets proteins involved 
in NHEJ. The active form of ATM is a monomer that originates from inactive ATM 
dimers and oligomers that dissociate upon DSB sensing. ATR activation is induced by 
the presence of ssDNA, a signal that is produced by many types of DNA damage. In 
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addition to direct phosphorylation and transcriptional control of DNA repair factors, 
ATM and ATR activation regulates other cellular processes to promote conditions that 
are conducive to repair. Local chromatin structure is modified via H2AX-dependent and 
-independent mechanisms to make lesions more accessible and increase recruitment of 
repair factors. More global changes to the cellular environment are also effected. Among 
these alterations, checkpoint activation is the most important. It is achieved through 
phosphorylation of the effector kinases Chk1 and Chk2 by ATR and ATM respectively. 
Cell cycle progression can be halted at various checkpoints, depending on cell cycle 
phase (G1/S, intra-S, G2/M). One important consequence of checkpoint activation is that 
it postpones the interaction between damaged DNA and replication or mitosis. This 
effectively increases the time the cell has to repair DNA the initial damage and thereby 
avoids the formation of more complex and potentially lethal lesions. ATM and Chk2 
knockout mice are viable whereas disruption of ATR or Chk1 is embryonic lethal(J. 
Smith et al. 2010). These findings suggest that the ATR-Chk1 branch plays a wider and 
more generalised role in repair and checkpoint response whilst ATM-Chk2 has a more 
specialised function in the DDR following direct DSB induction. The DDR also controls 
deoxynucleotide (dNTP) levels through increased activity of ribonucleotide reductase 
(RNR) and may target RNR to sites of damage to provide dNTPs for repair 
processes(Sirbu & Cortez 2013). 
 
The MRN complex senses DSBs and activates ATM. MRN binds free DNA ends where 
NBS1 interacts with ATM and localises it to the break. The histone variant H2AX is an 
important early target of ATM; its phosphorylation occurs within minutes of DSB 
formation and propagates >500kb into the flanking chromatin. Spreading of 
phosphorylated H2AX is facilitated by the action of Mdc1 that recruits RNF8 followed 
by RNF168, an E3 ligase that polyubiquitinates H2A and H2AX. This modification 
results in the association of BRCA1 and 53BP1, two factors integral to DSB repair 
(discussed in more detail in Section 1.3.5). The p53 protein is another important target of 
ATM (and also ATR, DNA-PKcs, Chk1 and Chk2). Phosphorylation of the p53 N-
terminus prevents the ubiquitination and degradation that occur in the absence of DNA 
damage. p53 binds DNA in a sequence specific manner and regulates expression of 
numerous target genes by interacting with transcription factors. Outcomes of p53 
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activation include cell cycle arrest, senescence, autophagy and apoptosis(Zilfou & Lowe 
2009).   
 
The RPA-coated ssDNA regions that activate ATR can be formed by DSB end resection 
by HR factors. The more extensively resected ends become, the more likely they are to 
activate ATR rather than ATM, and there is a shift from Chk2 to Chk1 activation over 
time. RPA coated ssDNA also arises during the course of repair and during replication 
stress, when helicase-polymerase progression is uncoupled by DNA lesions. ATR binds 
to RPA via its interacting partner ATRIP and is activated by autophosphorylation. 
ssDNA-dsDNA junctions are recognised by Rad17-Rfc2-5, which in turn loads the 
Rad9-Rad1-Hus1 (9-1-1) clamp. Assisted by the recently identified RHINO protein, the 
9-1-1 clamp recruits TopBP1, which binds to the auto-phosphorylated site of ATR, 
increasing its kinase activity. Claspin, a target of ATR and a key mediator in Chk1 
activation, is also recruited. Chk1 phosphorylates BRCA1 whilst ATM and ATR can 
phosphorylate BRCA2 promoting HR repair. ATR also phosphorylates many members 
of the FA pathway and plays an important role in ICL repair(Sirbu & Cortez 2013). 
 
DNA repair is an integral part of the DDR. Defective DNA repair is responsible for the 
hereditary disorders XP and FA. Defective DDR signalling is also a feature of much 
human pathology including cancer and neurological disorders. An inability to respond 
appropriately to DNA damage as a consequence of hereditary ATM defects in ataxia 
telangiectasia and mutated p53 in Li-Fraumeni syndrome result in cancer predisposition. 
The role of the DDR in localising DNA damage, signalling its presence and activating 
and up-regulating the various repair pathways puts it at the center of cell maintenance. 
Its successful operation requires the optimal interactions between large numbers of 
component proteins. Damage to this extensive protein family carries the risk of 
compromising cellular well-being and, like DNA, the DDR proteome presents a 
significant target for inactivation by environmental insults.  
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1.4 Solar radiation  
Much like oxygen, the sun is a double-edged sword. On one hand, its energy allows life 
on earth to exist, both by providing habitable conditions and serving as the driving force 
for the food chain via photosynthesis. On the other hand, solar radiation can have 
deleterious consequences for biological systems through its interaction with, and 
subsequent modification of, biomolecules. 
 
1.4.1 The solar radiation spectrum 
Solar radiation comprises wavelengths from across the electromagnetic spectrum 
although predominantly between 100 and 106 nm. This band contains the ultraviolet 
(UVR), visible and infrared regions (IR) (red line, Figure 1-10), all of which have 
biological relevance. The visible region (400-700nm) is required for photosynthesis 
whilst the IR (700-106 nm) imparts the majority of solar thermal energy to the earth’s 
surface. Historically, the deleterious effects of solar radiation were solely ascribed to the 
UVR region (Diffey 1991) but more recent findings suggest contributions from visible 
and IR(Zastrow et al. 2009). The UVR region is arbitrarily subdivided into three 
wavelength categories: UVA (400-320nm), UVB (320-280nm) and UVC (280-100nm).    
Absorption by the canonical nucleic acid bases peaks at around 260nm whilst proteins 
absorb maximally at around 280nm. As a result, shorter wavelengths of UVR are more 
damaging to cells.  
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Figure 1.10 Incoming solar wavelengths 
Solar radiation at the top of the atmosphere (red) is selectively attenuated by atmospheric 
constituents resulting in an altered wavelength profile at the Earth’s surface. American Society 
for Testing and Materials: Terrestrial Reference Spectra. 
 
Interaction with the atmosphere significantly alters the wavelength profile of solar 
radiation arriving at the Earth’s surface, (blue line, Figure 1-10). For living organisms, 
the most important consequence of this is the loss of shorter UVR wavelengths. 
Atmospheric oxygen absorbs wavelengths below 240nm, triggering photolysis and the 
formation of ozone. The resulting stratospheric ozone layer absorbs UVR with 
wavelengths ≤ approximately 310nm. These two processes ensure that the Earth’s 
surface is entirely shielded from UVC and the majority of UVB radiation(de Gruijl & 
van der Leun 2000). UVR comprises around 5% of incident sunlight. Approximately 
95% of this is UVA and 5% UVB. Visible light comprises 45% and infrared around 
50%(Svobodová & Vostálová 2010). The ratio of UVA to UVB is not fixed and varies 
with latitude, season, time of day and cloud cover. 
1.4.2 Solar radiation and Cellular Components 
The skin is the main target for solar radiation where its effects are mediated by 
interactions with DNA, proteins and lipids. The wavelength of the incident radiation 
determines the nature of the interactions. Cellular macromolecules can be modified 
directly via absorption of radiation, or as a consequence of interactions with 
endogenous chromophores (photosensitisers) and the formation of RS. Historically, the 
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action spectrum of radiation in mammalian cells has focused studies on the interaction 
between DNA and UVC. In recent years, recognition of the contribution of other 
wavelengths and macromolecules has increased.  
1.4.2.1  UVB 
UVB induces DNA photoproducts in the form of CPDs and 6-4 PPs. The yields and 
relative frequencies of these lesions can be found in Table 1-2. Other products (cytosine 
hydrates, adenine containing dimers) have been generated in model systems but have 
not been observed in skin DNA(Cadet et al. 2012). 8-oxoG is present in skin DNA and 
its formation suggests indirect RS production by UVB. Since photoproducts account for 
99% of UVB modifications, 8-oxoG is probably not a significant contributor to the 
genotoxicity of these wavelengths(Kielbassa et al. 1997).  
 
Some amino acid side chains (Trp, Tyr, Phe, His, Met, Cys) also absorb UVB and 
undergo oxidation (Pattison et al. 2011). UVB absorption generates radical cations that 
react with oxygen to give peroxyl products(M. J. Davies & Truscott 2001). Tryptophan 
is the most significant UVB chromophore and is converted to the tryptophan oxidation 
products outlined in Figure 3-3. Other endogenous UVB photosensitisers such as fatty 
acids and vitamins can generate 1O2 and other RS(Regensburger et al. 2012). Nitric 
oxide and H2O2 are also an integral part of the signal transduction pathways activated 
by UVB. Nitric oxide is crucial for melanogenesis(Romero-Graillet et al. 1996) whilst 
H2O2 is produced as part of apoptotic signalling(Peus et al. 1999). UVB can also cause 
lipid peroxidation in keratinocytes albeit at doses that exceed natural 
conditions(Morliere et al. 1995). 
1.4.2.2  UVA 
UVA can damage DNA by direct photoexcitation of DNA or by indirect triplet energy 
transfer from excited photosensitisers. UVA-induced CPDs are overwhelmingly (79%) 
T<>T and since the levels are similar in DNA irradiated in vitro and extracted from 
irradiated cells, the former mechanism appears to predominate (S. Mouret et al. 2010). 
Exogenous photosensitisers such as xenobiotics can shift this balance, however. UVA-
induced 6-4PPs have not been detected in mammalian cells(Sage et al. 2011) possibly 
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due to the nature of the excited state induced by UVA(Banyasz et al. 2011). Although 
CPD induction by UVA is 1000 times less efficient than by UVB, the higher proportion 
of UVA in sunlight together with its greater penetration into the dermis, means that up 
10% of CPDs in sun-exposed skin may be UVA-induced(Sage et al. 2011).  
 
Table 1.2 Photoproduct induction in human skin by UVA and UVB  
Values are lesions/ 104 bases per kJ/cm2 for UVA and per J/cm2 for UVB. Modified from Cadet 
et al(Cadet et al. 2012). 
 
UVA also causes oxidative DNA damage and 8-oxoG is the major oxidative DNA 
lesion. Approximately 80% is produced from 1O2 and the remainder from OH derived 
from O2- (Cadet & Douki 2011). The production of OH, also accounts for the SSBs 
and oxidised pyrimidines that constitute minor products of UVA irradiation. OH 
generation may be amplified by Fenton chemistry involving UVA-induced iron release 
from ferritin(Pourzand et al. 1999). 8-oxo-G was previously considered the signature 
lesion of UVA irradiation but it has since been shown that CPDs are induced at five-
fold higher levels (S. Mouret et al. 2006). Within skin, the CPD:8-oxoG ratio is cell-
type dependent and is reduced from 5.2 in keratinocytes to around 1.4 in melanocytes, 
possibly as a result of 1O2 produced by melanin photosensitisation(S. Mouret et al. 
2011a). 
 
UVA induces protein oxidation(Vile & Tyrrell 1995) and this is mediated by 1O2. 
Protein carbonyls and oxidised sulfhydryls(Vile & Tyrrell 1995)have been detected 
after UVA irradiation of human fibroblasts(Sander et al. 2002). Examples of UVA 
damage to specific proteins include PCNA(Montaner et al. 2007) and XRCC3(Girard et 
al. 2011). High UVA doses inactivate SOD and catalase in mouse skin but not SOD 
irradiated in vitro (Shindo et al. 1994). In human fibroblasts, SOD is unchanged 
immediately after irradiation but catalase activity is depleted and only recovers upon 
 T<>T  6-4 TT T<>C  6-4 TC C<>T C<>T 
UVA 0.69 - 0.12 - 0.06 - 
Yield 79%  - 14%  - 7% - 
UVB 2.06 0.19 1.58 0.72 0.56 0.44 
Yield 37% 3% 28% 13% 10% 8% 
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synthesis of new enzyme(Shindo & T. Hashimoto 1997). UVA also inactivates enzymes 
in intact human lenses irradiated in vitro(Linetsky et al. 2003). Protein carbonyls are 
detectable in dermis but not the epidermis of normal skin (Dimon-Gadal et al. 2000). 
This may reflect the higher epidermal antioxidant capacity(Rhie et al. 2001). Depletion 
of non-enzymatic antioxidants may also promote protein oxidation as endogenous RS 
levels are not longer controlled(Rhie et al. 2001). 
 
UVA also induces lipid peroxidation, which appears to coincide with the upregulation 
of MMP-1, a collagenase, providing another potential route to photoaging in addition to 
protein oxidation(Polte & Tyrrell 2004). Numerous other genes such as antioxidant and 
stress response factors are also upregulated by UVA in a 1O2 dependent manner(Tyrrell 
2011). UVA also stimulates NADPH oxidase at sub-lethal doses, which besides the 
increasing cellular RS burden, results in the synthesis of prostaglandin E2, in important 
immunosuppressive factor(Kalinski 2011) 
1.4.3 Solar radiation and the skin 
The above-mentioned cellular effects of UVR result in a number of adverse 
consequences for skin including photoaging and skin cancer. 
 
Photoaging is characterised by dermal dyspigmentation, laxity, yellowing, wrinkles, 
telangiectasia and cutaneous malignancies(Yaar & Gilchrest 2007). This correlates with 
decreasing and disordered collagen and the accumulation of partially degraded elastin in 
the upper dermis. UVA is thought to make the main contribution to photoaging due to 
its relative abundance and penetration. There may also be contributions from visible and 
IR wavelengths(Holzer et al. 2010). 
 
Skin malignancies occur frequently and incidence rates continue to increase in the 
Western world as changes in human behaviour and increasing life expectancy result in 
greater exposure to UVR, the main risk factor. They are classified in the first instance as 
either cutaneous malignant melanoma (CMM) or non-melanoma skin cancer (NMSC); 
the two main classifications of NMSC are basal cell carcinoma (BCC) and squamous 
cell carcinoma (SCC). 
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1.4.3.1 Cutaneous Malignant Melanoma (CMM) 
CMM describes a range of melanocytic neoplasms that can be further subdivided 
depending on growth patterns and site of occurrence(Bastian 2014). Incidence rates 
have increased more than any other cancer over the last 30 years(Parkin et al. 2011). 
Risk factors include large numbers of moles, organ transplantation and family history of 
melanoma. UVR exposure is a risk factor with the nature and timing seemingly most 
important; more than one severe sunburn in childhood causing a two-fold increase in 
melanoma risk(Narayanan et al. 2010). CMM shows limited dependence on cumulative 
sun exposure(S. Wu et al. 2014). Metastatic melanoma has a median survival of 6-10 
months after diagnosis and is responsible for the vast majority of skin cancer deaths. In 
2011, there were 13348 diagnoses of MM in the UK and 2209 deaths (Cancer Research 
UK). Two drugs, ipilimumab and vemurafenib (Section 4.1.4), showed promise in 
clinical trials and have now been approved for use although their survival benefits are 
still under assessment. 
 
1.4.3.2 Non Melanoma Skin Cancer (NMSC) 
NMSCs are keratinocyte-derived malignancies for which UVR exposure is an 
acknowledged risk factor. They are the most frequent cancers in Caucasian populations 
and account for 90% of all skin cancers and 20% of total malignancies in the UK 
(NCIN Data Briefing 2013). There were 102628 cases of NMSC in the UK in 2011, of 
which 74% were basal cell carcinomas (Section 1.4.3.3) and 23% squamous cell 
carcinomas (Section 1.4.3.4). Mortality rates are low as most lesions are curable. 
NMSCs can be disfiguring, however, and this is exacerbated by their propensity to 
appear on the face. The BCC:SCC ratio in immunocompetent individuals is around 4:1 
but this ratio is inverted in immunosuppressed patients(Mudigonda et al. 2012). Risk 
factors which are common to both BCCs and SCCs include fair skin, UV exposure and 
exposure to chemical carcinogens(Emmert et al. 2013). 
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1.4.3.3 Basal cell carcinoma 
BCCs are slow growing, translucent malignancies that form de novo with no detectable 
precursor lesion(Epstein 2008). They can cause morbidity by local invasion and 
multiple recurrences but less than 0.1% metastasise. BCCs are normally surgically 
excised which is curative in most cases with minimal recurrence. Other treatment 
options include curettage, cryosurgery, laser ablation and photodynamic therapy.  
 
Aberrant signalling is implicated in the development of BCCs. Signalling by Sonic Hh 
(SHh), the only Hh protein expressed in human skin, coordinates hair growth and stem 
cell proliferation and is usually turned off in adult skin(Saran 2010). The signalling 
cascade is mediated by the SMO receptor, which is repressed under normal 
circumstances by Ptch1; SHh lifts the repression upon binding to Ptch1 and permits 
SMO signalling resulting in activation of the Gli transcription factors, which target cell 
cycle regulators and itself, turning off the signal. Hh signalling can become 
pathologically activated by Ptch1 loss-of-function mutations (70% of sporadic BCCs) or 
SMO activating mutations (10-20%)(De Zwaan & Haass 2009).. 
 
UVR is the primary etiologic agent of BCC genesis although the precise nature of the 
relationship remains unclear. There appears to be a similarity to melanoma induction by 
UVR (i.e. a history of childhood and intermittent extreme exposure) although there is a 
also correlation with total UVR exposure albeit less strong than that of SCC (Dessinioti 
et al. 2010). 
1.4.3.4 Squamous Cell Carcinoma (SCC) 
SCC is the second most common cancer amongst Caucasians however unlike BCC, it 
carries a risk of metastasis and is therefore associated with greater morbidity and the 
majority of NMSC mortalities. Primary cutaneous SCCs are generally cured through 
excision but metastatic SCC has ten-year survival rates of less than 20%(Alam & 
Ratner 2001). SCC primarily occurs in the elderly with 70 years being the mean age of 
onset(Emmert et al. 2013). Long-term immunosuppressed patients have a 100-250 fold 
increased risk of SCC and the rate of metastasis exceeds 10%(Euvrard et al. 2003).  
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SCCs mainly develop from precursor lesions, principally actinic keratoses (AK). The 
vast majority of AKs do not progress to SCC and 26% may spontaneously 
regress(Emmert et al. 2013). Much like BCC, surgical excision remains the best option 
for SCC treatment although topical alternatives exist(Bahner & Bordeaux 2013). 
 
SCCs are thought to occur via a multistep process. 60-90% of AKs and SCCs have 
CT transitions in p53. UV-exposed but morphologically normal skin contains patches 
with p53 mutations that potentially represent an even earlier stage in carcinogenesis 
than AKs(de Gruijl & Rebel 2008). Loss-of-function NOTCH mutations are found in 
around 75% of SCCs however these are considered a stage progression rather than an 
initiatory event (N. J. Wang et al. 2011). Other pathways frequently dysregulated in 
SCC include ERK and EGFR/Fyn via RAS mutation, which affect proliferation and 
invasion respectively. Cell cycle inhibitor p16INK4a is also mutated in some tumours. 
One study showed that just two mutations (RAS in combination with CDK4 or RAS 
and NF-κB) may be sufficient for SCC formation(Dajee et al. 2003). 
 
1.4.3.5 Signature mutations in skin tumours 
Recent advances in whole exome sequencing have offered unprecedented insight into 
the genetics of cancer. In the most comprehensive study of SCC genetics to date, South 
et al found that 82% of sporadic SCCs contained a NOTCH mutation, confirming the 
earlier work of Wang et al, with a high (68%) proportion of CT transition mutations, 
confirming an etiologic role for UVR(South et al. 2014). Also notable was the 
extremely high mutational burden of SCCs (around 50 mutations per Mb DNA) which 
far exceeded the next highest cancer with metastatic potential (lung squamous cell 
carcinoma, 8.1 per Mb, (Hammerman et al. 2012)); only BCCs reach comparable levels 
(around 75 mutations per Mb(Jayaraman et al. 2013)). The mutational burden of both 
skin cancers suggests that skin possesses an extraordinary capacity to withstand tumour 
formation likely conferred by tumour suppressors such as NOTCH and PTCH1. 
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The link between skin cancer and DNA repair is made starkly apparent by the 
autosomal recessive disorder, xeroderma pigmentosum (XP). XP is characterised by 
mutagenic inactivation of one of 8 genes, 7 of which coordinate the NER response (XP-
A to XP-G) and the other (XP-V) which corresponds to loss of Pol η, the TLS 
polymerase responsible for bypassing unrepaired UVR photoproducts. XP patients have 
a 10,000 fold increased risk of NMSC with first onset at a median age of 9 vs. 67 in the 
general population(DiGiovanna & Kraemer 2012). Melanoma risk is also 2000-fold 
higher than average. Cells taken from XP patients can be defective in GG-NER (XP-C 
and XP-E), defective in both forms of NER (XP-A, XP-B, XP-D, XP-F or XP-G) or 
NER-proficient but with a defect in TLS (XP-V). It is clear that UVR mediated DNA 
damage and its persistence in the genome are key determinants of carcinogenesis. 
 
1.5 Photosensitisers 
Photosensitisers are molecules that potentiate the effects of radiation by the formation 
of RS upon photonic excitation. Many UVR and visible photosensitisers are present 
endogenously within cells and are responsible for some of the cutaneous effects of solar 
radiation described above. These effects can be exacerbated by the introduction of 
xenobiotics, usually in the form of pharmaceuticals, which act as exogenous PS and 
increase the RS burden on the cells resulting in an abnormal response to sunlight in 
patients.  
1.5.1 Mechanisms of photosensitisation 
The initial step in photosensitisation is absorbance of UVR or visible light by the 
photosensitiser (red arrow, Figure 1-11) to form an excited singlet state which can then 
undergo intersystem crossing to the first excited triplet state (purple arrow, Figure 1-11). 
This triplet state can decay back to the ground state (phosphorescence, orange arrow, 
Figure 1-11) or damage cellular targets by one of two mechanisms, known as type I and 
type II photosensitisation. Type I damage involves electron transfer or hydrogen 
abstraction by the excited photosensitiser and formation of photosensitiser and substrate 
radicals. Electrons can be transferred to suitable acceptors such as disulphides or 
oxygen, yielding O2- (Silvester et al. 1998; M. J. Davies & Truscott 2001). Radicals can 
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react with O2 to give peroxyl products that can decompose to give HO, which is also 
formed via the H2O2 generated by dismutation of the photosensitiser-derived O2-. Type 
I mechanisms can proceed in anoxic conditions via direct reaction of the excited PS for 
example the photocycloaddition of psoralen to DNA. Type II reactions are oxygen 
dependent and result from energy transfer to ground state oxygen to give 1O2 (blue 
arrows, Figure 1-11) which then reacts with targets within the cell. Type II reactions 
comprise the majority of endogenous photosensitisation occurring within the cell upon 
solar irradiation. An efficient PS must have a high quantum yield for a long-lived triplet 
state and for type II reactions, the energy of the triplet state must be ≥95kJ mol-1. 
Taking fluorescein as an example, intersystem crossing is inefficient and hence 
fluorescence predominates with no 1O2 production; halogenation of fluorescein to give 
Rose Bengal, increases ISC efficiency thus giving a high quantum yield for 1O2 
generation with minimal fluorescence(Wondrak et al. 2006). Generally photosensitisers 
act via both type I and type II mechanisms concurrently; the mechanism that 
predominates is determined by the photochemistry of the chromophore and the reaction 
conditions although 1O2 formation is usually the faster process(M. J. Davies 2004). 
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Figure 1.11 Electronic transitions in photosensitisation 
Upon absorption of radiation (red arrow), the photosensitiser is excited from the singlet 
ground state (S0) to the first excited singlet state (S1). Fluorescence is the direct return to 
the ground state with emission of light (green arrow). The photosensitiser can transition 
to an excited triplet state (T1) via intersystem crossing (purple arrow). The excited 
triplet state can engage in electron transfer with other molecules (type I) or energy 
transfer to oxygen (blue arrow, type II), exciting it to its excited singlet state (1O2). 
 
 
1.5.2 Photosensitisers and their effects 
The outcome of photosensitisation is determined by a number of PS characteristics 
including quantum yield, excitation wavelength and cellular and subcellular localisation. 
The reactions of any generated RS with biomolecules (Sections 1.2.3 and 1.3.1) will 
also govern which targets are modified and how; the chemistry of the PS excited state 
will affect type I reactions. Ultimately the chemical modifications to DNA, protein and 
lipids within the abovementioned parameters determine the consequences of 
photosensitisation. The importance of localization and reaction mechanism can be 
illustrated by comparison of two dermatological procedures; photodynamic therapy 
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(PDT) and psoralen-UVA treatment (PUVA). Both cause apoptosis in their target cells 
upon UVA irradiation but the proposed mechanisms are different in each case.  
 
PDT utilises the photosensitising ability of porphyrins, which are synthesized by the 
cell to serve as prosthetic groups for various proteins. Porphyrins act as classical type II 
photosensitisers and their pathological accumulation in the skin (disease states known 
as cutaneous porphyrias) are characterised by skin fragility and necrosis. By topical 
application of a compound that induces porphyrin accumulation, localised 
photosensitisation can be achieved upon exposure to a UVA light source; PDT is used 
in the treatment of BCCs, AKs and other skin disorders. The burst of singlet oxygen 
produced upon irradiation triggers immediate apoptosis in a manner reminiscent of high 
doses of UVA alone(Godar 1999), possibly via the activation of p38/JNK (R. W. K. Wu 
et al. 2011). The action of porphyrins is oxygen dependent(Carraro & Pathak 1988). 
Psoralen derivatives, the active compound of PUVA, have a furocoumarin structure, 
which intercalates with DNA. Upon UVA irradiation, a 2+2 photocycloaddition occurs 
between the C5-C6 double bond of thymine and the 4,5 double bond of the furan of 
psoralen to give a DNA-monoadduct. Absorption of a second photon leads to another 
cycloaddition and yields an ICL(Bethea et al. 1999). PUVA also causes apoptosis but 
with a slower time course which is more akin to DNA damaging agents such as UVC 
and ionizing radiation(Godar 1999). Psoralens can also form adducts with double bonds 
in proteins and lipid and also produces 1O2 and O2- however DNA crosslinking is not 
oxygen dependent(Carraro & Pathak 1988). A recent study posits that transcription and 
replication blockage by ICLs is the major factor in apoptosis(Derheimer et al. 2009). 
The DNA damaging effects of PUVA likely underlie the increased risk of 
NMSC(Archier et al. 2012); in contrast, PDT has no reported carcinogenesis(Ibbotson 
2011). 
 
Photosensitisation is the key component of PDT and PUVA but photosensitivity can 
also arise as an undesired side effect of a wide range of pharmaceuticals(Drucker & 
Rosen 2011). 
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1.6 Aims 
At the outset of my work, 6-thioguanine, a potent UVA photosensitiser that becomes 
incorporated into DNA, was known to act via type I and type II mechanisms leading to 
a variety of DNA lesions. Little was known about the effects on cellular proteins caused 
by 6-TG treatment and UVA although previous work in the lab suggested that DNA 
repair proteins are damaged. My aims were to: 
• Establish a robust protocol for examining protein oxidation in cultured cells and 
use it to identify proteins reproducibly oxidised by 6-TG photosensitisation. 
• Examine the effects of protein oxidation on DNA repair capacity. 
• Apply the developed assays to other photosensitisers to provide information on 
the mechanism that underlies the effects of 6-TG. 
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Chapter 2. Materials & Methods 
2.1 Chemicals and reagents 
Unless otherwise stated, all chemicals and reagents were sourced from Sigma-Aldrich. 
 
Standard solutions of 1 M Tris-HCl, 0.5 M EDTA, 1 M MgCl2, 5 M NaCl, 10x Tris-
Borate-EDTA (TBE) and phosphate buffered saline (PBS) were provided by Cancer 
Research UK London Research Institute (LRI) Central Services. 
2.1.1 32P Labelling of Oligonucleotides 
Oligonucleotides were diluted to a concentration of 0.5pmoles/µl. 4µl of 
oligonucleotide solution was added to 1µl of T4 kinase buffer, 1µl of T4 PNK (New 
England Biolabs) and 4.5µl γ-ATP (Amersham Pharmacia). This was incubated at 37oC 
for 40 minutes, and then labelled oligonucleotide separated from residual γ-ATP and 
ADP in a G50 spin column (Amersham Pharmacia). Labelled oligonucleotides were 
stored at 4oC. 
2.1.2 Annealing of Complementary Oligonucleotides 
Equimolar amounts of the complementary oligonucleotides were mixed. An appropriate 
volume of 10X Annealing Buffer (0.1M Tris-HCl, pH7.5, 0.1M MgCl2) was added. The 
solution was heated to 80oC for 5 minutes followed by incubation for 1 hour at room 
temperature.  
 Sequence 5’ – 3’ Supplier 
A GATCTGATTCCCATCTCCTCAGTTTCACTTCTGCACCGCATG atdbio 
B CATGCGGTGCAGAAGTGAAACTGAGGAGATGGGAATCAGATC atdbio 
C CCTGACTGTATGATGAAGATGCTGACGAG Sigma 
D CTCGTCAGCATCTTCATCATACAGTCAGG Sigma 
E CTCGTCAGCATCXACATCATACAGTCAGG Sigma 
F CCTGACTGTATGATGAAGATGCTGACGAG Sigma 
Table 2-1: Oligonucleotides used in this work.  
X= 6-TG 
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2.2 Cell Biology 
2.2.1 Cell culture and cell maintenance 
 
Cell Line Organism Origin Gene Mutated 
DNA repair 
status 
CCRF-CEM Human 
Leukemic T cell 
Lymphoblast 
MLH1 MMR deficient 
CHO – K1 Hamster Ovary - Proficient 
CHO – xrs6 Hamster Ovary Ku80 NHEJ deficient 
Table 2-2: Cell lines used in this work. 
DMEM (CHO) and RPMI (CCRF-CEM) media were obtained from Life Technologies, 
antibiotics from CRUK LRI Central Cell Services. Sterile plastic ware was from 
Corning, Becton Dickinson and BD Pharmingen. CCRF-CEM cells were maintained in 
RPMI medium, supplemented with antibiotics (penicillin and streptomycin prepared by 
Cancer Research UK LRI Central Services) and 10% Foetal Calf Serum, at 37°C in a 
humidified atmosphere containing 5% CO2. CHO cell lines were maintained in DMEM 
medium supplemented with antibiotics and 10% Foetal Calf Serum (Invitrogen) at 37°C 
in a humidified atmosphere containing 10% CO2. Cell numbers were determined using 
a haemocytometer or Cellometer AutoT4 (Biotechnologie GmbH). 
 
2.2.2 Drug Treatments 
6-TG treatment: 6-TG stock solution (1mM in 0.1 M NaOH, filter sterilised) was added 
to cells growing exponentially at around 500,000 cells/ml and incubated for 24 hours. 
 
Fluoroquinolones: All fluoroquionolones were prepared as stock solutions (50mM in 
0.1M NaOH). They were added to exponentially growing cells at around 500,000 
cells/ml and incubated for 1 hour. 
 
Vemurafenib: As for 6-TG but with vemurafenib stock solution (100mM in DMSO). 
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After drug treatment, cells were washed twice with PBS, and resuspended, generally at 
1-2.5 x 106 cells/ml in 10ml PBS for irradiation.  
 
2.2.3 Irradiation 
2.2.3.1 UVA irradiation 
Cells were generally irradiated in PBS in 10cm dishes. UVA irradiation was carried out 
using a UVH 250W iron bulb (UVLight Technologies) fitted with a black filter glass 
with a low range cut off at 320 nm, and high range cut off at 400 nm (Fig 2.1). The 
standard dose rate, as measured using a UVA Light Meter dosimeter (UVLight 
Technologies), was 0.1 kJ/m2/s and was used throughout. A temperature control unit, 
coupled to the irradiation chamber maintains the temperature at between 10~15°C 
during irradiation. 
2.2.3.2 UVC irradiation 
UVC irradiation was performed using the built in 254-nm UV light bulbs in a 
Stratalinker UV Crosslinker (Stratagene). The dose rate for irradiation was 
approximately 10 J/m2/s and the preset dose was delivered automatically by the 
calibrated crosslinker. 
 
 
 
 
 
 
 
Chapter 2 Materials and Methods 
 
 74 
Figure 2.1 Emission spectrum of the UVA light source. 
Emission spectrum for iron doped metal halide UV bulb fitted with a black filter glass 
with a low range cut off at 320 nm and high range cut off at 400 nm. (Adapted from 
UVLight Technologies).  
 
2.2.4 Proliferation Assay 
Approximately 107 cells were that had been treated with drug and/ or UVA were 
resuspended at 200,000 cells/ml in fresh growth medium. Cell growth was monitored by 
cell counts taken at 24 and 48 hours. 
 
2.3 Biochemical Techniques 
2.3.1 RIPA cell extracts 
Three pellet volumes of RIPA (Radioimmunoprecipitation Assay) buffer, 
50mM Tris pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X 
100) was added to approximately 108 cells that were then disrupted by vortexing. After 
20 min on ice with intermittent vortexing, extracts were centrifuged at 14,000 x g for 10 
mins. Aliquots of the supernatant were stored at -80°C. 
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2.3.2 Protein Gel Electrophoresis 
Nu-PAGE 10-well Bis-Tris 10% polyacrylamide gels (Life Technologies) were 
electrophoresed in X-cell SureLock Mini Cells. Samples (25µl max) were 
electrophoresed at 200V until the dye front reached the bottom of the gel. Each gel was 
run with RPN-800 Full Range Rainbow Markers (5µl) (GE Lifesciences). 
 
2.3.3 Immunoblot 
Separated proteins were transferred to a PVDF membrane (Immobilon-P, Millipore) 
overnight at 20V using a Biorad wet transfer apparatus. Following transfer, membranes 
were washed and blocked for 90 minutes with 10% (w/v) non-fat powdered milk in 
PBST (PBS + 0.1% Tween-20) at room temperature. Primary antibodies (Table 2-3 for 
dilutions and suppliers) were incubated for 1h at room temperature or overnight at 4°C 
All antibodies were diluted in 5% milk in PBST. Membranes were washed 3 x with 
PBS-T then incubated with the appropriate secondary antibody (Table 2-3, 1:5000). 
Membranes were washed 3 x with PBS-T and detected using ECL substrate (GE 
Healthcare) and proteins visualised using Amersham Hyperfilm ECL (GE Lifesciences).  
 
 
2.3.4 FHA derivatisation 
Aliquots of Alexa Fluor Hydroxylamine 647 (FHA) (Invitrogen) 1 mg/ml in distilled 
water were stored at -20°C. 1 µl of this stock was added to 20µg protein to give a final 
concentration of 0.05µg/µl FHA in 20µl. Following incubation at 37°C for 2 hours 5µl 
5x SDS loading buffer was added and the mixture left to stand at room temperature for 
5 minutes before gel loading and electrophoresis. Following electrophoresis, the dye 
front was excised from the bottom of the gel (to remove highly fluorescent 
unincorporated FHA) which was then rinsed in distilled water. At this point, if total 
protein content was to be examined, gels were fixed and stained with Sypro Ruby (Life 
Technologies) according to the manufacturer’s “Quick” protocol. Gels were imaged 
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using the Typhoon 9400 scanner (GE Healthcare) at “Normal” sensitivity at 633nm and 
488nm concurrently. Western blotting was carried out on unfixed gels. 
 
 
 
2.3.5 AFM derivatisation  
The protocol of Baty et al(Baty et al. 2002) was followed with the exception of the 
derivatisation reagent, which was substituted by Alexa Fluor 647 Maleimide (AFM, 
Invitrogen). Briefly, 25 x 106 treated cells were resuspended in 200µl extract buffer 
(100 mM N-ethyl maleimide (NEM), 40 mM HEPES pH 7.4, 50 mM NaCl, 1 mM 
EDTA, protease inhibitors,) and incubated at room temperature for 15 minutes. Cells 
were lysed by the addition of CHAPS at a final concentration of 1% w/v and the extract 
was vortexed and incubated for a further 15 min at room temperature. Insoluble material 
was separated by centrifugation at 8000 g for 5 min. Excess NEM was removed by 
passage through a spin column that had been equilibrated with 40 mM HEPES pH 7.4, 
50 mM NaCl, 1 mM EDTA, protease inhibitors, and 1% CHAPS w/v. DTT (1 mM) was 
Table 2-3: Antibodies used in this work 
 Supplier Dilution 
Ku 70/80 Stratech 1:1000 
Ku 70 Abcam 1:400 
Ku 80 Abcam 1:1000 
MCM 4 Abcam 1:1000 
MCM 6 Abcam 1:1000 
MCM 7 Abcam 1:1000 
RPA 32 Abcam 1:1000 
PCNA Santa Cruz 1:2000 
DDB1 Abcam 1:1000 
DDB2 Abcam 1:250 
Goat Anti Mouse HRP Biorad 1:5000 
Goat Anti Rabbit HRP Biorad 1:5000 
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added to the column eluate a and the extract incubated for 10 min at room temperature. 
This step reduces the oxidized thiols. AFM (10 mM in DMSO) was added to the extract 
to a final concentration of 100µM and the mixture was incubated in the dark at room 
temperature for 10 min. Excess AFM and salts were then removed by passage through a 
second spin column equilibrated with PBS. Samples were subsequently processed as for 
FHA derivatised extracts. 
2.3.6 2-D PAGE 
To 250µg FHA-derivatised cell extract protein, 2.5 µl IPG buffer (GE Healthcare, broad 
range) and 237.5 µl rehydration buffer (8M Urea, 2% CHAPS, 5% glycerol, 
bromophenol blue) was added for a final volume of 250 ml. This mixture was loaded 
onto a 13cm ceramic strip holder. An Immobiline DryStrip (pH 3-10 NL, 13cm) strip 
was added to the sample and the strip holder placed in an Ettan IPGphor apparatus. 
Isoelectric focussing (IEF) was carried out overnight under the conditions described in 
Table 2-4. 
 
 Voltage (V) Volt Hours Step & Hold / Gradient 
Step 1 30 480 Step & Hold 
Step 2 500 500 Step & Hold 
Step 3 1000 800 Gradient 
Step 4 8000 11325 Gradient 
Step 5 8000 4400 Step & Hold 
Table 2-4: Conditions used during isoelectric focussing 
 
Following IEF, proteins were reduced by incubating the strips for 15 mins at room 
temperature in 5ml equilibration buffer (0.1M? Tris pH 8.8, 6M Urea, 30% glycerol, 
2% SDS, bromophenol blue) containing 1% DTT. Strips were then transferred to 5ml 
equilibration buffer containing 4% iodoacetamide and proteins were alkylated for a 
further 15 min. Processed strips were loaded onto 10% Bis-Tris gels (BioRad) and 
electrophoresed at 125V until the dye front had exited the gel. SyproRuby staining and 
fluorescence imaging were preformed as described above.  
Chapter 2 Materials and Methods 
 
 78 
Gel spot excision was performed under blue light illumination using a scale image as a 
guide. Excised spots were analysed by mass spectrometry by the LRI Department of 
Protein Analysis & Proteomics.  
 
2.3.7 EMSA 
2.3.7.1 Ku 
Approximately 108 cells were resuspended in extraction buffer (20mM HEPES, pH 7.9, 
1mM MgCl2, 5mM EDTA, protease inhibitors, 1% Triton X-100), incubated on ice for 
30mins, and then centrifuged at 20,000 x g. 20µg extract was incubated with 10 fmol 
radiolabelled oligonucleotide duplex A+B (Table 2.1) for 15 minutes at RT in binding 
buffer (20mM Tris.HCl pH 8.0, 2mM MgCl2, 0.1mM EDTA, 0.25mM DTT, 200mM 
KCl) in 12.5µl reaction volume. For antibody supershift analysis, 1µl Ku Polyclonal 
70/80 (Stratech) was added and incubation continued for a further 10 mins. To each 
sample, 2.5 µl 6x DNA loading buffer (300mM Tris.HCl, pH8, 60% glycerol, 12mM 
EDTA, bromophenol blue) was added and electrophoresis performed on a 5% 
polyacrylamide gels. Running buffer was 0.25x TBE at 100V. The gel was dried and 
then exposed to a Storage Phosphor Screen (GE Healthcare) and imaged using a Storm 
scanner (GE Healthcare). 
 
2.3.7.2 DDB2 
Extracts were prepared in the DDB2 EMSA binding buffer (Wittschieben et al. 2005) 
(20 mM Tris-HCl, pH 7.5, 5 mM DTT, 150 mM NaCl, 1 mM MgCl2, 0.2 mM EDTA, 
and 5% glycerol) with the addition of 1% Triton X-100 (Invitrogen) and protease 
inhibitors (Roche). Oligonucleotide D (Table 2-1) was irradiated with 5000 J/m2 UVC. 
Oligonucleotide E was either irradiated with 100 kJ/m2 UVA or MMPP in a 10:1 
MMPP:oligonucleotide ratio. Treated oligonucleotides were annealed to radiolabelled 
complementary strands. Control duplexes were assembled from untreated 
oligonucleotides D and E. For EMSA assays, 10 fmol duplex probes were incubated 
with 20µg extract for 15 minutes at room temperature in binding buffer (20 mM Tris-
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HCl, pH 7.5, 5 mM DTT, 150 mM NaCl, 1 mM MgCl2, 0.2 mM EDTA, 5% glycerol). 
Electrophoresis and analysis was performed as described in the previous section.  
 
2.3.8 NHEJ Assay 
The assay was adapted from Baumann & West(Baumann & West 1998). The substrate 
is an XhoI-digested plasmid. pFastBac Dual (Invitrogen) plasmid was digested with 
Xho1 (NEB) and gel purified. 400ng linearised plasmid was end-labelled with ATP-[γ -
32P].  
Extracts were prepared from 5 x 107 treated and pelleted cells by resuspension and 
freeze thaw in three pellet volumes of LB buffer (25mM Tris.HCl, pH 7.5, 333mM KCl, 
1.3mM EDTA, 4mM DTT, protease inhibitors (Roche), phosphatase inhibitor cocktail 
II (Sigma)). Following 20 mins incubation on ice, extracts were centrifuged at 14,000 x 
g for 20 mins. The supernatant was dialysed overnight at 4°C against E buffer (20mM 
Tris.HCl, pH8, 100mM K(OAc), 0.5mM EDTA, 1mM DTT, 20% glycerol). Aliquots 
were stored at -20oC. 
 
For NHEJ assay, 10ng DNA substrate and 20µg extract were combined in a final 
volume of 10µl ligation buffer (50mM Tris. HCl, pH 8.0, 60mM K(OAc), 0.5mM 
Mg(OAc)2, 1mM ATP, 1mM DTT, 0.1mg/ml BSA) for 2 hours at 37°C. 
2.5µl buffer (10mg/ml Proteinase K, 2.5% SDS, 50mM EDTA, 100mM Tris.HCl, 
pH7.5) was then added and digestion carried out for 30mins at 55°C. 2.5 µl 6x DNA 
loading buffer (30% glycerol, 0.25% w/v bromophenol blue) was added and 
electrophoresis performed on a 0.7% agarose gel in TBE. The gel was dried, exposed to 
a Phosphor Screen and imaged using a Typhoon 9400 Scanner. 
 
For complementation, 1µl aliquots of appropriate dilutions of recombinant Ku 70/80 
(Trevigen) was added to the initial reaction mixture. 
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2.3.9 CM-H2DCFDA Assay 
Drug-treated cells (5.106) were resuspended in 1ml CM-H2DCFDA (Life Technologies 
solution (final concentration 7.2µM) and incubated at 37oC for 30 minutes. Cells were 
harvested, resuspended in PBS and UVA irradiated. They were then resuspended in 1ml 
PBS in 12 x 75mm tubes with cell strainer caps. FACS analysis was performed on a 
Beckton Dickinson FACScan using the FL1 channel for green fluorescence. Data 
acquisition and analysis was performed using CellQuest v3.3 software. 
 
2.3.10 RNO assay 
100µM p-nitroso-N,N-dimethylaniline was prepared in 0.1M sodium phosphate buffer 
pH 7.0 prepared with water or D2O. Stock solutions of each drug (10mM) and histidine 
(100mM) were prepared in phosphate buffer. These solutions were combined in a final 
volume of 800µl in triplicate wells of duplicate 96 well plates. One plate was kept in the 
dark whilst the other was irradiated with UVA (100 kJ/m2). Sample absorbance was 
then measured at 440nm using a plate reader. Mean values for the A440 remaining were 
calculated. 
 
In the modified assay all component were dissolved at the same concentrations in 
DMSO except histidine, which could only be dissolved in water-based buffer. 
 
2.3.11 Enzyme-linked immunosorbent assay 
The induction and persistence of CPDs and 6-4PPs in cellular DNA was determined by 
enzyme-linked immunosorbent assays (ELISA) performed according to the 
manufacturer’s (Cosmo Bio Co) instructions. 
Genomic DNA was extracted from treated cells using the QiaAMP DNA Mini Kit 
according to the manufacturer’s instructions, diluted in PBS and quantified using the 
Nanodrop spectrophotometer (NanoDrop Technologies). 96-well plates were pre-coated 
with 50 µl/well protamine sulphate (0.003% in H2O), dried at 37°C overnight, and 
washed with H2O. Triplicate samples of DNA: 200ng per well for 6-4PP detection or 
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10ng per well for CPD detection were added to the pre-coated plates which were dried 
overnight at 37°C. 6-4PPs or CPDs were detected using anti-6-4PP(Cosmo Bio Co LTD, 
1:1500 dilution) or anti-CPD (Cosmo Bio Co LTD, 1:1000 dilution) primary antibodies 
respectively, the biotin- F(ab’)2 fragment of goat antimouse IgG (H+L) (Invitrogen, 
1:2000 dilution) and streptavidin-coupled peroxidase (Invitrogen, final concentration 
0.1 µg/ml). Plates were incubated for 30 min at 37°C followed by five washes with 
PBST (0.05% Tween-20 in PBS). To the wells were was added 150µl citrate-phosphate 
buffer (pH 5.0) followed by 100µl substrate (8 mg o-Phenylene diamine/4 µl H2O2 
(35%) in 20 ml citrate-phosphate buffer, pH 5.0) and incubated at 37°C for 
approximately 10 min to allow colour development. The absorbance of each well was 
measured at 492 nm in a plate reader. 
To determine NER efficiency, treated cells were also irradiated with UVC (20 J/m2) and 
returned to full growth medium before DNA extraction and ELISA.  
 
2.3.12 DNA immobilisation for DDB2 binding 
DNA was extracted from treated cells using the QiaAMP Mini kit. Cell X-100 extracts 
were prepared from approximately 108 cells using the DDB2 EMSA binding buffer 
(Wittschieben et al. 2005) (5 mM DTT, 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 1 mM 
MgCl2, 0.2 mM EDTA, and 5% glycerol) with the addition of 1% Triton X-100 
(Invitrogen) and protease inhibitors (Roche). Cells were resuspended in 3 pellet 
volumes of buffer, incubated on ice for 20 mins and then centrifuged at 20,000 x g. 
Aliquots were stored at -80°C. 
 
Genomic DNA, diluted in 200µL 0.1M sodium citrate, pH5, was immobilised on a 
positively charged nylon membrane (Immobilon ny+, Millipore) using a slot blot 
apparatus attached to a vacuum manifold. The membrane was dried overnight at 37°C 
and then washed once with PBS-T. The membrane was blocked with 10% milk, then 
cut into narrow strips and incubated in 1ml of the X-100 extract for 15 min at room 
temperature to allow DDB2 binding. The membrane was then washed five times with 
PBS-T and probed with DDB2 antibody as described for the immunoblot procedure. 
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Chapter 3. Protein oxidation by 6-TG/UVA   
3.1 Introduction 
3.1.1 Protein oxidation by reactive species 
The relative abundance of cellular proteins (they account for 70% of dry mass) and the 
kinetic favourability of RS-reactions with amino acid side chains(M. J. Davies 2005) 
makes them a major target for oxidative damage. Protein oxidation usually 
compromises protein function although a few examples of activating oxidation also 
exist, most notably activation of protein kinase C by cysteine oxidation(Cosentino-
Gomes et al. 2012). Inactivating oxidation is not invariably detrimental and RS and 
protein oxidation are now seen as key features of cell signalling. Accumulation of 
oxidised proteins is associated with aging and with a number of disease states including 
diabetes, atherosclerosis and cancer (reviewed in (Berlett & Stadtman 1997)).  
 
Despite the ostensive chaos of unchecked RS production that characterises oxidative 
stress, protein oxidation exhibits a degree of specificity that has both chemical and 
biological underpinnings. The products of protein oxidation depend on the identities of 
the RS and the chemistry of the amino acids. Multiple products can be formed from side 
chain oxidation and these may undergo secondary reactions with other cellular 
molecules. Products from the oxidation of non-protein cellular components such as 
lipids can also modify proteins. All these factors combine to make the oxidised fraction 
of the proteome a chemically heterogeneous mixture.  
3.1.2 Factors affecting likelihood of oxidation 
Each RS has a specific profile of amino acid reactivity. At one extreme, typified by O2- 
and H2O2, reaction can only occur with activated protein thiols. At the other extreme, 
HO will react with any amino acid although the reaction rates span three orders of 
magnitude(Xu & M. R. Chance 2007). The reaction between an RS and an amino acid 
side chain is affected by multiple variables. Firstly, adjacent residues can influence the 
nucleophilicity of an amino acid, which makes it more attractive to many RS as they are 
generally electrophilic. Secondly, nearby bound metal atoms increase the likelihood of 
Chapter 3 Protein Oxidation by 6-TG/UVA 
 84 
Fenton chemistry. In addition, protein structure affects RS access - buried amino acids 
are less easily oxidised(Lundeen & McNeill 2013) and non-polar microenvironments 
within a protein can impede the formation of charged transition states. On a larger scale, 
protein reactivity can be influenced by subcellular location and its proximity to the 
source of RS as well as local pH. 
 
Given the diverse chemistry of amino acid side chains and RS, myriad oxidative 
modifications are possible. To simplify analysis, general markers of oxidation are 
frequently used and the two most common are discussed below.  
 
3.1.3 Thiol oxidation 
Protein thiols are a major target of oxidation in vivo(Conte & Carroll 2013). The 
sulphur atom can occupy various oxidation states and cysteine can function as a redox 
switch, as well as an active site nucleophile and structural element. Thiol oxidation is 
more kinetically favourable than the majority of oxidative modifications; in this way, 
preferential oxidation of methionine in particular may serve as an intrinsic antioxidant 
system as its first oxidation product, methionine sulfoxide, can be reduced 
enzymatically(Stadtman & Levine 2001). A number of enzymes (e.g. thiol proteases) 
utilise nucleophilic cysteines in their active sites. These are activated by hydrogen bond 
formation or deprotonation mediated by adjacent residues. This activation also increases 
their susceptibility to oxidation.  
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Figure 3.1 Oxidation products of cysteine and methionine 
Sequential oxidation of cysteine yields the cysteine oxyacids, sulfenic, sulfinic and 
sulfonic acid. Sulfenic acid can also react with an reduced thiol to yield a new 
disulphide bind. Methionine is sequentially oxidized to give the sulfoxide and sulfone 
products. [O] denotes an unspecified oxidant. 
 
Cysteine oxidation(Figure 3.1) generally proceeds via a short-lived intermediate, 
sulfenic acid. Sulfenic acid can be reduced by another thiol to yield a new disulphide 
bond or further oxidised to sulfinic acid. Disulphides can be intramolecular or 
intermolecular, for example protein-protein or protein-glutathione. Thioredoxins and 
glutaredoxin catalytically reduce disulphides and thus restore cysteine to its reduced 
state. Although initially considered to be a protective measure, protein glutathionylation 
is now recognised as a regulatory post translational modification(Dalle-Donne et al. 
2007). Further oxidation of sulfinic acid yields sulfonic acid. Sulfinic and sulfonic acids 
are generally stable and irreversible. 
 
Reversible thiol oxidation (sulfenic acid and disulphides) plays a role in cell signalling 
and is usually studied by the “switch” strategy (Figure 3.2). Mass spectrometry can 
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identify the oxidised proteins labelled by the switch method and may pinpoint 
individual oxidised cysteines.  
 
Studying irreversible thiol oxidation is more challenging as their relative chemical 
inertness precludes selective tagging with currently available probes. One approach 
used antibodies generated against a sulfonic acid-containing peptides modelled on the 
active sites of various proteins(Woo & Rhee 2010). Although both sulfinate and 
sulfonate can be detected directly by mass spectrometry, inefficient ionisation and 
ambiguous fragment masses complicate analysis(Murray & Van Eyk 2012). The 
negative charge of sulfonate may provide a route to affinity purification but this has 
only been demonstrated for model peptides(Y.-C. Chang et al. 2010). A sulfinic acid-
specific probe has been developed and is currently being evaluated(Conte & Carroll 
2012). 
Figure 3.2 The “switch” method for derivatising reversibly oxidised cysteines.  
Reduced thiols in the sample are irreversibly blocked with an alkylating agent denoted X 
(common reagents include N-ethyl maleimide and iodoacetamide). Samples are then treated 
with a reducing agent, returning any reversibly oxidised cysteines to their original state. These 
can then be irreversibly alkylated allowing derivatisation with a range of probes that facilitate 
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detection. Examples include probes detectable by fluorescence and immunoblot or probes that 
facilitates identification by mass spectrometry. 
 
3.1.4 Protein carbonyls 
Protein aldehydes and ketones are the most widely-used general oxidation marker. They 
are less prone to artefactual induction during cell lysis than thiol modifications and as 
they cannot be repaired chemically or enzymatically, they are effectively irreversible. 
Under non-stressed conditions, the basal level of protein carbonyls is around one for 
every ten proteins. During oxidative stress, this increases to around one in every three 
with deleterious consequences for cellular function(Stadtman & Levine 2001).  
 
Carbonyls can form directly on susceptible side chains by reaction with RS. Metal 
catalysed oxidation (MCO), the combination of H2O2, Fe(II) and a reducing agent, is 
probably the most relevant in a biological setting. Lysine, arginine, proline and 
threonine residues are the most likely targets. Glutamic and aminoadipic semialdehydes 
(Figure 3.3), the products of arginine and proline, and lysine oxidation respectively, 
constitute 60% of carbonyls induced by MCO(Requena et al. 2001). Carbonyl 
formation is not limited to MCO and different carbonyl containing products can occur 
by direct reaction between 1O2 and aromatic amino acids (Figure 3.3).  The residues that 
are carbonylated by a given treatment is therefore determined by the specific oxidant 
(Temple et al. 2006).  
 
Protein carbonyls can also be introduced indirectly via covalent adducts of bifunctional 
electrophiles derived from lipids and sugars. The altered proteins are known as 
advanced lipid peroxidation end products (ALEs) and advanced glycation end products 
respectively (AGEs). Levels of 4-HNE and MDA protein adducts (Figure 1.4), the most 
common ALEs, increase with a wide range of disease states(Negre-Salvayre et al. 2008). 
AGEs are especially indicative of hyperglycaemia in diabetics(Vistoli et al. 2013).  
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3.1.4.1 Carbonyl Detection 
The carbon atom of protein carbonyls can be derivatised with an appropriate 
nucleophile (Figure 3.4). 2,4-dinitrophenylhydrazine (DNPH)(Levine et al. 1990), the 
first carbonyl probe to be developed is still routinely used. DNPH-derivatized proteins 
can be detected spectrophotometrically by absorbance at365nm or immunochemically 
using anti-DNP antibodies (the Oxyblot kit). The Oxyblot kit is by no means ideal. 
Identified concerns include loss of sensitivity on storage(P. Wang & Powell 2010), 
artefactual oxidation(S. Luo & Wehr 2009) and possible cross-reaction with sulfenic 
acids(Dalle-Donne et al. 2009). DNPH-derivatisation combined with mass spectrometry 
has been used to identify proteins carbonylated during various disease states(Pignatelli 
et al. 2001; Telci et al. 2000) (Cocciolo et al. 2012), as a product of aging(Breusing et 
al. 2009) or after oxidant treatment of cells(Bollineni et al. 2014). 
 
In recent years, other carbonyl probes have become available. These include 
fluorophore and biotin conjugates. Fluorescent hydroxylamine (FHA) has been used in 
conjunction with mass spectrometry to identify oxidised proteins(Poon et al. 2004). It is 
superior to the Oxyblot because it avoids the need for immunoblotting. This permits the 
visualization of both oxidised and total protein content on a single gel. Biotin 
conjugates have been used to affinity purify carbonylated proteins prior to mass 
spectrometric identification(Madian & Regnier 2010). 
 
Carbonylation of a protein is often correlated with inactivation but it is important not to 
conflate an increase in any given marker with functional significance. This was 
demonstrated by Jimenéz et al who showed that increased protein carbonyl content 
broadly correlated with inactivation of lysozyme but that oxidation of an active site 
tryptophan was actually the underlying cause(Jiménez et al. 2000). 
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Figure 3.3 Carbonylation by MCO and 1O2. 
The two most common carbonyl products of MCO are shown although many others are 
possible. Glutamate semialdehyde can also result from proline oxidation. Carbonyl containing 
products on aromatic amino acids derive from the cycloaddition products shown in Figure 1.3 
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3.1.5 Protein oxidation by photosensitisers 
Protein oxidation during PDT (Chapter 1.5.2) mainly results from the action of 1O2 (M. 
J. Davies 2004). The main protein residues found to be oxidised after in vitro 
photosensitised reactions are the known targets of 1O2: tryptophan, histidine, methionine 
and to a lesser extent tyrosine (Oleinick et al. 2009; Silvester et al. 1998). Protein 
carbonyls are formed, predominantly the oxidation products of aromatic amino acids 
(Silvester et al. 1998). These are the most commonly studied modifications in 
photosensitised cells(Szokalska et al. 2009; Sakharov et al. 2003; Tsaytler et al. 2008).  
 
Figure 3.4 Derivatisation of protein carbonyls. 
Protein carbonyls resulting from both MCO and 1O2 can be derivatized with a nucleophilic 
probe (depicted in green). Nucleophilic nitrogen attacks the electrophilic carbonyl carbon 
resulting in covalent binding of the probe. Detection strategies include fluorescence, 
immunoblot and mass spectrometry. 
 
Photosensitised reactions inactivate several enzymes including catalase, superoxide 
dismutases(J. Luo et al. 2006) and mitochondrial enzymes(Benov et al. 2010); Benov et 
al demonstrated the importance of photosensitiser subcellular localisation. Increasing 
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the lipophilicity of a porphyrin derivative causes localisation to membrane and results in 
enhanced phototoxicity. Photosensitisation can also induce widespread protein-protein 
crosslinking. This can occur between two histidines(Shen, Spikes, C. J. Smith & 
Kopeček 2000a), a histidine and a lysine (Shen et al. 1996) or two tyrosines(Shen, 
Spikes, C. J. Smith & Kopeček 2000b). 
 
The purine analogue 6-thioguanine (6-TG) is a known photosensitiser(O'Donovan et al. 
2005). At the inception of this study some of the photosensitised reactions of DNA 6-
TG had been identified. Among these, photosensitized crosslinking of PCNA(Montaner 
et al. 2007) suggested that protein oxidation might be widespread and determining the 
extent of 6-TG/UVA-mediated protein oxidation was the initial focus of my project.  
 
 
3.2 Results 
I opted to focus on carbonylation as a marker of photosensitised protein oxidation. 
Carbonyls are also less susceptible than oxidized thiols to artefactual oxidation 
obviating the possible need for a low oxygen environment. Depending on exposed 
residues, any protein that is carbonylated is also likely to be subject to thiol oxidation. 
My aim at the outset was to develop a robust detection protocol that could be combined 
with two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and mass 
spectroscopy to identify putative oxidation targets in cultured human cells.  
 
3.2.1 Detecting protein carbonyls 
DNPH derivatisation combined with immunoblotting (Oxyblot kit) is the most widely 
used detection system for protein carbonyls. Based on my initial experience with this kit, 
I decided that derivatisation with fluorescent hydroxylamine (FHA) might offer a 
number of advantages. Firstly, fluorescent in-gel detection removes the need for 
blotting. Oxidised proteins can be identified and excised from a single gel thereby 
eliminating inter-gel variation as a potential source of error (matching spots between 
blotted and non-blotted gels is often problematic). The approach was a modification of 
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the method of Poon et al(Poon et al. 2007). The original study measured basal carbonyl 
levels but adapting the procedure to measure pathological RS resulting from 
photosensitisation seemed a realistic goal. By altering the procedure for use with FHA 
containing Alexa Fluor 647 rather than Alexa Fluor 488, I was able to use Sypro Ruby 
to stain for total protein, which is an order of magnitude more sensitive than the 
commonly used Coomasie Blue and more compatible with mass spectrometry than 
silver staining(Lopez et al. 2000). The excitation spectra (Figure 3.5) exhibit little 
overlap and essentially none at 633nm, the wavelength for AlexaFluor excitation. 
 
Figure 3.5 Excitation spectra for Sypro Ruby and Alexa Fluor 647.  
Sypro Ruby shown in blue, Alexa Fluor 647 in red. Fluorophore data obtained from Invitrogen 
Spectraviewer (Invitrogen.com). 
 
I optimised the reaction conditions for FHA derivatisation using bovine serum albumin 
(BSA) that had been oxidised in vitro via MCO (detailed in Materials and Methods). 
BSA treated with NaBH4 to reduce all carbonyl groups to alcohols served as a negative 
control. Figure 3.6 (top) illustrates that FHA derivatisation of oxidized BSA produced a 
robust fluorescent signal. The sensitivity was comparable to that of the DNPH-based 
Oxyblot kit and the clear specificity for protein carbonyls was evidenced by the 
minimal response for reduced BSA. Refinements to the reaction conditions (Figure 3-6, 
bottom) improved the sensitivity still further and reduced the detection limit to 
considerably below that of the Oxyblot (<50ng of oxidised BSA). The optimised 
protocol of 0.05mg/ml (~40µM) FHA in PBS (pH7.4) at 37°C for 2 hours was used for 
all subsequent experiments. Another significant advantage of FHA over DNPH is that 
derivatisation does not need to be carried out in 1M HCl (which can affect protein 
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solubility) although lowering pH did improve sensitivity (data not shown). The 
compatibility of FHA with cell extracts and Sypro Ruby was examined (Figure 3-7). 
Extracts from 6-TG/UVA treated cells showed a strong signal indicating that the 
optimised protocol is compatible with cell extracts (Figure 3-7, left). No bleedthrough 
into the 633nm channel was observed reducing the likelihood of false positives. With a 
robust method for detecting both total protein and protein carbonyls in place, I then 
investigated the effects of UVA sensitization of 6-TG.  
Figure 3.6 Optimization of FHA derivatisation 
Top: BSA, oxidised in vitro as outlined in Materials and Methods, served as a model protein. 
BSA reduced with NaBH4 was used as a negative control. Decreasing amounts of oxidised BSA 
were treated with 0.025mg/ml AlexaFluor647-fluorescent hydroxylamine (FHA, Invitrogen) for 
120mins in PBS (pH7.4) at room temperature. Electrophoresis was performed and the gel (10% 
Bis-Tris) imaged at 633nm. A similar experiment performed using the Oxyblot kit (Millipore) 
following the manufacturer’s protocol is provided for comparison. Bottom, left: Decreasing 
amounts of oxidised BSA were treated as above over a range of FHA concentrations. Bottom, 
right: 0.05 µg oxidised BSA was treated with 0.05mg/ml FHA at 25 or 37°C over a range of 
incubation times.  
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3.2.2 The effects of 6-TG/UVA on carbonylation 
CCRF-CEM (CEM) cells that had been grown in the presence of 6-TG were UVA 
irradiated. Whole cell extracts were treated with FHA according to the conditions 
established in Section 3.2.1 and derivatised proteins separated by SDS-PAGE. Gels 
were stained with Sypro Ruby and scanned at 633nm and 488nm concurrently.  
Figure 3.7 (right) demonstrates a 6-TG- and UVA-dependent increase in protein 
carbonyls. There is some background derivatisation in extracts from untreated cells. 
This presumably reflects the steady-state level of protein carbonylation. It was not 
increased significantly by this UVA dose (20kJ/m2) although higher doses of UVA 
(>100kJ/m2) do induce detectable carbonylation (not shown). Treatment with the 
highest 6-TG dose (0.75 µM) increased carbonylation slightly but the effect of 6-TG 
and UVA are clearly more than additive. The azide ion (N3-) is a known 1O2 
scavenger(Klotz et al. 2003). Preincubation with sodium azide prior to irradiation 
induces a loss of FHA signal suggesting carbonylation is 1O2-mediated (Figure 3.8).  
Figure 3.7: Protein carbonylation induced by 6-TG/UVA treatment 
Left: Oxidised BSA (0.05µg) and extracts from cells treated with 6-TG (1µM/24h) and UVA 
(20kJ/m2) were treated using the optimised FHA protocol. Samples were subject to SDS-PAGE 
and gels were scanned at 633nm and 488nm concurrently. The FHA and Sypro Ruby signals are 
shown in green and red respectively. Right: CEM cells were treated with 6-TG (24h) at the 
indicated doses and UVA irradiated (20kJ/m2) as indicated. Cell extracts were prepared, 
derivatised with FHA and processed as above. 
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Figure 3.8 Treatment with azide reduces carbonylation by 6-TG/UVA 
CEM cells were treated with 6-TG (0.6µM/24h) and UVA (20 kJ/m2) or left untreated. Prior to 
irradiation, cells were incubated with NaN3 in PBS at the indicated concentration for 10 minutes.  
 
3.2.3 Thiol oxidation 
Reversible thiol oxidation was investigated using the “switch” methodology outlined in 
Figure 3.2. The protocol was based on Baty et al (Baty et al. 2002) with the inclusion of 
a Sypro Ruby-compatible detection reagent. Briefly, treated cells are incubated with N-
ethylmaleimide (NEM). This cell-permeable alkylating agent blocks all free SH groups 
prior to cell lysis. Following cell lysis, all oxidized thiols - disulphides and sulfenates - 
are reduced with dithiothreitol and then derivatised with Alexa Fluor 647 maleimide 
(AFM). The samples are then processed as for carbonyl detection. Figure 3-9 (left) 
shows that 6-TG/UVA significantly increased the level of thiol oxidation. Thus, my 
experiments reveal that, by the two commonly used criteria of oxidative protein damage, 
carbonylation and thiol oxidation, UVA sensitized 6-TG is a significant threat to the 
proteome.  
 
In Figure 3.9 (left), it is apparent that widespread thiol oxidation coincided with reduced 
Sypro Ruby signal indicating protein loss during processing, probably due to 
precipitation. A titration of AFM concentrations (Figure 3.9, right) confirmed that 
protein losses were proportional to the extent of thiol derivatisation. This drawback 
meant that the technique was not pursued further but the approach clearly provides a 
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clear qualitative indication of widespread thiol oxidation by this photosensitizing 
treatment. 
 
  
 
 
 
 
 
 
 
 
Figure 3.9 Detecting thiol oxidation 
Left: CEM cells were treated with 6-TG (0.6µM) for 24 hours and irradiated with UVA 
(20kJ/m2) as indicated. Cells were then processed according to the AFM protocol (Materials and 
Methods). Right: NEM-blocked, DTT-reduced extracts from 6-TG/UVA treated cells were 
incubated with decreasing amounts of AFM and then processed according to the standard 
protocol. 
 
3.2.4 Identification of carbonylated proteins 
Extracts from 6-TG/UVA treated cells were separated by 2D-PAGE in order to identify 
individual carbonylated proteins. Figure 3.10 shows the gel image of one of three 
independent experiments in which untreated and 6-TG/UVA treated cell extracts are 
compared.  
FHA derivatisation appeared to be broadly compatible with 2D-PAGE (Figure 3.10) 
and indicated the presence of relatively few oxidized proteins (green spots) in the 
untreated or UVA treated extract. Inspection of the gel from the 6-TG/UVA treated 
extracts revealed an increase in FHA signal as expected but a number of issues were 
apparent. Most obviously, treatment was associated with vertical and horizontal 
streaking, which reflects protein precipitation during electrophoresis and incomplete 
isoelectric focusing, respectively. This made spot location and comparison between 
replicates less straightforward than anticipated. Mass spectrometry analysis (carried out 
by Dr David Frith of the Proteins and Proteomics Department, Clare Hall) of protein 
spots excised from the 2D gels revealed that they were frequently heterogeneous, 
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possibly resulting from deposition of aggregated proteins and/or inaccurate excision. 
Since streaking was only observed in extracts from treated cells, it seems likely that the 
intrinsic inferior solubility of carbonylated proteins exacerbated by derivatisation with a 
bulky chromophore is responsible for the precipitation. Furthermore, the presence of 
unincorporated FHA in the sample may prevent proper isoelectric focussing.  
 
MS analysis of the excised FHA fluorescent spots identified the presence of numerous 
proteins with >80% certainty. RPA32 and p53 were identified in all three replicate 
analyses whilst RPA70, Ku70, MCM4 and PCNA were identified in two of the three. 
Although clearly not optimal, this approach identified DNA repair/replication-
associated proteins (including PCNA that was known to be damaged by this treatment). 
At this point, I elected to focus on the effects of photosensitisation on these identified 
proteins rather than to further refine the 2D gel procedure.  
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Figure 3.10 Two dimensional gel electrophoresis of the FHA treated samples 
Samples were FHA derivatised and subjected to 2D-PAGE as outlined in Materials and 
Methods. FHA spots were excised and analysed by mass spectrometry. This an example of one 
of three replicates. Top: UVA (20 kJ/m2) Bottom: 6-TG (0.6µM, 24h) plus20 kJ/m2. 
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3.2.5 Ku oxidation 
Western blot analysis of identified proteins Ku70, MCM4 and RPA32 revealed the 
presence of treatment-dependent slower migrating species in each case (Figure 3.11). 
The subunits adjacent to MCM4 in the MCM complex (MCMs 6 and 7) exhibited a 
similar migration pattern strongly suggesting the formation of inter-subunit crosslinks. 
Due to its abundance and important role in DNA repair, I chose to investigate the 
effects of 6-TG/UVA on the Ku protein complex. Western blot analysis revealed that 
the slowly migrating forms of Ku70 cross-reacted with a monoclonal Ku80 antibody 
indicating that both partners of the Ku complex were present (Figure 3.12).  
 
Figure 3.11 Effects of 6-TG/UVA on identified proteins from 2D gels 
Cells were treated with 6-TG and irradiated with UVA (20kJ/m2) as indicated. Extracts were 
analysed by western blotting Left: CEM cell extracts Ku70 probe Centre: MCM4/6 or 7 probes 
as indicated Right: RPA 32 probe (performed by Melisa Guven). 
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Figure 3.12 Crosslinking of the Ku Complex 
CEM cells were treated with 6-TG(24h) and irradiated with UVA (20kJ/m2) as indicated. Cell 
extracts were prepared and analysed by western blot with Ku70 or Ku 80 probe as indicated.  
 
The complexes were resistant to the denaturing conditions in western blot sample 
preparation (100mM DTT, 5 mins, 95°). This rules out S-S formation and suggests 
crosslinking is covalent. The mass as judged by molecular weight markers is 
approximately the size of the sum of the Ku70 and Ku80 subunits. I concluded that the 
complexes represent covalent crosslinking of the subunits of the Ku heterodimer.  The 
crosslinked species decreased with time, suggesting proteolytic degradation (Figure 
3.13). 
 
 
 
 
 
 
 
 
Figure 3.13 Persistence of Ku crosslinking 
CEM cells were UVA (20 kJ/m2) irradiated with or without 24h 6-TG (0.6µM) treatment. Cell 
extracts were prepared at the indicated time after irradiation and analysed by western blot with a 
Ku70/80 antibody. 
 
The functional impact of photochemical Ku damage was explored. An electrophoretic 
mobility shift assay (EMSA) using a radiolabelled dsDNA probe and extracts from 6-
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TG/UVA treated cells indicated that Ku-mediated DNA binding was impaired in a 6-
TG concentration-dependent manner (Figure 3.14, top).  
 
The EMSA was validated and the Ku dependence of binding was confirmed in two 
ways. Firstly, anti-Ku antibody induced a supershift of the entire complex (Figure 3.14, 
middle left). Secondly, the complex was not observed when extracts from the Ku80 
deficient xrs6 cell line were used (Figure 3.14, middle right). In addition, when 
recombinant Ku70:80 was incubated with 6-TG and UVA irradiated in vitro it was also 
crosslinked (Figure 3.14, bottom left). In vitro Ku crosslinking was also associated with 
reduced DNA binding activity (Figure 3.14, bottom right).  
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Figure 3.14 Electrophoretic mobility shift assays of Ku binding.  
Top: CEM cells were treated with 6-TG as indicated and UVA irradiated (20kJ/m2). Extracts 
were prepared and EMSA performed (see Materials and Methods). Middle, left: Cell were 
treated with 6-TG/UVA (0.6µM/20kJ/m2). Extracts were prepared and EMSA was performed 
following a 10-minute incubation with polyclonal Ku70/80 antibody (Stratech, 1µl) prior to 
electrophoresis. Middle, right: EMSA analysis of extracts from the Ku80 deficient hamster cell 
line xrs6 and its parent cell line CHO K1. Bottom, left: Western blot analysis of recombinant 
Ku70/80 (Trevigen) treated with UVA (20kJ/m2) or 6-TG(100µM) and UVA. Bottom, right: 
EMSA analysis of the 6-TG/UVA treated recombinant Ku samples 
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3.2.6 Ku damage and NHEJ 
The Ku heterodimer is an essential component of non-homologous end joining (NHEJ), 
the major pathway of DNA double strand break repair. The effect of 6-TG/UVA on 
NHEJ activity was examined. Cell extracts prepared by freeze-thaw lysis were 
incubated with an end-radiolabelled, linearised 5237bp plasmid probe. Products of 
ligation were separated by agarose gel electrophoresis and detected by autoradiography. 
In the first instance, I determined the optimum ratio of DNA probe to cell extract for 
NHEJ activity (Figure 3.15, top) Based on these data, 10 fmol radiolabelled DNA with 
20µg extract were used for the remaining experiments.  
 
Since the DNA probe contains complementary ends, a number of steps were taken to 
ensure that the assay reflected true NHEJ and not simple plasmid recircularisation. 
Wortmannin, an inhibitor of DNA-PKcs(M. Hashimoto et al. 2003), inhibited 
oligomerisation in a dose-dependent fashion. (Figure 3.15, middle left). Incubation of 
the probe with T4 DNA ligase generated a distinct pattern of ligation products 
compatible with expected recicularisation (Figure 3.15, middle right). Finally, depletion 
of Ku70 via immunoprecipitation abolished NHEJ activity confirming that the assay is 
Ku dependent (Figure 3.15, bottom). The assay therefore provides a true reflection of 
the NHEJ capacity of the extracts. 
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Figure 3.15 Optimisation and validation of the NHEJ assay 
Top:  Optimising DNA protein ratios. Extracts from untreated CEM cells were combined with 
end-radiolabelled linearized plasmid DNA as indicated. Following incubation, end-joined 
products were separated by agarose gel electrophoresis and detected by autoradiography. 
Ligation products are indicated. Middle, left: Inhibition by wortmannin. Wortmannin was 
included in the NHEJ assay at the concentrations shown. Middle, right: Recircularisation by 
T4 DNA ligase. Bottom, Left: Ku was removed from CEM extracts by immunoprecipitation 
with a polyclonal Ku70/80 antibody. Ku depletion was verified by western blotting. Bottom, 
right: NHEJ was assayed in non-depleted and Ku depleted extracts as indicated. 
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Extracts prepared from CEM cells treated with 6-TG (0.1µM) and UVA (20kJ/m2) were 
deficient in NHEJ whereas extracts from cells treated with either this low 6-TG 
concentration or UVA alone were fully NHEJ-proficient (Figure 3.16, left). Following 
treatment with 6-TG concentrations higher than 0.1µM TG, NHEJ activity was reduced, 
even in the absence of UVA irradiation (Figure 3.16, right). Thus the dynamic range for 
this assay as a test for photosensitisation is rather small.  
 
 
 
 
 
 
 
 
 
 
Figure 3.16 The effect of 6-TG/UVA on NHEJ in vitro 
Extracts were prepared from CEM cells treated with 6-TG at the indicated concentrations (24h) 
with and without UVA (20kJ/m2) irradiation. The NHEJ assay was performed as described in 
Materials and Methods.  
 
Defective NHEJ in cell extracts could be complemented by the addition of recombinant 
Ku and full end-joining activity was restored (Figure 3.17, left ). High Ku 
concentrations were inhibitory, however. Addition of Ku to extracts from untreated 
cells also slightly stimulated end-joining activity (Figure 3.17, right). This rather 
surprising observation suggests that, despite its abundance, Ku may be limiting for end-
joining in this in vitro assay 
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Figure 3.17 Complementation of in vitro NHEJ.  
NHEJ extracts were prepared from CEM cells treated with 6-TG and UVA (20kJ/m2) as 
indicated. Left: treated, right: untreated. NHEJ activity was assayed with the addition of 
recombinant Ku70/80 (Trevigen) at the indicated amounts. 
 
 
3.3 Discussion 
3.3.1 Detecting protein oxidation 
The protocol I devised for FHA derivatisation offers a number of advantages over the 
more commonly used DNPH-based immunoblot (Oxyblot kit). These include: in-gel 
detection, Sypro Ruby compatibility, neutral derivatisation conditions and simpler 
sample processing (no need for neutralisation). In its current form, the procedure 
provides a sensitive and reproducible indication of protein carbonylation when used 
with one-dimensional electrophoresis. The problems that became evident upon 
application to 2D-PAGE may be tractable and possible solutions will be discussed 
below.  
 
3.3.2 FHA and 2D-PAGE 
Protein insolubility leading to gel streaking and a negative impact on experiment 
repeatability are frequently reported problems in 2D-PAGE analysis of carbonylated 
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proteins(Baraibar et al. 2013). Although FHA was used successfully to measure basal 
levels of oxidation in mouse brain(Poon et al. 2007), it is possible that this analysis is 
not appropriate for more severely oxidised samples. FHA is a fairly large molecule 
(~1200Mw) that carries a negative charge and as such its presence will affect both 
isoelectric focussing and gel migration. This problem will be particularly acute if 
multiple FHAs are bound to a single protein. This is a possible explanation for the 
identification of multiple proteins in a single spot in my experiments.  
 
Due to this limitation, no FHA spot can be reliably attributed to an individual protein 
and therefore its oxidation status cannot be assessed by this technique. The observed 
modifications to Ku70, MCM4, RPA32 and PCNA by photosensitization provide a 
retrospective validation of their identification. However, the majority of proteins 
identified are among the most abundant proteins in the cell according to a recent 
quantitative analysis of a human cell line(Beck et al. 2011). PCNA and Ku70 are 96th 
and 115th in a list of over 7000 proteins organised by abundance; each is present at over 
1 x 106 copies per cell and therefore their identification could be entirely serendipitous. 
An unbiased and validated list of proteins damaged by the action of photosensitisers 
may be a useful tool in understanding their effects.  Populating this list would have been 
a significant investment of time and effort and my preferred approach was rather to 
investigate possible functional consequences of tentatively identified oxidation changes.  
 
I have considered a number of alternative approaches to alleviate these problems. A 
recent study by Tamarit et al (Tamarit et al. 2012) used a BODIPY hydrazide conjugate, 
to study proteins carbonylated after H2O2 treatment of yeast. BODIPY is a relatively 
small fluorophore with no net charge and its derivatisation results in greatly improved 
spot alignment.  
 
In principle, derivatisation with a biotinylated probe followed by affinity purification 
offers the best approach since the use of gels is avoided entirely. A reagent originally 
designed for labelling abasic sites in DNA, aldehyde reactive probe (ARP), has been 
used to purify and identify carbonylated proteins resulting from MCO in rat 
mitochondria(Chavez et al. 2010). In addition to permitting enrichment of oxidised 
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proteins, detection of ARP-containing fragments during mass spectroscopic analysis can 
identify specific carbonylation sites. Using ARP I was able to confirm the 6-TG/UVA-
induced increase in carbonylation (Figure 3.18). Although further attempts at 
enrichment were hindered by excessive non-specific binding and these efforts were 
discontinued, these problems appear to be tractable. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18 ARP derivatisation 
Extracts from 6-TG/UVA treated and untreated cells were derivatised with ARP (Materials and 
methods) and separated using SDS-PAGE. After blotting, proteins carrying ARP were detected 
using Streptavidin-HRP. Ponceau S detected total protein content. 
 
3.3.3 6-TG/UVA and protein carbonylation  
6-TG-induced protein carbonylation was essentially all UVA dependent within the 
normal working dose range. High 6-TG doses (≥ 0.75 µM) induced a small increase in 
protein damage. This might reflect oxidative stress induced in the absence of 
UVA(Brem & Karran 2012).  
 
6-TG can photosensitise via type I and type II mechanisms(O'Donovan et al. 2005).  
O2- and H2O2 resulting from type I photosensitisation are unable to induce 
carbonylation directly and any type I-mediated carbonylation is probably via HO. The 
most probable mechanism is MCO with its intrinsic preference for carbonyl formation 
at arginine, lysine, proline and threonine. (HO does react with other amino acids but 
mainly forms hydroxy-addition products with aliphatic and aromatic side chains). 
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Singlet oxygen (type II) is significantly reactive with only five amino acids: cysteine, 
methionine, tryptophan, histidine and tyrosine(M. J. Davies 2003) (Table 3-1). 
Carbonyls will form predominantly from oxidation of tryptophan, histidine and tyrosine. 
Although 1O2 is much less reactive than HO, its greater lifetime and consequent ability 
to diffuse far greater distances compensate for its reduced activity and 1O2 poses a 
major threat to cellular proteins. The oxidising species could subtly affect response to 
carbonyl derivatisation as MCO will mainly induce aldehydes, which are more 
electrophilic than the ketone products of 1O2 oxidation. Figure 3-8 shows a decrease of 
FHA signal after incubation with sodium azide prior to irradiation. This suggests that 
carbonylation is at least in part 1O2-mediated although levels do not return to those of 
untreated cells. Whether this represents a type I component to carbonylation or 
incomplete scavenging cannot be determined from this experiment, although increasing 
the dose ten-fold had no effect which supports the former conclusion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Rate Constant for Reaction (M-1 s-1) 
Residue 1O2 HO  
Histidine 3.2 x 107 4.8 x 109 
Tryptophan 3.0 x 107 1.3 x 1010 
Methionine 1.6 x 107 8.5 x 109 
Tyrosine 0.8 x 107 1.3 x 1010 
Cysteine 8.9 x 106 3.5 x 1010 
Arginine - 3.5 x 109 
Proline - 6.5 x 108 
Threonine - 5.1 x 108 
Lysine - 3.5 x 108 
Table 3-1: Rate constants for reaction of selected amino acids with 1O2  and HO  
1O2 data reproduced from Davies et al(M. J. Davies 2003) . HO reproduced from Xu and 
Chance(Xu & M. R. Chance 2007) 
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My experiments do not exclude the possibility of 6-TG/UVA-induced secondary 
carbonyl formation ALEs and AGEs. 1O2 lifetime is increased in the non-aqueous 
environment of the lipid bilayer and it is known to be a potent inducer of 
peroxidation(Gaboriau et al. 1995). Specific antibodies for MDA and 4-HNE protein 
adducts could address this possibility. 
 
To summarise, for standard SDS-PAGE, this protocol offers numerous advantages over 
the more commonly used DNPH-derivatisation and is a simple, specific way to 
demonstrate treatment-related increases in protein carbonylation. My adaptation of 
existing an FHA protocol for use with Sypro Ruby makes it simple to assess total and 
oxidised protein levels concurrently. 
 
3.3.4 Thiol oxidation 
My data indicate that, as expected, thiol oxidation occurs concurrently with carbonyl 
formation in cells treated with 6-TG/UVA. Oxidized thiol detection therefore provided 
an approach to measuring the effects of oxidative stress. Although somewhat limited as 
an analytical tool, visualisation of oxidized thiols highlighted another facet of protein 
oxidation. Heavily oxidised proteins bearing sulfinate and sulfonate modifications 
would not give a fluorescent signal as they cannot be reduced (see Figure 3.2) which 
could limit the utility of thiol oxidation to studying harsh oxidising conditions.   
 
3.3.5 Ku oxidation 
The covalently crosslinked forms of Ku were visualised as a series of proteins with 
apparent molecular weights of around 200 kDa all of which contained both Ku70 and 
Ku80. This is larger than the ~150 kDa expected for the Ku heterodimer. Their 
migration properties might reflect a non-linear (possibly multiply) crosslinked structure 
with anomalous electrophoretic properties. The involvement of another unidentified 
crosslinked protein, whilst possible, seems less likely.  
 
Chapter 3 Protein Oxidation by 6-TG/UVA 
 111 
Sitte et al(Sitte et al. 1998) demonstrated that oxidized proteins are removed by the 20S 
proteasome. I observed a reduction in the crosslinked species with time after irradiation 
consistent with the degradation of oxidised protein. High carbonylation levels are 
associated with attenuated proteasomal activity although the underlying mechanism is 
currently unclear. Possibilities include inhibition of the proteasome by crosslinked 
proteins or direct damage to proteasomal factors; alternatively, high levels of 
carbonylation may be a symptom rather than a cause of proteasome inhibition. 
 
6-TG/UVA treatment is a known source of 1O2 and hence aromatic amino acids will be 
preferentially oxidised. One of the products of histidine oxidation by 1O2, a 
hydroxyimidazolone is susceptible to nucleophilic attack at C5 (Figure 3.19). Visual 
inspection of the crystal structure of the Ku heterodimer suggests a number of potential 
crosslinking sites. Most obvious are the three Ku70 lysine-Ku80 histidine pairs 
(highlighted in Figure 3.20, inset). A Ku70 histidine-Ku80 lysine pair, a histidine-
histidine pair and a tyrosine-tyrosine pair (not shown) could also potentially react. 
(Since HO can also form this product with histidine(Xu & M. R. Chance 2007), type I 
photosensitisation could also induce crosslinking although there is a high probability 
that HO would be intercepted before reaching the susceptible amino acid). In sum, 
there are several plausible sites at which photochemical crosslinking between these two 
subunits might occur.  
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Figure 3.19 Mechanism of histidine-lysine crosslink formation mediated by 1O2. 
Histidine forms a short-lived endoperoxide upon attack by 1O2 that rearranges to give a 
hydroxy-imidazolone species. This is a target for nucleophilic addition (lysine is shown here but 
histidine or cysteine could substitute). Water is eliminated from the addition product to give the 
stable covalent crosslink.  
Figure 3.20 Ku heterodimer structure with highlighted candidate residues for crosslinking. 
3D model of Ku bound to DNA. Ku 70 is shown in pink and Ku80 in blue. Inset: Spatially 
proximate lysines (Ku70) and histidines (Ku80) are highlighted in red or blue respectively. 
Crystal structure from Walker et al (Walker et al. 2001). Image rendered using CCP4mg 
(McNicholas et al. 2011). 
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Ku was identified as a target for sulfenate modifications(Leonard et al. 2009) and in 
keeping with this its DNA binding activity is regulated by oxidation(Andrews et al. 
2006). Oxidation of thiols by diamide causes a conformational change that increases koff 
rates thereby reducing DNA binding. The oxidised thiol(s) that triggers the switch is not 
known although cysteine 249 is the current leading candidate (Dolan et al. 2013). It is 
therefore likely that crosslinked Ku is symptomatic of inactivation rather than uniquely 
causative and that inactivation could plausibly occur before crosslinked Ku is detectable. 
 
Attenuated Ku binding could result in promotion of alt-NHEJ with mutagenic 
consequences. Oxidative stress reduces the assembly of DNA-PK at DNA ends with a 
consequent inhibition of NHEJ (Bacsi et al. 2005) –an observation that is consistent 
with Ku damage and reduced end-binding. Remarkably, other DNA repair proteins 
including OGG1(Bravard et al. 2006), RPA(Men et al. 2007), MGMT and 
XRCC3(Girard et al. 2013) are also inactivated by thiol oxidation and experiments from 
this laboratory have shown that OGG1 activity is lower in extracts from cells treated 
with 6-TG/UVA ((Gueranger et al. 2014)). Quite why this functional vulnerability has 
evolved is unclear as it would appear antithetical to an efficient DNA damage response. 
 
3.3.6 Ku damage and NHEJ 
Having identified Ku as target of oxidative damage, I was prompted to examine NHEJ 
which was achieved using an in vitro extract-based assay, based on the protocol 
published by Baumann and West(Baumann & West 1998). After extensive validation of 
the assay, I demonstrated that 6-TG caused a synergistic inhibition of NHEJ with UVA, 
which potentiated otherwise non-inhibitory drug treatments. High 6-TG concentrations 
caused UVA-independent inhibition of NHEJ. One possible explanation is transcription 
modulation caused by treatment with 6-TG although none of the gene products reported 
to be down-regulated seem especially relevant to NHEJ(F. Zhang et al. 2013). In 
addition, higher 6-TG concentrations are a source of RS (by depleting antioxidant 
levels)(Brem & Karran 2012) thus the effect could still be redox-mediated. 
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The complementation of defective NHEJ extracts with recombinant Ku firstly 
strengthens the link between Ku damage and NHEJ inactivation and secondly, suggests 
that sufficient levels of other NHEJ factors remain functional at least after treatment 
with 0.1µM 6-TG/UVA.  
 
On the basis of my findings, NHEJ activity in 6-TG/UVA treated cells was examined 
and found to be diminished (performed by Quentin Gueranger, Figure 3.21). Neutral 
comet assays with treated HeLa cells, which are less susceptible to 6-TG than CEM 
cells, revealed that 1 µM 6-TG and 50 kJ/m2 UVA significantly inhibited repair of 
double strand breaks in vivo. Thus UVA-dependent inhibition of NHEJ is detected both 
in cells and in an in vitro assay. If photoactivation of DNA-6-TG can induce significant 
oxidative stress in patient skin, a chronic reduction in NHEJ capacity may result. This 
could have adverse consequences for genome stability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21 Neutral comet assay of 6-TG/UVA treated cells 
Hela or CHO xrs6 (Ku80-deficient) cells were synchronised at G1/S by double thymidine block. 
HeLa cells were grown in 6-TG containing medium between thymidine treatments. Maintaining 
the block, cells were irradiated with IR (15Gy) or UVA (50kJ/m2) and DSBs remaining were 
assessed via neutral comet assay over a 4-hour time course. Each dot represents a single comet 
measurement. Performed by Quentin Gueranger, taken from (Gueranger et al. 2014). 
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3.4 Summary 
I have developed a robust detection method for assessing the carbonylation of proteins 
induced by photosensitisation that offers a number of advantages over commercially 
available options. Its compatibility with 2D gels is currently limited although these 
problems could be overcome. An increase in thiol oxidation due to treatment was also 
detected. 
 
Several important DNA repair/replication proteins were identified in a screen for 
carbonylation. Among these, the essential NHEJ heterodimer, Ku, was crosslinked and 
functionally inactivated by 6-TG/UVA treatment. DNA binding and NHEJ activity in 
extracts were both impaired. Activity was restored by the addition of recombinant Ku.  
 
With protocols in place to examine a number of different markers of protein oxidation, I 
was able to turn my attention to the effects of other known photosensitisers. 
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Chapter 4. Other photosensitisers and protein 
oxidation 
4.1 Introduction 
4.1.1 Photosensitisers and their effects 
Upon absorption of characteristic wavelengths of light, photosensitisers participate in 
photochemical reactions that damage biomolecules and in so doing potentiate the 
effects of incident radiation. Their presence in human skin leads to an exaggerated skin 
response to sun exposure. 
 
This reactivity has been harnessed therapeutically as part of PDT (Section 1.5) but is 
also an undesired side effect of a wide range of pharmaceuticals(Drucker & Rosen 
2011). The experimental work described in this chapter compares the photosensitizing 
effects of DNA 6-TG with those of selected pharmaceuticals. 
 
4.1.2 Thiopurines 
4.1.2.1 Treatment with thiopurines  
DNA-6-TG is one of the end products of the metabolism of the thiopurine group of 
pharmaceuticals. Originally developed in the 1950’s for cancer therapy, the thiopurines 
are now mainly prescribed as anti-inflammatory and immunosuppressive agents 
although 6-mercaptopurine (6-MP) remains one of the main treatments for childhood 
acute lymphoblastic leukaemia(McLeod et al. 2000). The 6-MP prodrug azathioprine 
has long been used as an immunosuppressant in organ transplant patients, often in 
combination with a calcineurin inhibitor and/or corticosteroids(Kasiske et al. 2009). The 
use of azathioprine has declined markedly with advent of newer immunosuppressants 
such as mycophenolate mofetil(Karran & Attard 2008) but it is nevertheless still taken 
by thousands of patients worldwide. Azathioprine continues to be prescribed for the 
management of inflammatory bowel disease and other disorders(Carter 2004). In total, 
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azathioprine was prescribed 814,000 times in the UK in 2012. 6-MP (49,000) and 6-TG 
(100) prescriptions were less frequent (Centre 2013).  
 
All thiopurines require metabolic conversion to their common active metabolite, 
6-thioguanine nucleosides (TGN). The metabolic process is detailed in Figure 4.1. 
Notably, 6-MP, 6-TG, thioinosine monophosphate (TIMP) and thio-guanine 
monophosphate (TGMP) are all inactivated by thiopurine S-methyltransferase (TPMT) 
and patients with low activity variants of TPMT are a risk of effective thiopurine 
overdose and require careful monitoring. Methylated TIMP (meTIMP) is an effective 
inhibitor of de novo purine biosynthesis and this has been proposed as an explanation 
for thiopurine cytotoxicity but the anti-proliferative and immunosuppressive activities 
of thiopurines are more likely a consequence of TGN formation and incorporation into 
DNA (discussed in (Karran & Attard 2008)).  
 
The mechanism of thiopurine cytotoxicity is still not fully understood. TGN are 
efficiently incorporated into replicating DNA and DNA-6-TG comprises 0.01%-0.03% 
total DNA guanine in patient skin and lymphocytes(Attard & Karran 2011). A low level 
of incorporated DNA-6-TG does not block polymerases and is not significantly toxic or 
mutagenic. The cytotoxic activity of DNA-6-TG is thought to reflect its in situ chemical 
methylation, replication and recognition of me6-TG-containing base pairs by post-
replicative mismatch repair(Swann et al. 1996) (Detailed in Figure 4.2).  
 
4.1.2.2 6-TG and UVA 
6-TG absorbs maximally at 342nm (Figure 4.3) and its presence in DNA shifts the 
DNA absorption profile into the wavelength range of incident solar radiation. Various 
DNA lesions are produced upon excitation of DNA-6-TG by UVA (reviewed in(Brem 
& Karran 2011)). These include guanine-6-sulfinate (GSO2) and guanine-6-sulfonate 
(GSO3)(Ren et al. 2010), DSBs, DNA interstrand crosslinks (ICLs)(Brem et al. 2011) 
and DNA-protein crosslinks(Gueranger et al. 2011). ICLs are important contributors to 
lethality and FA-deficient cells are very sensitive to 6-TG/UVA. NER-deficient cells 
are not hypersensitive indicating that toxic 6-TG/UVA DNA lesions are not excised by 
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NER. Oxidative DNA damage occurs by the action of 1O2 on guanine to give 8-
oxoG(COOKE et al. 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Metabolism of thiopurines 
The substituted imidazole ring is non-enzymatically removed from azathioprine to yield 6-MP, 
which, along with 6-TG, is actively transported into cells(Conklin et al. 2012). Once within the 
cell, it enters the purine salvage pathway. Hypoxanthine-guanine phosphoribosyl transferase 
(HPRT) catalyses the addition of ribose-5-phosphate to 6-MP to generate thioinosine 
monophosphate (TIMP). TIMP is then further metabolised via a two-step process catalysed by 
inosine-5’-monophosphate dehydrogenase (IMPDH) and guanine monophosphate synthetase. 
This yields thioguanine monophosphate (TGMP), which can also be formed directly via the 
action of HPRT on 6-TG, which reduced and phosphorylated to yield TGN, a substrate for 
DNA polymerases. 6-MP is also subject to a competing catabolic reaction with xanthine oxidase 
and thus allopurinol, an XO inhibitor, potentiates thiopurine effects. Reproduced from Karran 
and Attard(Karran & Attard 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 Other photosensitisers and protein oxidation 
 
 119 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Toxicity of thiopurines 
Non-enzymatic S-methylation of DNA-6-TG by S-adenosylmethionine occurs at 1 in 104 DNA-
6-TGs. Methylation of incorporated 6-TG promotes the formation of me6-TG:T which is 
recognised by MutSα-MutLα, triggering MMR. As the lesions cannot be correctly paired, MMR 
is unsuccessful and the strand opposing the lesion is left as a SSB. Upon replication forks 
meeting SSBs during a subsequent round of replication, cells enter ATR-Chk1 mediated G2 
arrest with aberrant DNA structures. Reproduced from Karran and Attard (Karran & Attard 
2008). 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Absorption spectra of guanine and 6-TG 
The absorption spectrum of guanine (green) shows little absorption above>300nm whilst the 
absorbance maximum of 6-TG (blue) peaks at 342nm. Reproduced from Karran and Attard 
(Karran & Attard 2008). 
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Replication-arresting 6-TG/UVA-induced DNA lesions cause PCNA 
monoubiquitination (Montaner et al. 2007), ATR-Chk1 checkpoint activation and 
subsequent G2/M arrest(Brem et al. 2010). Montaner et al also demonstrated a UVA 
and 6-TG dose-dependent formation of a crosslinked form of PCNA termed PCNA*, 
which they attributed to oxidative modification. PCNA* was most apparent in S-phase 
cells suggesting intimate association with DNA may place proteins at increased risk of 
DNA-6-TG-mediated oxidation. 
 
4.1.2.3 Therapy-related cancer 
As organ transplant rates and patient and organ survival increased over the latter half of 
the 20th century, a susceptibility of organ transplant recipients (OTRs) to NMSC 
became apparent. A recent 22-year cohort study in the UK found that after 30 years of 
immunosuppression 74% of patients had developed malignancies of which 73% were 
SCCs and 24% were BCCs(Harwood et al. 2012). SCCs occur 150-fold times more 
frequently relative to the general population thus inverting the usual BCC:SCC ratio. 
SCC in OTRs seems to be qualitatively different from SCC occurring in the general 
population; onset is earlier plus metastasis and mortality are significantly 
increased(Euvrard et al. 1995).  
 
Epidemiological analysis has identified sun exposure and the duration and level of 
immunosuppression as risk factors for NMSC development. Since the immune system 
is important in cancer prevention, chronic immunosuppression is an inherently 
oncogenic intervention. Cancers with viral aetiologies have greatly increased incidence 
rates in pharmacologically immunosuppressed patients(Buell et al. 2005). A comparison 
of cancer incidence rates in HIV/AIDS patients and OTRs suggests the 
immunosuppressants have oncogenic properties in addition to their immunosuppressive 
abilities(Grulich et al. 2007). In particular, although virus-associated malignancies are 
increased in both HIV/AIDS patients and OTRs, NMSCs are disproportionally 
associated with the latter patient group(Grulich et al. 2007).  
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4.1.3 Fluoroquinolones  
The fluoroquinolones (FQs), a diverse group of antimicrobial agents, are derived from 
nalidixic acid. Structural modifications to the nalidixic acid structure resulted in a wide 
range of compounds with improved pharmacological properties and diverse activities 
versus different bacterial species (Figure 4-4). Addition of a fluorine atom to C6 
increased efficacy by up to two orders of magnitude and created the FQ class. A C7 
piperazine group (norfloxacin and ciprofloxacin) inhibited drug efflux and yielded 
improved activity versus Gram-negative bacteria (Andersson 2003). A second fluorine 
atom at C8 (lomefloxacin) improves potency but increases the innate photoactivity of 
FQs(Martínez et al. 1998). Despite later iterations with improved pharmacokinetics, 
ciprofloxacin remains the most prescribed FQ in the UK by a wide margin (789,100 
prescriptions in 2012). It was also the 4th most prescribed antibiotic in the USA in 
2010(Hicks et al. 2013). Ciprofloxacin is a first line treatment for many UTIs and STDs 
and frequently used as an alternative to penicillin if a patient is allergic. Levofloxacin, 
the active enantiomer of ofloxacin, is indicated for community-acquired pneumonia due 
to its action against S. Pneumoniae and is the second most frequently prescribed FQ in 
the UK. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Structures of nalidixic acid and notable fluoroquinolones. 
Nalidixic acid, the parent compound of the FQs, is highlighted. Norfloxacin was one of the first 
FQs synthesized but has been largely supplanted by ciprofloxacin, which is currently the most 
prescribed FQ. Ofloxacin is supplied as a racemic mixture (its levo- enantiomer is the second 
most prescribed FQ). Use of lomefloxacin, a difluoroquinolone, is limited due to phototoxic 
effects. 
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4.1.3.1 Action of fluoroquinolones 
FQs are potent inhibitors of bacterial DNA gyrase and topoisomerase IV, both of which 
are essential for bacterial DNA replication(Blondeau 2004). Both enzymes create a 
DSB (stabilised by covalent binding between a phosphotyrosine and the 5’-P), pass 
another duplex through the break and then reseal the original strands. By these actions, 
DNA gyrase relaxes supercoiling ahead of the replication fork and topoisomerase IV 
decatenates the replicated daughter chromosomes to permit segregation. In Gram-
negative bacteria the primary target is DNA gyrase whereas in Gram-positive bacteria, 
it is topoisomerase IV. FQs bind the enzyme-DNA complex by intercalating into DNA 
at the newly formed nick and trapping the complex in the cleaved form by blocking the 
phosphotyrosine from the active site(Wohlkonig et al. 2010).  
 
4.1.3.2 Fluoroquinolones and UVA 
Treatment with ciprofloxacin is associated with very mild phototoxicity in <2.4% of 
patients(Ferguson 1995). Phototoxicity associated with the difluoroquinolone, 
lomefloxacin, occurs more frequently (4-10%) and is more severe(Ferguson 1995) and 
it is only used topically.  
 
The UVA MED of patients taking ciprofloxacin is reduced by around 50%, which 
correlates with an absorbance peak at around 340nm, and thus it is a weak UVA 
photosensitiser(Ferguson & Dawe 1997). In mice, UVA photosensitisation of various 
FQs, including ciprofloxacin and ofloxacin induced a modest increase in benign 
papillomas. The effect of photosensitised lomefloxacin was more severe and resulted in 
multiple SCCs(Klecak et al. 1997).  
 
The higher photocarcinogenic risk associated with lomefloxacin is supported by 
increased SCC formation in UVA-irradiated XPA-/- mice treated with lomefloxacin but 
not ofloxacin (Itoh et al. 2005). 
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In practice, FQ-mediated phototoxicity is generally mild and short course lengths 
minimise the risk of phototumourigenesis in patients although ciprofloxacin has been 
recommended as a prophylactic antibiotic which requires extended course lengths (10 
weeks)(Hart & Beeching 2001).  
 
4.1.4 Vemurafenib 
4.1.4.1 Treatment with Vemurafenib  
Vemurafenib is an inhibitor of the BRAF protein kinase. It was recently approved for 
advanced metastatic melanoma patients carrying the BRAF V600E mutation, which is 
found in around 60% of cases(Roberts & Der 2007). It is currently the first-line 
treatment for advanced melanoma with a >50% response rate and a median survival of 
16 months (vs. 6-10 months with previous best treatments)(Sosman et al. 2012). 
Resistance to vemurafenib invariably develops and can arise by several mechanisms 
including upregulation CRAF, activating Ras mutation and BRAF truncation to yield a 
constitutively dimerised protein that is resistant to inhibition(Bollag et al. 2012). 
Importantly, cutaneous SCCs are diagnosed in 26% of patients treated with 
vemurafenib(Sosman et al. 2012). 
4.1.4.2 Action of Vemurafenib 
The RAF/MEK/ERK pathway is a sub pathway of the larger MAPK family that plays a 
regulatory role in cellular growth, differentiation and survival. Upon stimulation by 
growth factors, mitogens or cytokines, cell surface receptors prompt membrane-bound 
Ras to recruit and activate RAF. The complex activation procedure involves 
phosphorylation, dephosphorylation and disruption of autoinhibitory binding. 
Importantly, it also forms a side-to-side dimer, which is essential for activation. RAF is 
present in three isoforms A, B and C although in practice, the RAF B-C heterodimer is 
most prevalent followed by RAF B homodimers(Freeman et al. 2013). BRAF exhibits 
significantly higher activity than the other RAF isoforms and is considered to be the 
main RAF transducer. RAF activates MEK by phosphorylation of its catalytic domain, 
which then goes on to activate ERK. ERK phosphorylates over 160 cytoplasmic and 
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nuclear targets. Nuclear targets of ERK lead to altered gene expression through the 
action of numerous transcription factors including NF-κB, c-Myc and AP-1. (McCubrey 
et al. 2007).  
 
Mutational upregulation of the ERK pathway occurs in around 30% of human 
cancers(Wellbrock et al. 2004). Ras is mutated in 15% of all cancers whilst BRAF is 
mutated in 8%(H. Davies et al. 2002). Strikingly BRAF mutation is found in 70% of 
malignant melanomas; a TA transversion that leads to V600E, accounts for 90% of 
these(Roberts & Der 2007). V600E is effectively a phosphomimetic mutation that 
exchanges a hydrophobic Val for a charged Glu, causing a conformational change that 
destabilises inactive BRAF and promotes constitutive activation(Cantwell-Dorris et al. 
2011). In contrast to wild-type RAF, V600E mutants are kinase active in the absence of 
dimerization(Freeman et al. 2013) thus ERK activation is promoted in the absence of 
Ras or upstream signalling.  
 
Vemurafenib inhibits V600E BRAF at doses more than ten times lower than wild type 
BRAF and shows even greater discrimination against other kinases(Tsai et al. 2008). 
The drug is complementary to RAF-specific structural features and its binding induces a 
conformational change that only inactivates the V600E mutant.  
 
4.1.4.3  Vemurafenib and UVA 
Photosensitivity and SCC formation were among the reported side effects in the initial 
clinical trials of vemurafenib(P. B. Chapman et al. 2011). A more recent collation of 3 
trial data sets reported photosensitive reactions 35-63% of patients and development of 
SCCs in 19-26%(Lacouture et al. 2013). Of these SCCs, 41% were HRAS mutated. The 
photosensitivity associated with vemurafenib is UVA dependent(Dummer et al. 2012). 
Although the precise action spectrum has not yet been elucidated, it is clear that 
vemurafenib is a UVR photosensitiser.  
 
Whilst vemurafenib blocks ERK signalling in cells carrying the V600E mutation, it 
causes paradoxical ERK activation in cells with wild type BRAF. The mechanism is 
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still not fully understood but it seems that upon binding to the active site of one RAF in 
a dimer, it transactivates the binding partner (Poulikakos et al. 2011). The effect 
requires the presence of CRAF and an activated Ras to induce RAF dimer formation. 
Sequencing of SCCs arising during vemurafenib treatment reveals that 60% contain a 
Ras mutation(Su et al. 2012). The speed of SCC development (weeks) suggests that 
vemurafenib potentiates pre-existing Ras mutations via ERK activation. Although the 
development of SCCs is likely distinct from vemurafenib-mediated photosensitisation, 
little information is available regarding vemurafenib as a photosensitiser. 
 
In these experiments, I sought to further characterize the as yet poorly understood 
phototoxic effects of vemurafenib. As non-DNA incorporated type II photosensitisers, 
FQs were chosen to offer a point of comparison to 6-TG such that the effects of its RS 
generation might be decoupled from its incorporation into DNA. The techniques 
developed in Chapter 3 in conjunction with other assays detailed below were used to 
assess the similarities and differences between known UVA photosensitisers. 
4.2 Results 
4.2.1 Phototoxicity in CEM-CCRF cells 
The ability of DNA-6-TG(O'Donovan et al. 2005) and the FQs(Zhao et al. 2010) to 
sensitise cultured cells to sub-lethal UVA doses has previously been documented. At 
the time my experiments were performed, UVA photosensitisation by vemurafenib had 
been observed only in patients but its effect on cultured mouse cells has since been 
reported(Boudon et al. 2013). To examine the in vitro photosensitising effects of the 
drug and the concentration range over which they are effective in the CEM cells, drug-
treated cells were UVA irradiated at 20 kJ/m2 and the outgrowth of surviving cells was 
determined over 48 hours. (20 kJ/m2 is a relatively mild UVA dose and is equivalent to 
around 30 minutes of midday sun in the British summertime). 
 
6-TG requires less metabolic processing prior to its incorporation into DNA and was 
used as an azathioprine proxy. Cells were allowed to incorporate 6-TG into DNA by 
growth in medium supplemented with the free base for 24 hours. Following washing 
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and resuspension in PBSA, cells were UVA irradiated in a closed Petri dish. Irradiated 
cells were returned to fresh growth medium and proliferation was monitored for 48 
hours. As expected, 6-TG and UVA were synergistically toxic to CEM cells (Figure 4-5, 
top left). Low 6-TG concentrations (0.1, 0.3 µM) that had no detectable effect on cell 
proliferation were cytostatic in conjunction with UVA. A higher 6-TG dose (0.6 µM) 
was required to cause even minor retardation of growth in the absence of irradiation. 
 
Photosensitisation by FQs was investigated using ciprofloxacin and ofloxacin. CEM 
cells were treated with the drug for 60 minutes. In all other respects, the procedure 
described for 6-TG was followed. Ciprofloxacin (Figure 4-5, top right) was a more 
potent photosensitiser than ofloxacin (Figure 4-5, bottom left). Cells treated with 50 µM 
ciprofloxacin survived 20 kJ/m2 UVA irradiation whereas irradiated cells treated with 
100 or 250 µM drug showed no sign of recovery. In contrast, irradiated cells treated 
with higher (500, 1000 µM) ofloxacin concentrations showed some signs of recovery. 
Neither drug detectably affected growth in the absence of UVA. 
 
Vemurafenib is also a UVA photosensitiser in CEM cells. 20 kJ/m2 UVA resulted in 
partial inhibition of growth in cells treated for 24 h with 5 µM vemurafenib (Figure 4-5, 
bottom right). Treatment with 20 µM vemurafenib and UVA abolished proliferation. 
Neither dose affected proliferation of unirradiated cells. Thus DNA 6-TG, ciprofloxacin 
and ofloxacin, and vemurafenib are all UVA photosensitisers in CEM cells over the 
examined dose ranges. 
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Figure 4.5 Proliferation of CEM cells after photosensitisation 
CEM cells were drug treated (6-TG & Vem 24h/ FQs 1h) and irradiated with UVA (20 kJ/m2) 
as indicated. After irradiation, cells were collected and resuspended in fresh growth medium. 
Cells were counted at 24 and 48 hours after irradiation. Top, left: 6-TG. Top, right: 
Ciprofloxacin. Bottom, left: Ofloxacin. Bottom, right: Vemurafenib  
 
4.2.2 Generation of RS 
Photosensitisation frequently involves generation of RS. UVA can produce RS from 
unincorporated 6-TG or following its incorporation into cellular DNA(X. Zhang et al. 
2007; O'Donovan et al. 2005). The ability of FQs to generate intracellular RS can be 
inferred by formation of 8-oxoG in genomic DNA following UVA irradiation of treated 
cells(Sauvaigo et al. 2001). The relationship between vemurafenib phototoxicity and RS 
in cultured cells has not been characterised.  
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Intracellular RS generation can be assayed using a suitable fluorescent probe in 
conjunction with fluorescent-activated cell sorting (FACS). 5-(and-6)-chloromethyl-
2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA) is a reduced 
fluorescein derivative that becomes fluorescent upon oxidation (Figure 4.6).  
 
 
Figure 4.6 Mechanism of CM-H2DCFDA function 
CM-H2DCFDA penetrates cells whereupon the acetate groups are cleaved by cellular esterases 
to give a charged form that is less able to cross cell membranes. The chloromethyl derivative 
used in these experiments reacts with cellular thiols to further increase retention. Oxidation by 
intracellular RS results in a fluorescent form that can be detected by FACS. 
 
After treatment with a range of drug concentrations (24 h 6-TG and vemurafenib, 1 h 
ciprofloxacin and ofloxacin), cells were incubated with CM-H2DCFDA and UVA 
irradiated. FACS analysis yields a frequency distribution as a function of fluorescence 
intensity, which is proportional to RS generation. Figure 4.7 shows that drug and UVA 
treatments are also synergistic for RS generation. In each case, there is a positive 
correlation between RS and drug concentration. A maximum response is reached at the 
highest doses of 6-TG and ciprofloxacin suggesting that the dynamic range of the assay 
is limited to around 50x the response of the untreated control. As a result, it is difficult 
to compare RS generating ability. Ciprofloxacin (Figure 4.7, top right) appears to be the 
most powerful RS source. The highest ciprofloxacin doses (250, 500 µM) and 6-TG 
(0.5µM) all gave maximal fluorescence values whereas this level was not reached 
following vemurafenib or ofloxacin treatment.  
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It is apparent from these findings that RS generation and cell killing are not related in a 
simple way. This is illustrated in Figure 4-8 in which approximately equitoxic 
treatments are compared. Ciprofloxacin and ofloxacin generate significantly more RS 
than the approximately equitoxic doses of 6-TG and vemurafenib. The discrepancies 
between RS formation and cytotoxicity may reflect differential contributions from type 
I and type II photosensitisation, different localisation of the photosensitiser within the 
cell, or drug-mediated alterations to cellular function that otherwise modulate UVA 
sensitivity 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 FACS analysis of intracellular RS by CM-H2DCFDA  
Cells were drug treated and UVA irradiated as indicated. Cells were incubated with 7.5µM CM-
H2DCFDA for 15 minutes prior to irradiation. They were then collected, washed and 
resuspended in PBS and subject to FACS analysis. Top, left: 6-TG. Top, right: Ciprofloxacin. 
Bottom, left: Ofloxacin. Bottom, right: Vemurafenib 
 
 
 
 
 
 
Chapter 4 Other photosensitisers and protein oxidation 
 
 130 
Figure 4.8 RS produced at equitoxic doses of photosensitiser 
Selected histograms from Figure 4.7 are replotted to allow easier comparison. 
 
To gain an insight into the relative photosensitising potency as well as the potential 
contribution of type I and II photosensitisation for each PS, in vitro photosensitising 
ability was assessed by secondary bleaching of p-nitroso-N,N-dimethylaniline (RNO) 
(Kraljić & Mohsni 1978). RNO is a yellow dye that becomes colourless upon oxidation 
(Figure 4.9). 1O2 cannot oxidise RNO directly. RNO does, however, react with 
endoperoxides formed by reaction of 1O2 with a diene (as seen in Figure 1.3) and 1O2 –
dependent bleaching can therefore only occur in the presence of an appropriate mediator, 
such as histidine. Strong oxidants such as HO oxidise RNO directly. Thus in the assay, 
histidine dependent RNO bleaching can be attributed to 1O2 production and histidine-
independent bleaching to type I photosensitisation.  Although semi quantitative, the 
assay does give an indication as to whether RS are produced and, if they are, whether 
1O2 represents a significant proportion.  
 
Samples were treated in accordance with the RNO assay protocol in Materials and 
Methods. An RNO/drug mixture with or without histidine in phosphate buffer is loaded 
into duplicate 96-well plates. One plate is UVA irradiated (100kJ/m2) whilst its partner 
is shielded from light. Absorbance at 440nm is then measured and the extent of 
bleaching is calculated relative to its unirradiated counterpart.   
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Figure 4.9 Reaction scheme for RNO bleaching 
Yellow dye molecule, RNO, can be converted to its colourless oxidised form by direct reaction 
with HO or via histidine mediated reaction with 1O2. Histidine dependence of bleaching 
indicates type II photosensitisation and histidine independence, type I. 
 
Figure 4.8 shows the data for 6-TG. The ratio of His-dependent to His-independent 
bleaching is around 2.5 indicating a significant production of 1O2. This ratio is increased 
to ≥3.0 when the reaction mixtures were prepared in D2O, which prolongs 1O2 lifetime, 
thereby confirming histidine dependence as indicative of 1O2 production. As expected, 
histidine-independent bleaching is largely unaffected by D2O. 
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Figure 4.10 RNO assay for 6-TG 
6-TG (0-300 µM) was assayed according to the RNO assay protocol (Materials and Methods). 
Values represent absorbance at 440nm relative to unirradiated sample. Samples without 
histidine are shown in blue, with histidine shown in red, without histidine and with D2O shown 
in green and with histidine and with D2O depicted in purple.   
 
In agreement with published data(Dall’Acquaa et al. 2007), ciprofloxacin was a 
significant source of 1O2. In contrast to 6-TG, a much higher proportion of RNO 
bleaching was histidine-dependent (the independent to dependent ratio was 
approximately 4.0) suggesting a larger role for singlet oxygen in its bleaching ability 
(Figure 4.11). I thus conclude that although 6-TG is an efficient producer of 1O2, it has a 
more significant type I component than ciprofloxacin. Both histidine-dependent and 
independent bleaching is significantly higher for 6-TG at lower concentrations 
suggesting that it is more effective at both type I and type II photosensitisation. 
Published data support this conclusion. The 1O2 quantum yield,  quantitatively related to 
type II photosensitising ability, is around 5x greater for 6-TG than for ciprofloxacin (0.5 
vs. 0.092 – for comparison, the quantum yields of most clinical photosensitisers are 
between 0.7 and 0.9 (DeRosa & Crutchley 2002)). 
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Figure 4.11 RNO assay for ciprofloxacin 
Ciprofloxacin (0-1000 µM) was assayed according to the RNO assay protocol (Materials and 
Methods). Values represent absorbance at 440nm relative to unirradiated sample. Samples 
without histidine are shown in blue and with histidine shown in red.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12 Modified RNO assay for vemurafenib 
Left: Vemurafenib (0-1000 µM) was assayed in a modified RNO assay prepared in DMSO 
(Materials and Methods). Samples without histidine are shown in blue and with histidine shown 
in red. Right: Samples prepared as for vemurafenib but with 6-TG (100µM).  
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Vemurafenib is very poorly soluble in aqueous solvents. To solve this problem, I 
carried out the RNO bleaching assay in DMSO. There are no previous reports of RNO 
bleaching in a non-aqueous solvent but since the lifetime of 1O2 in DMSO is around 6x 
longer than in H2O(Wilkinson & Brummer 1981) and triplet state lifetime are also 
extended, an increase in both type I and type II photosensitisation might be expected. 
DMSO is, however, a radical scavenger and this prevents detection of any HO 
mediated effects. Despite the anticipated increase in sensitivity, vemurafenib did not 
induce either histidine-dependent or independent photobleaching of RNO (Figure 4.12, 
left). I did observe extensive histidine-dependent and –independent bleaching by 
irradiated 6-TG in DMSO (Figure 4.12, right). This control indicated that using a non-
protic solvent does not prevent RNO bleaching and confirmed the predicted increase in 
sensitivity. Although not entirely definitive, these observations suggest that the effects 
of vemurafenib on cells are likely not 1O2 mediated and that it has no ability to act as a 
type II photosensitiser. 
 
4.2.3 Protein oxidation by UVA photosensitisers 
The effects of the non-DNA incorporated photosensitisers on protein oxidation were 
assessed using the endpoints identified in the previous chapter and the previously 
reported crosslinking of PCNA (Figure 4.13). FHA derivatized extracts from 6-
TG/UVA, ciprofloxacin/UVA and ofloxacin/UVA treated cells are shown in 
Figure 4.13, top. As the RS induction observed in the previous section predicted, a 
UVA and dose-dependent increase in carbonylation was observed in each case. Western 
blot analysis of Ku70 and PCNA revealed formation of the crosslinked species in a 
UVA and drug-dose dependent manner. Taken together these results indicate that the 
fluoroquinolones recapitulate the protein oxidation behaviour of 6-TG. I conclude that 
extensive protein oxidation can also occur via non DNA-embedded UVA chromophores. 
 
Protein oxidation by vemurafenib presents a somewhat different picture. Carbonylation 
appears fairly modest (Figure 4.14, top left). A slight increase can be discerned in 
extracts from cells treated with 20 µM vemurafenib and UVA irradiated. Attempts to 
visualise this increase with a very high dose (50 µM) lead to significant UVA-
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independent carbonylation, which increased substantially upon irradiation (Figure 4.14, 
top right). Gels were western blotted (rather than Sypro Ruby stained) to interrogate the 
Ku oxidation status (Figure 4.14, middle). Crosslinking could not be perceived after any 
treatment, even in the heavily carbonylated samples, again suggesting a different 
mechanism may underlie vemurafenib photosensitisation.  PCNA crosslinking was also 
minimal although the signal was often slightly increased over that observed with UVA 
alone (Figure 4.14, bottom). (These experiments also highlighted the automatic signal 
adjustment that the acquisition software performs when saturated by highly fluorescent 
samples meaning that comparison between separately scanned gels is not necessarily 
meaningful). 
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Figure 4.13 Fluoroquinolones replicate the protein oxidation characteristics of 6-TG 
CEM cell extracts were prepared from cells drug treated (ciprofloxacin & ofloxacin/1 h, 6-
TG/24 h) and UVA irradiated (20 kJ/m2) as indicated. Left column: Ciprofloxacin Middle 
column: Ofloxacin. Right column: 6-TG. Top row: FHA gels and corresponding Sypro Ruby 
gels prepared according to FHA protocol in Materials and Methods. Middle row: Western blot 
analysis of Ku70. Bottom row: Western blot analysis of PCNA. 
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Figure 4.14 Protein oxidation by vemurafenib. 
RIPA extracts were prepared from cells treated with vemurafenib (24 h) and UVA irradiated (20 
kJ/m2) as indicated. Top: Extracts were derivatised with FHA according to the FHA protocol in 
Material and Methods. Middle: The FHA gels were western blotted after scanning and probed 
with Ku70 antibody. Bottom: Samples from same extracts used to prepare the left-hand FHA 
gel were western blotted and probed for PCNA.  
 
Incubation in PBS prepared using D2O prior to irradiation, exacerbated crosslinking of 
PCNA and Ku by 6-TG, ciprofloxacin and ofloxacin but not vemurafenib where it 
remained almost undetectable (Figure 4.15). This indicated that both phenomena were 
at least partially 1O2 mediated. As with, 6-TG/UVA treatment, levels of oxidised 
proteins decreased with time (Figure 4.16) consistent with proteolysis of the crosslinked 
material.  
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Figure 4.15 D2O-PBS incubation exacerbates Ku and PCNA crosslinking 
CEM cells were drug treated and UVA (20 kJ/m2) irradiated with and without 15 minute pre-
incubation with PBS prepared using D2O. Top: RIPA extracts were prepared and western 
blotted with anti-Ku70 primary antibody. Bottom: The same membrane was stripped and 
probed with anti-PCNA. 
 
 
 
 
 
 
 
 
 
 
Figure 4.16 Persistence of ciprofloxacin protein oxidation. 
CEM cells were treated with 500µM ciprofloxacin and 20 kJ/m2 UVA and returned to fresh 
growth medium. Samples were taken at 0, 2 and 4 hours after irradiation then subjected to FHA 
analysis and western blot analysis as detailed above. 
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4.2.4 The effects of UVA photosensitisation on NHEJ 
The fluoroquinolones ciprofloxacin and ofloxacin both combined with UVA to inhibit 
NHEJ (Figure 4.17). Ofloxacin did so less effectively than ciprofloxacin as evidenced 
by the presence of a dimer band in the lane corresponding to ofloxacin/UVA extracts 
that was not generated by extracts from ciprofloxacin/UVA treated cells. 
 
Like higher doses of 6-TG, vemurafenib inhibited NHEJ independently of UVA 
irradiation (Figure 4.18). Despite several attempts, I was unable to find a vemurafenib 
concentration that produced only UVA-dependent inhibition of NHEJ. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17 In vitro NHEJ assay of extracts from FQ/UVA treated cells 
Extracts were prepared from CEM cells that had been treated with ciprofloxacin (500 µM, 1h), 
Ofloxacin (500µM, 1h) and UVA (20 kJ/m2) as indicated. NHEJ was assayed as described in 
Materials and Methods. A representative autoradiograph from two independent experiments is 
shown. 
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Figure 4.18 In vitro NHEJ assay of extracts from vemurafenib/UVA treated cells 
Extracts were prepared from CEM cells that had been treated with vemurafenib (20 µM) and 
UVA (20 kJ/m2) as indicated. NHEJ was assayed as described in Materials and Methods. A 
representative autoradiograph from two independent experiments is shown. 
 
4.2.5 The effects of UVA photosensitisation on NER 
Treatment with 6-TG/UVA inhibits NER in MRC5VA and HeLa cells  
(Li 2010; Gueranger et al. 2014). I began by examining this combination in CEM cells. 
Cells were treated with 6-TG (0.6µM), irradiated with UVA (20 kJ/m2) followed 
immediately by UVC (20 J/m2). Genomic DNA was isolated at different times after 
irradiation and (6-4)PP levels were measured by ELISA. The half-time for (6-4)PP 
repair in untreated cells was 2-3 h and this was unaffected by either UVA or 6-TG 
treatment. In contrast, 6-TG/UVA treated cells performed no detectable repair during 
the 4-hour time course (Figure 4.19, top left). Having confirmed that 6-TG/UVA causes 
NER inhibition in CEM cells, I examined the effect of the other photosensitisers on (6-
4)PP removal. 
 
Ciprofloxacin/UVA inhibited NER in a similar manner to 6-TG/UVA and no (6-4)PP 
excision was observed over 4 hours (Figure 4.19, top right). The effects of ofloxacin 
were less marked. Although NER was inhibited over 2 hours following irradiation the 
cells recovered and excised (6-4)PP efficiently thereafter (Figure 4.19, bottom left). 
These findings also reflect the trend observed in the growth curves and RS 
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measurements, namely that the effects of ofloxacin are similar to those of ciprofloxacin 
but somewhat attenuated. The recovery of NER in ofloxacin/UVA treated cells 
demonstrates that that repair inhibition is potentially reversible, at least in the case of 
ofloxacin. 
 
A 24-hour treatment with vemurafenib (20 µM) combined with UVA also inhibited 
NER (Figure 4.19, bottom right). In this case, as with 6-TG/UVA and 
ciprofloxacin/UVA, there was no indication of recovery of NER. UVA alone or 6-TG, 
ciprofloxacin, ofloxacin or vemurafenib alone did not detectably affect repair. Taken 
together these results demonstrate that photosensitisers that are not incorporated into 
DNA can sensitise UVA toxicity and mimic the effects on NER inhibition of DNA-
embedded 6-TG.  
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Figure 4.19 Inhibition of NER by photosensitisers 
CEM cells were treated with drugs (6-TG and vemurafenib 24 h/ ciprofloxacin and ofloxacin 1 
h) and UVA (20 kJ/m2) as indicated and then immediately irradiated with UVC (20 J/m2). 
Irradiated cells were returned to fresh growth medium, genomic DNA was extracted at the 
indicated times and (6-4)PP levels measured by ELISA. Levels immediately after irradiation are 
set to 100%. A representative of two independent experiments is shown. Values shown are the 
mean of triplicate measurements. 
 
 
4.3 Discussion 
4.3.1 Assessing phototoxicity in the CEM-CCRF cell line 
Azathioprine (a DNA 6-TG precursor), ciprofloxacin, ofloxacin and vemurafenib are all 
pharmaceuticals known to sensitise patient skin to UVA to greater or lesser degrees. 
Consistent with this property, all were synergistically phototoxic with UVA in CEM 
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cells. The choice of CEM cells was initially dictated by their resistance to 6-TG (they 
are MMR-deficient and thus can proliferate in the presence of relatively high 
concentrations of the thiopurine). An additional advantage of using suspension cells 
such as CEM is that it facilitates the preparation of extracts for in vitro assays for which 
large quantities of cells are required. On the basis of the growth curves, a working dose 
range for phototoxicity was established for use in subsequent experiments, although I 
sometimes worked with supra lethal doses to demonstrate certain effects more 
conclusively.   
4.3.2 Generation of RS 
To measure intracellular RS, I elected to use the CM-H2DCFDA fluorescent probe. This 
has been the laboratory standard and enabled me to more easily compare my findings 
with previous results. Using the CM-H2DCFDA fluorescent probe, I demonstrated that 
all the compounds tested caused an increase in cellular RS when combined with UVA, 
although the magnitude of this effect varied. Over the tested dose ranges (taken from 
the proliferation assays), ciprofloxacin reached the maximal fluorescence value most 
quickly, followed by 6-TG. Ofloxacin and vemurafenib did not reach this maximum 
although vemurafenib is a notably weaker RS inducer than ofloxacin. Although CM-
H2DCFDA is by far the most commonly used probe for interrogating oxidative stress in 
cells, there are often misconceptions regarding its specificity. An important but often 
unheeded caveat when using CM-H2DCFDA is that most primary RS (i.e. the products 
of initial RS forming reactions) such as O2-, H2O2 and 1O2 cannot oxidise the probe 
directly(Wardman 2007). More reactive secondary RS such as HO, NO2 (the product 
of reaction between NO and O2) and CO3- (from ONOO-) oxidise CM-H2DCFDA as 
does the thiyl radical resulting from GSH deprotonation. Radical cations arising from 
type I photosensitisation may also be sufficiently reactive. The mechanism of probe 
oxidation is outlined in Figure 4.20 along with some putative routes through which 
photosensitisation may give rise to fluorescence. For the purposes of this thesis, CM-
H2DCFDA can be said to provide a general indication of cellular redox status.  Each of 
the drug/UVA combinations increases intracellular RS to some degree although this 
technique can give no information with respect to their identity. 
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Figure 4.20 Chemistry of CM-H2DCFDA oxidation 
Top: Mechanism of H2DCF oxidation (Chloromethyl- and acetate esters omitted for 
clarity): The first step towards fluorescence is one electron oxidation or H abstraction 
by a radical species to give a radical probe intermediate which loses an electron to 
oxygen to give the oxidised fluorescent probe and O2-. Bottom: Some putative 
mechanisms by which photosensitisation may give rise to CM-H2DCFDA oxidation are 
presented. 1O2 may upset the redox state of the cell by depleting antioxidants or 
liberating free iron, which can then lead to HO formation and causing probe oxidation. 
Type I photosensitisation could contribute in a similar fashion through O2- generation 
or directly via a radical cation state.  
 
One additional concern regarding CM-H2DCFDA use applies particularly to 
vemurafenib. Although the charged form of the probe generated intracellularly cannot 
traverse membranes by diffusion, it can be actively exported by multidrug-resistant 
efflux pumps(Wardman 2007). The recently reported stimulation of the MDR-1 efflux 
pump by vemurafenib(Michaelis et al. 2014) may lead to underestimation of the 
induced RS, although subsequent results do not suggest this is the case. 
 
The RNO bleaching assay partially addresses some of the limitations of CM-H2DCFDA 
and serves as a complementary approach to shed light on the likely nature of RS and 
provide qualitative information on the balance between type I and type II oxidation. The 
assay indicated that photosensitisation by 6-TG had a more significant type I component 
than that of ciprofloxacin; this has some bearing on the relative phototoxicities of these 
two compounds. From Figure 4-8, it is apparent that equitoxic treatments do not 
correspond to intracellular RS levels. A combination of 6-TG’s incorporation into DNA 
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and its type I photoreactivity means that it can induce lethal damage such as strand 
breaks, ICLs and DNA-protein crosslinks directly. For photosensitisers with greater 
type II character, 1O2 mediated damage must accumulate until enough biomolecules are 
oxidised to cause disruption to cellular processes hence the requirement for greater RS 
levels to achieve equitoxicity. 
 
Whilst the RS assays described in this section revealed notable differences between 6-
TG and ciprofloxacin, vemurafenib gave somewhat unexpected results. In accordance 
with previous findings(Boudon et al. 2013), I found vemurafenib to be phototoxic in 
CEM cells. CM-H2DCFDA staining indicated that vemurafenib/UVA treatment was 
toxic with little concomitant RS generation in a similar fashion to 6-TG. The main 
conclusion drawn from the RNO assay is that vemurafenib does not produce 1O2 and 
this finding was later supported by its inability to induce significant Ku or PCNA 
crosslinking. Taken together, these results suggest vemurafenib photosensitises 
exclusively by a type I mechanism. Its lipophilicity suggests it will localise to 
membranes and organelles once inside the cell, which has to be shown increase lethality 
of photosensitisers (Benov et al. 2010). Within a membrane, a type I photosensitiser can 
initiate lipid peroxidation which occurs via a chain reaction (Section 1.2.3.1) leading to 
carbonyl stress via ALEs and release of pro-apoptotic factors from disrupted organelles, 
a possible route to vemurafenib mediated cell death. Similar low RS, high toxicity, no 
1O2 behaviour is also seen in Crystal Violet, which mainly photosensitises via type I and 
localises to mitochondria(Oliveira et al. 2011). 
 
A more “exotic” route to cellular damage became apparent upon comparing the 
structures of vemurafenib and lomefloxacin. Lomefloxacin is noted to undergo 
defluorination upon UVA irradiation(Fasani et al. 1997).; an amine adjacent to the 
fluorine site stabilises the resulting reactive carbene species (outlined in Figure 4.21 
(bottom)). Carbenes are very reactive and would form adducts with biomolecules via 
the modes of reactivity outlined in Figure 4.21 (top). Vemurafenib contains a similar 
structure and therefore an interesting alternative mechanism for photosensitisation 
arises, which would not be detected by the abovementioned techniques. 
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Figure 4.21 A potential route to carbene formation by vemurafenib 
Top: The major reactions of carbenes are addition to double bonds and insertion into C-H 
bonds; Middle: The fluorinated ring with adjacent amine (blue) predisposes lomefloxacin 
towards defluorination; Bottom: Vemurafenib posses structural similarity to lomefloxacin that 
may also lead to formation of reactive carbenes that could damage cellular components. 
 
4.3.3 Protein oxidation by UVA photosensitisers 
Photosensitisers with significant type II character as judged by RNO bleaching (i.e. 6-
TG and FQs) exhibit a similar suite of effects in combination with UVA including 
efficient carbonyl induction and the ability to crosslink susceptible multi-protein 
complexes. Vemurafenib, in contrast, gives a weak carbonyl response across the range 
of doses corresponding to its proliferation assay. A strong FHA signal occurs after 
treatment with 50 µM vemurafenib and UVA, 2.5x higher than the dose needed to 
abolish proliferation. UVA independent protein oxidation is also seen after 50 µM 
treatment which could be a result of transcriptional modulation. Vemurafenib can 
activate and inhibit the ERK pathway in a biphasic dose response(Poulikakos et al. 
2011), which controls the numerous antioxidant genes with AP-1 promoter sites. 
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Shorter vemurafenib incubation times should elimination identification of transcription-
mediated effects and these experiments are currently underway in the lab.  
 
Ciprofloxacin and ofloxacin mirror 6-TG in their UVA-dependent generation of 
crosslinked Ku species (Figure 4-13). Vemurafenib induced no significant Ku 
crosslinking, even at 50 µM/UVA (Figure 4-14), which is associated with significant 
protein carbonylation. This suggests that Ku crosslinking is not a general marker for 
protein oxidation but rather a specific response to certain photosensitisers.  
 
A similar pattern is observed for crosslinking of PCNA. Since Montaner et al’s initial 
observation(Montaner et al. 2007), other labs have reported crosslinking of PCNA as a 
result of photosensitisation by non-DNA incorporated compounds(Bae et al. 2008; 
Bracchitta et al. 2013). These later reports importantly demonstrated 1O2 dependence of 
the effect through D2O potentiation (and histidine inhibition). PCNA is more readily 
crosslinked than Ku and appears to be a more sensitive measure of intracellular 1O2 
production. The D2O exacerbation shown in Figure 4-15 supports the conclusion that 
crosslinking of these complexes by 6-TG, ciprofloxacin and ofloxacin is 1O2-mediated. 
The functional consequences of PCNA crosslinking remain to be determined. The 
inability of vemurafenib to induce significant PCNA or Ku crosslinking further supports 
the likelihood, suggested by the RNO bleaching assay, that it is not a type II 
photosensitiser. Overall, study of protein oxidation elucidated fundamental differences 
between UVA photosensitisers and provides an indication as to how they photosensitise. 
4.3.4 The effects of UVA-induced phototoxicity of NHEJ 
Like 6-TG, ciprofloxacin and ofloxacin cause UVA-dependent inhibition of NHEJ. 
Inhibition was synergistic and UVA potentiated the effects of non-inhibitory drug 
treatments. Photosensitisation with ofloxacin produced an attenuated version of the 
effects seen with ciprofloxacin. The FQs provided a useful comparison to 6-TG and the 
findings demonstrate that NHEJ inhibition is not dependent on the specific 
photochemistry of 6-TG.  
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Vemurafenib also causes NHEJ inhibition but unfortunately UVA-dependence was not 
established. At sufficiently high doses, vemurafenib inhibits the ERK pathway in cells 
that do not have the target V600E mutated BRAF. This alters transcription profiles and 
proliferation(Poulikakos et al. 2011). ERK pathway inhibition has previously been 
shown to reduce expression of DNA-PKcs(Marampon et al. 2011) and MEK inhibitors 
sensitise cells to ionising radiation. In light of these data, vemurafenib might influence 
NHEJ through an effect on DNA PKcs expression. Reducing treatment time to 1 hour 
should minimise any effects on transcription and allow photosensitising effects to be 
assessed. 
 
4.3.5 The effects of UVA induced phototoxicity on NER 
All tested compounds caused UVA-dependent inhibition of NER. Firstly, this confirms 
the finding of Dr Feng Li(Li 2010) that UVA activation of DNA-embedded 6-TG 
inhibits NER. My findings also indicate that the vulnerability of NER to photochemical 
inhibition extends to other photosensitisers, yielding new mechanistic insight. 
 
The two most obvious mechanisms by which 6-TG/UVA might cause NER inhibition 
are: 
• The introduction of competing or obstructing DNA lesions 
• Oxidation and inactivation of repair proteins 
 
DNA-6-TG photoactivation induces GSO2 and GSO3. These two polymerase-blocking 
lesions are not themselves NER substrates(Li 2010). They may however, prevent access 
of repair factor to UVC photoproducts. Photoactivated DNA 6-TG forms ICLs that 
prevent strand segregation(Brem et al. 2011). ICLs and DNA-6-TG related DNA-
protein crosslinks(Gueranger et al. 2011) might hinder access to lesions. The 
observation that XPA is among the crosslinked proteins suggests further that depletion 
of repair factors might also play a role in inhibiting NER. Thus all the available 
evidence of the effects of 6-TG/UVA is compatible with a DNA lesion-mediated NER 
inhibition. These findings do not, however, exclude non-DNA related mechanisms.  
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My finding that structurally unrelated photosensitisers are also able to inhibit NER 
establishes the principle the DNA incorporation is not essential for UVA sensitised 
inhibition of NER and provides more evidence for a DNA-independent mechanism. 
Evidence for an important contribution of protein-damage to NER inhibition was 
obtained from an in vitro NER assay that examines the ability of nuclear extracts from 
treated cells to excise a cisplatin intrastrand crosslink from plasmid DNA (Figure 4.22, 
top). Nuclear extracts from 6-TG/UVA treated cells have reduced NER activity in this 
assay(Gueranger et al. 2014)(Figure 4.22, middle left). Extracts prepared from UVA 
irradiated cells treated with ciprofloxacin or ofloxacin are also deficient in NER (these 
experiments were performed by Peter Macpherson, Figure 4.22 bottom), confirming the 
link to protein damage. In agreement with the generally more severe biological effects 
of ciprofloxacin/UVA that I have observed, this combination was more severely 
inhibitory than ofloxacin/UVA. 
 
Surprisingly, extracts from cells treated with vemurafenib/UVA appear to retain 
undiminished NER activity, contradicting the results from the ELISA. Although the 
reasons for this apparent discrepancy are not clear at present, there are several 
possibilities: 
• Altered UVA dosimetry. Large numbers of cells are required to make the active 
extracts, which could lead to shielding effects. Although measures are taken to 
minimise dose attenuation due to different irradiation conditions, it is possible that 
these are not sufficient and the UVA dose received by the cells used to prepare the 
extracts is sub-inhibitory for vemurafenib/UVA but not the other compounds. 
• The inherent artificiality of the in vitro assay. In preparing nuclear extracts, it is 
essential that high protein concentrations be maintained, as dilute extracts are 
invariably inactive. It is therefore possible that by concentrating levels of NER 
proteins that would be sub-optimal in vivo, it is possible to prepare an active nuclear 
extract. In addition, inclusion of high concentrations of reducing agent is essential 
during extract preparation. Partial restoration of enzyme activity by artefactual 
reduction of oxidised proteins is also a possibility. One could envisage a scenario in 
which strong (e.g. ciprofloxacin) and weak (e.g. vemurafenib) RS-generating 
photosensitisers both inhibit NER in cells through thiol oxidation, with the more 
potent photosensitiser leading to formation of irreversible sulphur oxidation 
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products (i.e. sulfinates and sulfonates). Exposure to reducing agents upon extract 
preparation would be able to reduce disulphides and restore activity in extracts from 
the weaker photosensitiser hence giving a discrepant response between in vivo and 
in vitro experiments, whilst the stronger photosensitiser would give a negative result 
in both cases. 
• Chromatin effects. The in vitro NER substrate is naked plasmid DNA. Any effects 
related to chromatin will not be apparent in the assay. 
 
Further experimental work is required to test the various possibilities and reconcile 
these discrepant observations. 
 
Although some of the finer mechanistic details are yet to be elucidated, the available 
data indicate that oxidation of key proteins is responsible for the inhibition of NER. 
NER can restored in vitro by complementation of extracts with purified 
RPA(experiment performed by Quentin Gueranger, in collaboration with Annabel 
Larnicol-Fery, Figure 4-22, middle right), which is known to be redox-sensitive(Men et 
al. 2007) (Further discussion of enzyme susceptibilities in Chapter 6). The in vitro assay 
does not entirely recapitulate the situation within cells and contributions from other 
oxidised NER factors or DNA damage that inhibits repair cannot be excluded. 
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Figure 4.22 Nucleotide excision repair in vitro 
Top: Schematic of the in vitro NER assay. A circular duplex DNA substrate containing a single 
cisplatin intrastrand crosslink is incubated with nuclear extracts or purified NER proteins. 
Excision products are detected by hybridization to a complementary oligonucleotide with a 5’-
GGG overhang that permits radiolabelling with Sequenase and α-[32]P labeled dCTP. Labeled 
products are resolved by denaturing PAGE. Middle, left: The detected products of the in vitro 
assay for nuclear extracts from HeLa cells treated with 6-TG and UVA as indicated. Middle, 
right: Nuclear extracts from 6-TG/UVA treated cells replace omitted factors in a reconstituted 
NER system. Extracts cannot fully complement a reaction missing RPA. In the reciprocal 
experiment, purified RPA is able to complement defective extracts. Bottom: The detected 
products of the NER assay for extracts made from CEM cells treated with FQs/UVA and 
Vem/UVA as indicated. 
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4.4 Summary 
I have demonstrated a number of consequences arising from UVA-dependent 
photosensitisation of cultured cells. Comparative measurements of phototoxicity and RS 
production suggest that different mechanisms could operate in the three different drug 
classes. The FQs replicated the protein oxidation behaviour of 6-TG characterised in 
Chapter 3 whereas vemurafenib did not and appears to be mechanistically distinct from 
the other tested compounds.  
 
Extracts from 6-TG and ciprofloxacin treated cells showed significant UVA-dependent 
abrogation of NHEJ activity. The effect of ofloxacin/UVA is less dramatic, in keeping 
with generally less severe photosensitisation in other assays.  Vemurafenib affected 
NHEJ in a UVA-independent fashion that may reflect its influence on transcription. 
 
My findings, together with those of other lab members, provide strong evidence that 
NER is compromised in photosensitised cells and that this reflects, at least in part, 
damage to repair proteins, including RPA. As such, the link between protein oxidation 
and DNA damage repair seems worthy of further investigation. 
 
In the final results chapter, a potential mechanism for repair inhibition without the direct 
damage to repair factors seen here is explored. 
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Chapter 5. Possible sequestration of an NER factor 
by 6-TG/UVA photoproducts 
5.1 Introduction 
The in vitro assays discussed in the previous chapter indicate that protein damage 
induced by oxidative stress conditions can inhibit DNA repair in cultured cells. DNA 
damage-related events may also contribute to this inhibition in intact cells. The 
preliminary experiments described in this chapter were performed to investigate 
whether NER capacity may be affected by interference with lesion recognition. 
 
5.1.1 Lesion recognition in NER 
NER is a versatile system that can excise a variety of DNA lesions in addition to UVR 
photoproducts. Rather than recognising the structure of a particular lesion, the NER 
damage sensing factors, XPC (with its partner HR23B) and UV-DDB, utilise a β-
hairpin to probe for helical distortion and thermodynamic destabilisation induced by the 
lesion. They do this via subtly different mechanisms. XPC binds to the strand opposite 
the lesion, inserting the hairpin to flip out and bind the undamaged bases opposite the 
lesion whilst loosely binding the lesion itself(Min & Pavletich 2007). Provided that 
disruption of base pairing is sufficient to permit extrusion of the damaged base pair, 
XPC can perform lesion recognition. The most abundant UVR photoproducts, CPDs, 
are poor XPC substrates probably due to their relatively mild effect on duplex structure 
and Tm(Jing et al. 1998). Localisation of the XPC complex to CPDs is stimulated by 
DDB2, the product of the XPE gene(Fitch, Nakajima, et al. 2003b). DDB2 is the DNA 
binding element in a larger, constitutively assembled complex that also contains DDB1, 
CUL4A and RBX1(Scrima et al. 2008). In contrast to XPC binding, the DDB2 complex 
binds to the damaged DNA strand. This binding induces a 40° kink and it is this 
enhanced distortion that is thought to stimulate subsequent recruitment of XPC. The β-
hairpin of DDB2 displaces the lesion into a shallow recognition pocket that appears to 
be optimised for binding to CPDs(Fischer et al. 2011). Thus, the current consensus is 
that DDB2 selectively enhances CPD recognition by XPC. Consistent with this 
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possibility, XP-E cells, which lack functional DDB2, have normal TC-NER but are 
defective in repair of CPDs by GG-NER(Hwang et al. 1999). Since repair of the more 
distorting (6-4)PPs occurs predominantly through direct recruitment of XPC, (6-4)PP 
excision by XP-E cells is normal although rates may be somewhat reduced especially at 
low UV doses(Nishi et al. 2009; Moser et al. 2005).  
 
The ubiquitin ligase activity of the DDB2-DDB1-CUL4-RBX1 complex plays an 
important role in orchestrating repair events. It is activated by binding to DNA and 
catalyses the ubiquitination of DDB2, XPC and other targets, including histones(Fischer 
et al. 2011). Histone ubiquitination is responsible for the chromatin remodelling activity 
of DDB2(Luijsterburg et al. 2007) which may be important for access by repair factors 
especially in nucleosomes. Importantly, ubiquitination reduces DDB2’s affinity for 
DNA and marks it for degradation. In contrast, XPC ubiquitination increases its affinity 
for DNA. The differential effects of this modification may underlie the handover of 
lesions from DDB2 to XPC for subsequent processing(Sugasawa et al. 2005). 
 
Although DDB2 binds a variety of non-photoproduct lesions in vitro including abasic 
sites and mismatches (Wittschieben et al. 2005) as well as adducts induced by nitrogen 
mustard, N-methyl-N’-nitroso-N-nitrosoguanidine and cisplatin(Payne & Chu 1994), it 
probably does not participate in their repair. Indeed, cisplatin does not induce XPC 
ubiquitination suggesting that in vitro recognition by DDB2 is not necessarily a good 
indication of in vivo recognition(Sugasawa 2006); cisplatin intrastrand crosslinks are a 
good substrate for in vitro NER assays suggesting that direct XPC recognition may 
predominate.  
 
In principle, the effectiveness of NER in preventing mutation by sunlight might be 
compromised if skin cells sustain DNA damage that competes at the initiating 
recognition step. UVA irradiation of cells containing DNA 6-TG leads to the formation 
of bulky sulfinate and sulfonate lesions (Figure 5. 1) that impede replicative 
polymerases but can be bypassed by lower fidelity translesion polymerases. The 
biological consequences of this type of DNA damage are unclear.  
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Figure 5.1 6-Thioguanine and its oxidation products 
UVA irradiation of DNA-6-TG leads to the formation of the 6-TG photoproducts, guanine 
sulfinate (GSO2) and sulfonate (GSO3). 
 
These lesions appear not to be processed by TC-NER as CSB mutant cells are no more 
sensitive to 6-TG than their repair proficient counterparts(Brem et al. 2009). This is also 
true of XPG mutants but cells lacking XPF or polymerases Polη, Polι, and Polζ are all 
sensitive to 6-TG/UVA presumably reflecting the role of translesion synthesis in 
processing 6-TG-mediated ICLs or other lesions(Brem et al. 2011). GSO2 and GSO3 do 
not appear to be good substrates for removal by NER and the levels of these lesions 
decrease at similar rates in NER proficient and deficient (XPA) cells (around 60% 
remained after 24 hours)(Li 2010). UVA activation of some FQs induces T<>T CPDs 
by a triplet energy transfer mechanism, which could increase the burden on the NER 
system.  The ability of vemurafenib to cause DNA damage has not been investigated.  
 
To examine whether these photosensitising treatments might compromise lesion 
recognition, I first assessed their ability to provoke a DDB2 response. 
 
5.2 Results 
5.2.1 UVC and DDB2 
The effects of UVC on DDB2 have been widely studied(Rapić-Otrin et al. 2002). 
Figure 5-2 (top) shows that DDB2 is detectable by western blotting of low-salt extracts 
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of CEM cells and that following UVC treatment it is no longer extractable under low 
salt conditions. This is in accordance with previously published data that indicate a 
damage-dependent DDB2 relocalisation to chromatin, and a requirement for high salt 
extraction for its removal(Otrin et al. 1997). DDB2 levels remained low for 1-2h but 
recovered within 3 hours. During this period, DDB1 levels remain unchanged and are 
included as a loading control. Although p53 status is known to affect DDB2 expression 
levels(Hwang et al. 1999) and CEM is a p53-negative cell line, this is only likely to 
become important at time points later than 24h(Rapić-Otrin et al. 2002) and it appears, 
at least at early time points, CEM cells have a the normal DDB2 response to UVC. 
Figure 5-2 (bottom) shows loss of extractable DDB2 can be induced at doses of UVC as 
low as 1-5 J/m2. High doses of UVA are needed (200kJ/m2) to see even partial loss of 
DDB2 from extracts, in keeping with the relative DNA damaging abilities of these 
wavelengths. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Effects of UVC and UVA on DDD2 on CEM cells 
Top: CEM cell extracts prepared at the indicated time after UVC (20 J/m2) irradiation were 
analysed by western blot with DDB2 and DDB1 primary antibodies.  
Bottom: Extracts prepared immediately after the indicated dose of UVA or UVC were analysed 
by western blot. 
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5.2.2 DDB2 relocalisation induced by photosensitisers 
Figure 5-3 shows a western blot analysis of the effects of 6-TG, ciprofloxacin and 
vemurafenib treatment with and without UVA irradiation. In the absence of UVA, none 
of the drug treatments affected the levels of extractable DDB2. After irradiation with 
UVA, DDB2 is not recovered in extracts from cells treated with 6-TG or ciprofloxacin 
whereas vemurafenib had no discernable effect. The 6-TG dose was titrated to 
determine the minimum needed to induce DDB2 relocalisation (Figure 5-4). The 
minimum dose required to yield a visible effect lies between 0.03 µM and 0.1 µM in 
growth medium concentration. Thus, the loss of extractable DDB2 one of the most 
sensitive indicators of 6-TG photosensitisation found to date.  
 
The kinetics of DDB2 relocalisation after 6-TG/UVA were also examined. Figure 5-5 
confirms that DDB2 in 6-TG treated cells becomes resistant to low salt buffer extraction 
immediately after UVA irradiation. No recovery of extractable DDB2 was apparent 
during subsequent 3 h incubation in full growth medium. Including the recombinant 
endonuclease Benzonase in the extraction buffer leads to partial recovery of DDB2. 
Since Benzonase degrades chromatin DNA and releases bound proteins, this 
observation confirms that the treatment induces tight binding of DDB2 to DNA. 
 
 
5.2.3 DNA Damage 
Some FQs are known to induce T<>T CPDs by a Type I UVA photosensitised reaction. 
This provides a possible explanation for the ability of ciprofloxacin/UVA to induce 
DDB2 relocalisation although there appear to be no reported data for CPD induction by 
ciprofloxacin. Ofloxacin is reported not to photosensitise this type of DNA 
damage(Cuquerella et al. 2011). Whether 6-TG/UVA induces these lesions is not 
known.  
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Figure 5.3 Effect of photosensitisers on DDB2 
Extracts prepared from UVA (20kJ/m2) irradiated drug-treated CEM cells (24h 6-TG and 
vemurafenib/1h ciprofloxacin) were analysed by western blotting.  
 
 
 
 
 
 
Figure 5.4 Effects of 6-TG dose on DDB2 relocalisation  
Extracts prepared from UVC (20J/m2) irradiated or UVA (20 kJ/m2) irradiated 6-TG-treated 
(24h) CEM cells were analysed by western blotting.  
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Figure 5.5 Kinetics of DDB2 localisation induced by 6-TG 
Cells were treated with 6-TG (0.6µM/24h) and UVA (20kJ/m2) and extracts were prepared at 
the times indicated. Cells were harvested and divided into two fractions that were extracted in 
the presence or absence of Benzonase (>2.5 U/µL). 
 
 
CPD and (6-4)PP induction was therefore examined by ELISA. Figure 5-6 (top) shows 
that ciprofloxacin/UVA is a significant source of CPDs in UVA-irradiated CEM cells. 
CPD induction was dose-dependent over the concentration range examined and levels 
were approximately equivalent to UVC doses of 5-20 J/m2. The same assay showed that 
UVA alone induces barely detectable CPDs at the doses relevant to these experiments 
whilst CPDs were undetectable following 6-TG/UVA treatment. UVC induced the 
expected dose dependent increase in (6-4)PPs (Figure 5-6, bottom). Treatment with 
ciprofloxacin/UVA, 6-TG/UVA or UVA alone did not yield detectable (6-4)PPs.  
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Figure 5.6 CPD and (6-4)PP ELISA absorbance after UVC, UVA, 6-TG and ciprofloxacin 
treatment. 
Top: CPD  and  Bottom: (6-4)PP  ELISAs were performed on genomic DNA from CEM cells 
treated with UVC, UVA, 6-TG/UVA, or Ciprofloxacin/UVA as indicated. 
 
The ELISA data place ciprofloxacin in the group of FQs that photosensitise T<>T CPD 
formation by UVA. To establish whether this photochemical DNA damage is 
responsible for DDB2 relocalisation, I compared CPD induction and DDB2 
relocalisation in the same cells treated with ciprofloxacin/UVA or ofloxacin/UVA. As 
positive controls I included the fluoroquinolones lomefloxacin and norfloxacin as both 
are reported to induce CPDs with UVA (Cuquerella et al. 2011). Figure 5.7 (top) shows 
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that ciprofloxacin, norfloxacin and lomefloxacin all induced DDB2 relocalisation when 
combined with UVA radiation. In contrast, ofloxacin had a barely detectable effect on 
the yield of extractable DDB2. ELISA (Figure 5.7, bottom) confirmed that 
ciprofloxacin, norfloxacin and lomefloxacin induce significant levels of CPDs in 
cellular DNA whereas ofloxacin is much less effective in this regard. I conclude that 
relocalisation of DDB2 by UVA activated FQs reflects their ability to induce CPDs, 
which may lead to direct competition for NER recognition with UVB-induced DNA 
lesions. Importantly, 6-TG/UVA does not generate CPDs (or (6-4)PPs) main lesions 
recognised by DDB2. This treatment does, however, cause DDB2 relocalisation. I 
therefore examined possible binding of DDB2 to DNA 6-TG photoproducts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 Comparison of CPD induction with DDB2 extractability for FQs 
CEM cells were treated with FQs for 1h at the doses indicated and then irradiated with 
UVA (20 kJ/m2). Cells were split into two fractions. From one half, DNA was extracted 
and a CPD ELISA was performed (top). The other half was extracted and Western blot 
analysis for DDB2 was performed. 
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5.2.4 DDB2 binding 6-TG photoproducts 
I used two approaches to investigate possible DDB2 binding to DNA 6-TG 
photoproducts. In the first, genomic DNA from untreated and 6-TG/UA treated cells 
was immobilised on a nylon membrane and used as a bait for DDB2 binding. Following 
blocking and extensive washing, membranes were exposed to cell extracts. After further 
washing, membranes were probed with anti-DDB2 antibody. DNA binding was 
checked Sybr Green staining. Figure 5.8 (top) shows a comparison of binding to DNA 
from untreated and from 6-TG/UVA treated cells. At 1µg DNA, a DDB2 signal is seen 
for both untreated and treated samples, consistent with the known high DDB2 affinity 
for DNA even in the absence of damage(Wittschieben et al. 2005). At 100ng DNA from 
6-TG/UVA cells recruits more DDB2 than undamaged DNA. Figure 5.8 (bottom) 
reveals that differential DDB2 binding could also be observed to DNA from 
UVC-treated and ciprofloxacin/UVA- treated cells.  Since the extracts used were from 
naïve cells that had not been exposed to damaging treatment, DNA lesion recognition is 
a more likely explanation for these findings than, for example, an oxidative activating 
DDB2 modification. 
 
In a second approach, I used EMSA analysis to explore the possible identity of lesions 
provoking DDB2 recruitment. A 30mer oligonucleotide containing a single 6-TG and 
its non 6-TG-containing counterpart were end-labelled and either UVC (25kJ/m2) or 
UVA (20kJ/m2) irradiated. After annealing to a complementary oligonucleotide, the 
duplex probes were incubated with a CEM cell extract. Figure 5.9 (top) shows that the 
reaction conditions (originally developed to investigate DDB2 binding(Wittschieben et 
al. 2005)) reveal binding by CEM cell extracts that produces a shift in migration of the 
UVC-irradiated probe. A retarded complex with similar migration was apparent with 
the UVA-irradiated 6-TG containing duplex. No binding was observed in the absence of 
irradiation or to the non-6-TG probe irradiated with UVA. 
 
In the experiment shown in the lower panel of Figure 5.9, a third probe is included in 
which the 6-TG was stoichiometrically converted to GSO3 by treatment with the mild 
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oxidising agent, magnesium monoperoxyphthalate (MMPP). Binding was more 
pronounced than to the same oligonucleotide irradiated with UVA. Since UVA 
irradiation generates a mixture of 6-TG photoproducts and not exclusively GSO3, this 
observation suggests that GSO3 is a likely target for DDB2 binding. Inclusion of a 25-
fold excess of unlabelled UVC competitor in the binding assay abolished the low level 
binding to the UVA-irradiated 6-TG duplex. This concentration of competitor 
oligonucleotide had little impact on the more extensive binding to the MMPP-treated 
substrate. It also had only a minor effect on the UVC-irradiated complex, however. 
 
Taken together, the filter binding and EMSA experiments indicate that a damaged-DNA 
binding protein, most likely DDB2, recognises and binds to DNA 6-TG photoproducts. 
This case is further strengthened by the observation that chemical oxidation of the DNA 
6-TG with MMPP, which does not react with canonical bases and has previously been 
used to quantitatively generate GSO3(X. Zhang et al. 2007) increases binding. This 
indicates that the GSO3 photoproduct is a good substrate for DDB2 binding and for 
possible irreversible sequestration in cells treated with 6-TG and UVA.  
 
In summary, although these observations should be regarded as preliminary, they are 
consistent with sequestration of DDB2 by non-productive binding to 6-TG 
photoproducts, most likely GSO3, that are not NER substrates. 
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Figure 5.8 Binding of DDB2 by membrane bound genomic DNA 
Top: Genomic DNA from untreated cells and cells treated with 0.6µM 6-TG/ 24 h and UVA 
(20kJ/m2) was slot blotted onto a nylon membrane. The membrane was exposed to a whole cell 
extract in 1% Triton X-100-HEPES buffer (Materials and Methods). After blocking and 
washing, membrane strips were probed with anti-DDB2. DNA loading was checked by Sybr 
Green staining (lower panel). Bottom: The procedure was carried out as above with the 
inclusion of DNA from UVC (100J/m2) and ciprofloxacin/UVA treated cells (500µM/1h) at a 
fixed DNA loading of 250 ng. 
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Figure 5.9 EMSA for irradiated 6-TG containing oligonucleotide 
Top: 32P end-labelled 30 mer single stranded oligonucleotides with or without 6-TG were 
irradiated with UVC (25kJ/m2) or UVA (20kJ/m2) and annealed to a complementary strand. The 
radiolabelled double stranded probe was incubated with CEM cell extract for 30 mins at room 
temperature in the presence of 1µg poly(dA:dT). Bottom: As above with a third probe: a 6-TG 
oligonucleotide oxidised chemically with 10 fold-molar excess of MMPP. A 25-fold excess of 
non-radioactive competitor oligonucleotide that was irradiated with UVC where indicated was 
included. Buffers and conditions can be found in Materials and Methods. 
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5.3 Discussion 
5.3.1 The effect of photosensitisation on DDB2 localisation 
Despite more than two decades of study, a full understanding of the role played by 
DDB2 in NER remains elusive. It was initially linked to NER by the inability of XP-E 
cell extracts to delay the migration of UVC-damaged DNA in EMSA assays(Chu & E. 
Chang 1988). There exists a broadly accepted consensus that upon UV-DDB binding, a 
lesion is rendered more attractive to XPC due to amplified helical distortion. 
Concurrently the ubiquitin ligase activity of DDB1-CUL4-RBX1 is stimulated leading 
to ubiquitination of DDB2, XPC and nearby histones, serving to target DDB2 for 
degradation, increase XPC’s affinity for DNA and relax the local chromatin structure, 
respectively. The recruitment of a number of other chromatin remodelling factors has 
been also reported(Marteijn et al. 2014). There are some seemingly dissenting reports 
that complicate the picture including a 2 minute DNA retention time for DDB2 as 
judged by FRAP and the fact that its dissociation from DNA is independent of 
XPC(Luijsterburg et al. 2007; Alekseev et al. 2008), which both speak against a 
handover mechanism. There is also the puzzling issue of DDB2 being degraded before 
CPD repair is complete and at a time when it is presumably most needed. An alternative 
mechanism has been proposed wherein a transient DNA-independent association 
between DDB2 and XPC allows the former to target the latter to damage although this 
does not appear to have gained widespread acceptance(Fei et al. 2011). I have 
interpreted my observations in the context of the majority opinion that the primary 
function of DDB2 is to bind UV photoproducts and facilitate their recognition by XPC. 
 
UVC irradiation of CEM induces loss of extractable DDB2 in agreement with 
previously published data(Rapić-Otrin et al. 2002; Fitch, Cross, et al. 2003a) and 
consistent with its recruitment to chromatin. Levels of extractable DDB2 could be 
affected by numerous factors including the cell type used, the UVR dose and the 
composition of the extraction buffer(Rapić-Otrin et al. 2002). DDB2 is targeted for 
degradation immediately following UVC irradiation (half-life ~2 hours (Luijsterburg et 
al. 2007)) and its expression is induced by p53 around 24 hours after irradiation(Rapić-
Otrin et al. 2002). The near-quantitative recruitment of DDB2 to DNA is compatible 
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with the expected number of lesions. A UVC dose of 20 J/m2 is estimated to induce 
around 2.6 x 106 CPDs and 6.4 x 105 (6-4)PPs(Perdiz et al. 2000), which far exceeds the 
number of DDB2 molecules in a cell, which is estimated to be ~1 x 105 (Beck et al. 
2011; Keeney et al. 1993).  
 
The return of extractable DDB2 seen 3 hours after UVC treatment in my experiments is 
somewhat surprising considering it should be earmarked for degradation. Fitch et al 
reported return of extractable DDB2 at 4 hours in human fibroblasts whilst Rapic-Otrin 
reported absence of extractable DDB2 until 18 hours after irradiation in monkey TC-7 
cells. The UV dose was equal in both cases (10 J/m2) thus an explanation may lie in the 
extraction conditions used. The former study used an SDS-containing lysis buffer whilst 
the latter used a high salt (0.5 M NaCl) in combination with freeze-thaw; the RIPA 
buffer used in my experiments more closely resembles the extraction conditions of Fitch 
et al. Curiously, Rapic-Ortin et al previously used the same extraction technique to 
show a recovery of lost UV-DDB binding activity in extracts 3-6 hours after 
irradiation(Otrin et al. 1997), which seems entirely contradictory to their later paper. 
Another explanation could be the expression of high levels of proteasomal subunits in 
CEM cells(Kumatori et al. 1990) which may accelerate the cycle of degradation and 
expression. 
 
The effect of photosensitisers on DDB2 does not appear to have been considered before 
aside from one report of which found that psoralen-UVA-induced crosslinks are not 
recognised by DDB2 and XP-E cells are not sensitive to psoralen/UVA(Muniandy et al. 
2009). The results for vemurafenib and FQs are in keeping with my findings in Chapter 
4 and previous reports. FQs induce CPDs through type I photosensitisation provided the 
energy of the excited triplet state is sufficiently high(Cuquerella et al. 2011). Although 
not previously reported for ciprofloxacin, the significant induction of CPDs is 
compatible with its ranking as a more potent photosensitiser than ofloxacin, which does 
not induce CPDs to any significant degree. That ofloxacin/UVA treatment does not 
result in significant DDB2 recruitment suggests that the effects of ciprofloxacin are 
related to CPD induction rather than to the effects of 1O2. Although little is known of 
the effects of vemurafenib on DNA, its highly lipophilic nature suggests it will mainly 
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localise to membranes and organelles, perhaps reducing its ability to affect DNA(Benov 
et al. 2010). Photosensitised CPD induction, whilst by no means exclusive to FQs, is not 
a feature of the majority of photosensitisers and thus it is unlikely that vemurafenib 
would possess this attribute.  
 
The recruitment of DDB2 after 6-TG treatment was unexpected; DDB2 had recently 
been reported to dimerise upon DNA binding(Yeh et al. 2012) so dimer crosslinking 
was the expected outcome. Binding is rapid and seems qualitatively different to the 
UVC-induced binding in that DDB2 does not return to an extractable form after 3 hours. 
This could reflect higher levels of damage or lesions that are slower, or indeed, 
impossible to repair. 6-TG had never been noted as an inducer of CPDs, and this was 
confirmed by ELISA (Figure 5-6). This suggested that the recruitment was either 
caused by recognition of 6-TG photoproducts or via some cellular process resulting 
from 6-TG photosensitisation (for example, post translational modification of DDB2).  
 
5.3.2 DDB2 binding 6-TG photoproducts  
The ability of membrane immobilised genomic DNA from 6-TG/UVA treated cells to 
recruit DDB2 from untreated cells more efficiently than DNA from untreated cells 
supports a DNA lesion-binding interpretation. This is a somewhat insensitive technique. 
Nevertheless, DDB2 recruitment by DNA from UVC and ciprofloxacin treated cells 
provides some validation.  
 
Data from the EMSA assays are also consistent with recognition of a UVA/6-TG 
induced photoproduct. Binding can be competed by an excess of UVC damaged DNA 
in an assay designed to reveal DDB2 binding to photoproducts. The substrate for 
binding was generated by irradiation of a single stranded oligonucleotide containing 6-
TG. This was then annealed to a complementary strand. This procedure obviates any 
complications from protein crosslinks or ICLSs. Under the conditions of my assay, 
DDB2-mediated binding generates the major band for EMSA of UVC-damaged 
DNA(Chu & E. Chang 1988). GSO3 is a minor product after UVA irradiation(Ren et al. 
2010) but the exclusive product of MMPP oxidation under the conditions I used. The 
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much larger shift seen after MMPP treatment is consistent with the recognised lesion 
being GSO3. The relative effectiveness of UVC-irradiated DNA as a competitor for 
UVA- and MMPP-treated 6-TG oligonucleotides is also compatible with this 
interpretation. Performing the assay with XP-E cell extracts would provide a definitive 
answer. 
 
The effect of 6-TG-mediated DDB2 recruitment in cells, if any, will be determined by a 
variety of factors. Firstly, GSO3 is not currently considered an NER substrate therefore 
stable recruitment without processing could result in persistent depletion of UV-DDB. 
The classification of GSO3 as NER intractable is based on the insensitivity of CSB, XP-
G and XP-A cells to 6-TG/UVA treatment(Brem et al. 2011; Li 2010). In view of the 
near complete abolition of NER after 6-TG/UVA treatment, the NER status of a cell 
line may be unimportant in determining 6-TG/UVA toxicity. A GSO3 containing 
substrate for the in vitro NER assay could resolve the matter.  
The total number of DNA GSO3 relative to the number of UV-DDB molecules will 
determine the extent of depletion. GSO3 is the minor product of 6-TG oxidation upon 
irradiation by UVA and accounts for around 10% of total 6-TG at the dose of 20kJ/m2 
used in my experiments(Ren et al. 2010). Substitution of guanine is normally between 
0.1-1% depending on dosage and guanine constitutes 20% of the genome. Therefore, 
taking the number of bases in a diploid human cell as 6 x 109, the substitution of 
guanine as 0.1% and the UVA dose of 20kJ/m2, the predicted number of GSO3 per cell is 
around 1.2 x 105 (6 x 109 x 0.2 x 0.001 x 0.1). This is around equal to the total number 
of DDB2 molecules thus accounting for the total loss extractable DDB2 observed after 
6-TG/UVA treatment and suggesting that depletion could be highly relevant. Finally, 
the ratio of photoproducts to GSO3 could influence the extent to which competition 
occurs. As stated above, in cultured cells, a UVC dose of 20 J/m2 is estimated to induce 
around 2.6 x 106 CPDs and 6.4 x 105 (6-4)PPs suggesting UV-DDB is quickly 
exhausted and that NER proceeds via XPC until increased DDB2 expression begins 
around 6 hours after irradiation(Fitch, Cross, et al. 2003a). In human skin, CPD levels 
will be influenced by skin type and sun exposure; Mouret et al found that one MED of 
either UVA or UVB induced around an average 30 CPD per 106 bases in patient skin or 
3 x 104 per cell(S. E. P. Mouret et al. 2011b). At the 6-TG substitution level of 0.02% 
Chapter 5 Possible sequestration of an NER factor by 6-TG/UVA photoproducts 
 
 170 
seen in patients, the predicted GSO3 per cell is 2.4 x 104 (exchanging 0.0002 for 0.001 in 
the above calculation) so levels are certainly comparable. 
 
As judged by microinjection of UV-DDB into XP-E cells, CPD repair can function with 
around 10% of total DDB2(Keeney et al. 1994). This may mean that sequestration of 
UV-DDB by GSO3 is insignificant although the stage at which NER is abandoned or 
blocked is unknown and therefore more limiting factors such as XPC may also be 
sequestered. There is a precedent for sequestration of NER factors leading to a repair 
defect. Recently, sequestration of RPA at stalled replication forks was shown to reduce 
NER capacity(Tsaalbi-Shtylik et al. 2014). As 6-TG/UVA treatment also causes 
replication blockage, RPA sequestration as a possible contributor to NER inhibition is 
currently under investigation in the lab. Cells from patients with the Hutchinson-Gilford 
progeria syndrome exhibit accumulation of mutated lamin proteins, which specifically 
sequester XPA resulting in an NER defect(Musich & Y. Zou 2009).  
 
Increasing cellular DDB2 levels offers protection from UVB induced-carcinogenesis in 
mice. This is seen after knockout of Cul4A (which prevents polyubiquitination leading 
to accumulation) (L. Liu et al. 2009) or overexpression via transfection with a ectopic 
construct(Alekseev 2005) both of which restore CPD repair in mice and delay the onset 
of UVB-induced tumours. If the converse is true, and loss of a significant fraction of 
free DDB2 effectively induces a transient XP-E-like state then this may exert further 
genomic stress on cells that are already subject to protein oxidation and DNA damage. 
 
5.4 Summary 
6-TG/UVA treatment results in the recruitment of DDB2 to DNA in a manner 
reminiscent of the UVC DNA damage response. Ciprofloxacin gives a similar response 
likely due to its ability to induce CPDs via type I photosensitisation. 6-TG treatment 
results in neither CPDs nor (6-4)PPs thus its recruitment is mediated by a different 
lesion. 6-TG containing probes irradiated with UVA or oxidised chemically are gel 
shifted by incubation with extracts and the binding of 6-TG/UVA can be reduced by 
inclusion of a UVC irradiated cold competitor. This suggests that the 6-TG/UVA and 
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UVC damage are bound by the same factor, which is likely UV-DDB, via the DDB2 
subunit. 
 
The data presented in this chapter are very preliminary and hence the above 
interpretation requires extensive validation under different conditions and in different 
cell lines before any firm conclusions can be drawn. If my conclusions are substantiated, 
this may represent yet another facet of 6-TG’s, and by extension azathioprine’s, 
carcinogenic potential. 
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Chapter 6. Discussion 
The results presented in this thesis span two established areas of research, protein 
oxidation and DNA repair, that have overlapped surprisingly little to date. Although 
protein oxidation is by no means a nascent field (initial characterisation of amino acid 
oxidation products was performed at the turn of the 20th century(Dakin 1906)), 
consideration of its biological effects awaited the development, in the 1990’s, of reliable 
techniques to detect oxidised proteins in biological samples(Hensley & Floyd 2002). 
Because genetic information has to be faithfully transferred to the next generation, 
DNA has historically been considered the most important target for damage by cellular 
RS. In contrast, the ease of replacement of damaged proteins suggests that oxidative 
stress presents less of a hazard to the proteome. In this final discussion, I aim to address 
differences in photosensitisation, why certain proteins are susceptible to photosensitised 
damage, the putative link between protein oxidation and carcinogenesis and the 
applicability of these findings to patients, especially with regards to therapy-related 
cancer in immunosuppressed individuals. 
 
The data presented in Chapter 4 indicate that different photosensitisers can have 
dramatically different effects on protein oxidation. This is most strikingly illustrated by 
the properties of vemurafenib. Vemurafenib/UVA induced little or no crosslinking of 
PCNA or Ku. It did not effect photobleaching of RNO in vitro. Vemurafenib 
phototoxicity was associated with little RS detectable by CM-H2DCFDA. These 
observations all indicate that vemurafenib has low type II photosensitising capability 
and that toxicity occurs by a type I mechanism. Of the photosensitizers I examined, 
vemurafenib is the most lipophilic and most likely localises to cell membranes or 
mitochondria(Castano et al. 2004). The phototoxic effects of vemurafenib might 
therefore be mediated through lipid peroxidation or release of pro-apoptotic factors 
following mitochondrial damage. More information regarding the photosensitisation 
mechanism of vemurafenib may allow co-administration with a compatible antioxidant 
to attenuate its adverse effects as has been achieved for doxorubicin(Deres et al. 2005) 
and chemo- and radiotherapy used to treat acute lymphoblastic leukaemia in 
children(Al-Tonbary et al. 2009).   
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One of the questions I wanted to address at the inception of this study was the extent to 
which 6-TG was a typical photosensitiser. In particular, the extent to which its 
photosensitisation by 6-TG requires its incorporation into DNA. Surprisingly, the FQs, 
which are not incorporated into DNA, replicated many of the properties of DNA 6-TG 
including damage to DNA repair proteins and inhibition of DNA repair. These effects 
most likely reflect type II photosensitization. DNA 6-TG is a mixed type I and type II 
photosensitizer and my findings show that compared to the FQs, its phototoxicity is 
associated with relatively low levels of RS. The particular effectiveness of DNA 6-TG 
as a type II photosensitizer may reflect its ability to serve as both a source and as a 
target of RS to generate potentially lethal DNA lesions. In addition, type I sensitisation 
of DNA 6-TG will promote the formation of additional lethal lesions in the form of 
ICLs and DNA-protein crosslinks. 
Through the combined action of type I and II photosensitisation, UVA-induced DNA 
lesions will form in the immediate vicinity of DNA-6-TG. As DNA 6-TG continues to 
produce 1O2, repair proteins that arrive to repair these lesions are in danger of 
inactivation by oxidation. This would confer a self-selecting component to DNA repair 
protein inactivation. If a suitable identification method can be developed, it would be 
interesting to examine the cross section of oxidised proteins from 6-TG/UVA vs. 
FQs/UVA to see if the former damages a higher proportion of DNA replication/repair 
proteins. 
 
6-TG/UVA treatment abrogates the cell’s ability to repair DSBs in G1 phase and to 
remove (6-4)PPs and 8-oxoG(Gueranger et al. 2014). These observations are 
complemented by in vitro assays for NHEJ, NER and BER that reveal defects in the 
functions of Ku, RPA and OGG-1 respectively. By contrast, the removal of DNA-uracil 
by cells and the in vitro activity of the UNG DNA glycosylase are not detectably 
changed by supra-lethal treatment with 6-TG/UVA.  The structures of the UNG and 
OGG-1 DNA glycosylases provide a tentative explanation for the greater sensitivity of 
OGG-1 to oxidizing conditions (Figure 6.1). OGG-1 can be inactivated by thiol 
oxidising treatments in vitro and activity is restored by treatment with reducing 
agents(Bravard et al. 2006). It has an active site cysteine that is constitutively 
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deprotonated(Banerjee et al. 2005) and assists in the stabilisation of 8-oxoG binding in 
the active site(Bruner et al. 2000)(highlighted in red, Figure 6.1, left).  
 
Figure 6.1 Structures of OGG1 and UNG with highlighted cysteines 
3D models of OGG-1 and UNG2 binding to DNA. Cysteines are shown in space-filling mode. 
Active site thiolate Cys253 in OGG-1 is highlighted in red. OGG-1 structural data from Bruner 
et al (Bruner et al. 2000), UNG2 structural data from Parker et al(Parker et al. 2007). Image 
rendered using CCP4mg (McNicholas et al. 2011). 
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Molecular modelling suggests that replacing the active site cysteine with a bulky 
residue would dramatically decrease catalytic activity(Lukina et al. 2013). Similarly, 
formation of an additional disulphide or sulphur oxyacid would probably also have an 
adverse effect on active site conformation. By contrast, no redox sensitivity has been 
reported for UNG. The enzyme has only three cysteines, none of which are in or 
proximate to the active site; uracil binding is stabilised by stacking with a conserved 
phenylalanine(Krokan et al. 1997).  
 
Ku(Bennett et al. 2009) and RPA(Men et al. 2007) are also susceptible to thiol 
oxidation-dependent inactivation in vitro. It may not be coincidental that the proteins I 
identified as susceptible to photosensitised inactivation exhibit thiol redox modulation. 
Optimising a more tractable system for identifying proteins with susceptible thiols may 
be a productive direction in which to continue this investigation; exploiting the 
biotinylated sulfenic acid probe would be a good starting point(Leonard et al. 2009). 
  
Based on my experience, I suspect that carbonylation, whilst a good measure of general 
oxidation, may not be the optimal tool for addressing the fates of susceptible proteins. 
That is to say, by the time protein carbonylation becomes detectable, thiol modification 
may already be extensive. In addition to the aforementioned proteins, other DNA repair 
factors including MGMT(Laval & Wink 1994) and XRCC3(Girard et al. 2013) are also 
inactivated by thiol oxidation. XPA, TFIIH and Ligase III all contain a zinc finger 
domain, and XPD has a Fe-S cluster, suggesting that other NER factors may also be 
susceptible to inactivation. Quite why this functional vulnerability has evolved is 
unclear as it would appear antithetical to an efficient DNA damage response. 
 
The idea that oxidation of repair factors may lead to increased fixation of mutations has 
been considered previously. Inflammatory cytokine treatment of adenocarcinoma cells 
induces nitric oxide synthase activity, leading to inactivation of OGG-1 and has been 
proposed as a link between inflammation and cancer(Jaiswal et al. 2000). Barry 
Halliwell, a leading figure in the biology of RS, downplayed the concept in a 2007 
review on the basis that most cancers retain repair capabilities(Halliwell 2007). An 
impact on mutagenesis and carcinogenesis does not require that repair is completely or 
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permanently inactivated, however. Transient abrogation or a chronic slight reduction in 
DNA repair capacity may, over many years also contribute to cancer risk. Consistent 
with this possibility, DNA repair capacity can be modulated by polymorphisms of 
repair genes(Spitz et al. 2001) and these variants may be associated with a higher risk of 
NMSC(Vogel et al. 2001).  
 
A link between protein oxidation and repair capacity has been established by the work 
from the laboratories of Radman and of Daly (for review see Slade and Radman(Slade 
& Radman 2011) and Daly (Daly 2009). In several publications, (Daly et al. 2010; Daly 
et al. 2007; Krisko & Radman 2010), these authors demonstrated a connection between 
the extraordinary radiation resistance of extremophiles and efficient non-enzymatic 
antioxidant protection of the proteome (Krisko & Radman 2010). More recently, they 
showed that increasing the susceptibility of cellular proteins to endogenous RS results 
in diminished repair capacity and a concomitant mutator phenotype(Krisko & Radman 
2013). These results support a role for protein oxidation in promoting genomic 
instability. Although these investigations were largely confined to bacteria, enhanced 
protein protection extends to other organisms(Krisko et al. 2012) and appears to be an 
adaptation to desiccation –a process that is known to be associated with the wholesale 
production of RS(Fredrickson et al. 2008). Since the chemistry of RS and proteins is 
independent of the organism, the concept warrants further study with regards to human 
carcinogenesis.  
 
My experiments for the first time demonstrate that protein oxidation is widespread in 
cultured cells treated with 6-TG and UVA. My findings, together with those of my 
laboratory colleagues, indicate that this oxidation decreases DNA repair capacity. Can 
these findings be extrapolated to patients taking the immunosuppressant azathioprine? 
Azathioprine treatment is associated with a huge increased skin cancer risk. Analysis of 
mutations from azathioprine-associated skin tumours does not provide evidence for a 
novel mutational mechanism (McGregor et al. 1997; Harwood et al. 2008). Instead, as 
in sporadic skin tumours, the majority of mutations are UVB signatures - consistent 
with less than optimal NER of sunlight-induced DNA lesions. The important parameters 
for 6-TG photosensitization are the level of DNA substitution and the incident UVA 
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dose. The steady state 6-TG substitution in patients’ skin is around 0.02% of DNA 
guanine(O'Donovan et al. 2005). My experiments were designed to amplify any 
phototoxic effects that might occur in patients’ skin and I estimate that they represent 
levels of DNA substitution around 10-fold higher than the clinical situation. The UVA 
doses used were mild and within reasonable exposure levels (equivalent to around 20-
30 minutes of midday sun in British summer time). These combinations were sufficient 
to completely inhibit UVC photoproduct removal by NER. Two caveats should be 
added, however. The O2 concentration in cultured cells is likely to be significantly 
higher than in skin. In addition, cultured cells lack the protective effect of the stratum 
corneum. Thus, the levels of RS generated in patient skin will inevitably be less than in 
my experiments. On the other hand, the high, localised RS concentrations associated 
with photosensitisation may hinder effective detoxification by antioxidants. Overall, 
although complete NER inhibition by photosensitised DNA 6-TG in patients’ skin is 
unlikely, significant attenuation remains a possibility. In PCNA and Ku crosslinking, 
and now loss of extractable DDB2, we have a number of sensitive measures that denote 
the effects of DNA 6-TG photosensitisation and 1O2 production. These may be 
exploited to provide an indication of the severity of 6-TG photosensitisation in samples 
taken from patients. If repair capacity is significantly compromised in sun exposed skin 
of patients taking azathioprine, topical application of molecules that counteract these 
effects (Yarosh et al. 2001) might increase protection against therapy-related cancer. 
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